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Abstract 
Skin integrity is essential for sustaining life and it is important to understand the 
processes involved in its maintenance and repair. There are several key stages 
involved in wound healing that rely on the complex communication through gap 
junctions and their connexins to ensure the resolution of the wound. Gap junctions 
are expressed in all cells linked with tissue repair and provide a regulated pathway 
linking the cytoplasm of neighbouring cells and allowing signals to pass freely 
between the two. In the skin there are three key connexins (Connexins 26, 30 and 
43) that undergo dynamic changes and regulate the stages of wound closure. To 
date, extensive research has shown that inhibiting Cx43 expression can achieve 
significant improvements in wound repair. Synthetic connexin mimetic peptide 
Gap27 which possess a conserved homology to the second extracellular loop of 
Cx43 is now being considered as a candidate to improve the rate of wound repair. 
At low concentrations Gap27 has been shown to block hemichannels but can target 
gap junctional intercellular communication at higher concentrations and for longer 
incubation periods. By using Gap27 as a tool, this thesis explores the importance of 
connexins, hemichannels and gap junctions in tissue injury and repair. I have 
dissected out the relative contributions of connexins and their involvement with 
hemichannels and gap junctions in wound repair while investigating if and how 
Gap27 reduces other connexins. Further work using in vitro wound healing models 
has shown how Gap27 can enhance the rate of wound healing in early stages. In 
the second half of this thesis I continue to use Gap27 to investigate the connexin 
based communication involved in the spread of cell death and damage during 
ischemia reperfusion injury in vitro and in vivo. The potential therapeutic implications 
of the wound healing properties of Gap27 are exciting, novel and promising. 
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1. Introduction 
1.1 The skin 
The integuementary system is the largest organ in the body and functions as a 
defensive barrier between the body and the external world. The skin is the body’s 
first line of defence against an often hostile environment. This complex and highly 
specialised tissue is constantly abraded, attacked by microorganisms, irradiated by 
ultraviolet (UV) rays from the sun and exposed to environmental chemicals. At the 
same time, the skin carries out essential roles in support, nourishment, 
waterproofing and protection. Its long term integrity is essential for life and therefore 
a thorough understanding of the processes involved in its maintenance and repair is 
extremely important. 
The skin (figure 1.1) can roughly be divided into two main layers; the thin external 
keratinocyte epidermal layer (consisting of sheets of plate-like cells) and the internal 
fibroblast dermal layer (rich in fibrous and elastic tissue, blood vessels, nerve fibres 
and accessory structures such as hair follicles and sweat glands). The deepest layer 
of the dermis anchors the skin to the underlying tissue. The thickness of human skin 
varies depending on its location in the body. Thick skin can be found on the palms of 
hands and soles of feet (approximately 4 mm thick) in areas where it is adapted to 
activities such as gripping. As these areas are subject to more ‘wear and tear’ 
thicker skin does not have hair follicles. Most of the rest of human skin is thin and is 
full of appendages such as hair follicles and sweat glands. The thinnest skin, found 
on the eyelids is approximately 0.5 mm thick (Waller and Maibach, 2005). 
Chapter 1 Introduction 
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Figure 1.1 The skin 
 (A) Diagram illustrating the structure of the epidermis in human skin. The epidermis is the 
body’s first barrier against the external environment, preventing pathogens from entering and 
regulating water loss. The epidermis is divided into five distinct layers. (B) Diagram 
illustrating the structure of the dermis in human skin. The dermis lies beneath the epidermis 
via the basement membrane and consists primarily of connective tissue to provide support 
and structure to the skin. The dermis contains many accessory structures including hair 
follicles, sebaceous glands and sweat glands. The deepest layer of the skin anchors to the 
underlying tissue. Diagram adapted from Nature 445; 874-880 (MacNeil, 2007). 
1.1.1 The epidermis 
The epidermis is formed of squamous epithelium and arranged in continuous layers 
of proliferating basal and differentiated suprabasal keratinocyte cells. It comprises 
(from interior to exterior) the stratum basal, the stratum spinosum, the stratum 
granulosum, the stratum lucidum and the stratum corneum.  Being avascular, the 
epidermis relies on the diffusion of oxygen and nutrients from the blood vessels 
within the dermis in order to function.  Cells in the stratum basal lamina have the 
highest metabolic demand (where the diffusion distance is short) and as a result 
superficial, differentiated cells far away from the source of nutrients are inert or 
dead, eventually shedding from the skin surface. Cells in the basal layer are the 
stem cells of keratinocytes that undergo a specified differentiation process through 
the layers of the epidermis, resulting in the production of flattened anucleate cells at 
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the stratum corneum (Fuchs, 2008). This final outer layer serves as the principle 
barrier and is formed as a continuous layer of protein enriched cells. Capable of 
withstanding mechanical stress (Madison, 2003), the stratum corneum is 
surrounded by extracellular non-polar lipids forming a hydrophobic matrix. 
1.1.2 The dermis 
The dermis lies between the epidermis and the subcutaneous layers and comprises 
two distinct levels; the superficial papillary layer (made up of capillaries, lymphatic 
tissue and sensory neurons that supply and sustain the epidermis) and the reticular 
layer (an interwoven meshwork of dense connective tissue). Both levels differ in 
composition and organisation of their matrices. The papillary dermis contains thin, 
poorly organised collagen fibre bundles whereas in comparison the reticular dermis 
is characterized by thick, well organised fibre bundles (Cormack 1987). The 
connective tissue protein elastin provides skin resilience, allowing it to resume its 
shape after stretching or contracting. In contrast to the highly orientated collagen 
fibres, elastin fibres occur naturally in a contracted state (Sephel and Davidson, 
1986). Together these two levels of tissue provide support and elasticity to the skin. 
The fundamental cell of the dermal connective tissue is the fibroblast. Representing 
heterogeneous populations of cells dependent on their location within the dermis 
(papillary or reticular), the main function of the fibroblast is to provide structural 
integrity to the skin. The first in vitro evidence regarding the origin of the fibroblasts 
was discovered within bone marrow by Friendenstein and colleagues (Friedenstein 
et al., 1970, Luria et al., 1971).  After plating bone marrow cells in just medium and 
foetal bovine serum, they discovered colonies of fibroblasts growing. These cells 
adhered to culture dishes and were elongated and polygonal cytoplasms that are 
typical characteristics of fibroblast cells. More recent studies using green fluorescent 
protein as a marker of donor cells has further supported that bone marrow is a 
Chapter 1 Introduction 
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source of both fibroblasts and myofibroblasts (Mori et al., 2005). Bone marrow is 
known to contain two types of stem cells; haematopoietic stem cells (HSCs) and 
mesenchymal stem cells (MSCs), both of which could be the source of origin of 
fibroblast cells.  Using tissue reconstitution Ogawa and colleagues have found that 
fibroblasts and myofibroblasts in many organs are derived from HSCs (Ogawa et al., 
2006) whereas Pittenger and colleagues have demonstrated that that human MSCs 
isolated from bone marrow can differentiate in a controlled manner into 
mesenchymal tissue that includes bone, cartilage, muscle and skin fibroblasts 
(Pittenger et al., 1999). Mesenchymal tissue is known as undifferentiated loose 
connective tissue that is derived from the mesoderm lineage.  
In addition to structural properties for uninjured skin, fibroblast cells engage in 
paracrine and autocrine interactions during tissue injury (Gilchrest et al., 1983, 
Moulin, 1995). Fibroblasts are known to produce and releases chemokines that 
initiate the recruitment of bone marrow cells during tissue trauma (Smith et al., 
1997) and also produce and release interleukin 8 (IL-8) when stimulated with 
primary cytokines such as IL-1α and IL-1β to assist in neutrophil recruitment to the 
site of the wound (Schröder, 1995). 
However, fibroblasts are largely responsible for the synthesis and remodelling of 
extracellular matrix laid down in the dermis during wound repair. Elastin and 
collagen fibre precursors are produced and secreted by human skin fibroblasts, 
playing a key role in the repair process when the dermal layer has been torn, cut or 
punctured (Giro et al., 1985). The classical view in dermal wound healing indicates 
that fibroblasts are locally recruited from the dermis to aid in the formation of the 
granulation tissue to fill the gap and then aid in the contraction of the wound. During 
the resolution of wound healing, fibroblasts differentiate into myofibroblasts, a 
cytoplasmic stress fibre that express alpha smooth muscle actin (α-SMA). This key 
Chapter 1 Introduction 
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differentiation process, which will be explored in more detail below, represents a 
significant phase during wound healing and repair and it is the high contractile force 
generated by myofibroblasts that plays a considerable role in physiological tissue 
remodelling (Hinz, 2007). The long term preservation of skin is fundamental for 
sustaining life and therefore, as highlighted above, a detailed understanding of the 
processes involved in its maintenance and repair is imperative. 
1.2 Wound healing 
The skin can regenerate effectively, even after considerable damage has occurred, 
through an overlapping sequence of events during the wound healing process (refer 
to figure 1.2). In brief; through a combination of platelet aggregation, 
vasoconstriction and a release of pro-inflammatory signals, wound repair begins 
within moments of the initial injury. A robust inflammatory response occurs soon 
after; signalling the arrival of the immune response cells whose main role is to 
defend the host from invasion by microbes while clearing debris from the wound. 
The granulation layer is formed once fibroblast cells and collagen tissue have 
migrated over the matrix of the fibrin plug and keratinocyte cells have re-
epithelialised. The granulation tissue, along with the dense population of 
macrophages, help contract the wound and reduce its size by bringing the wound 
margins closer together. Collagen tissue continues to be synthesised (exceeding the 
rate of collagen degradation) as the wound remodels and a scar is formed. The final 
process of wound healing is the resolution of the scar, where collagen levels return 
to normal. This can take between 6-12 months to complete fully, depending on the 
size and depth of the initial wound (see figure 1.3). The wound healing process is 
explored in further detail below. 
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Figure 1.2 The stages of normal wound healing 
There are three classic stages of wound repair; the immediate inflammatory response (A), 
new tissue formation (B) and remodelling (C). The diagram shows how the repair of skin 
requires the co-ordination of several sequential, yet overlapping, stages during wound 
healing. The processes involved in closing the wound begin immediately after the body’s 
protective barrier has become damaged and ends through the resolution of the scar. 
Diagram adapted from Nature 453; 314-321 (Gurtner et al., 2008). 
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Figure 1.3 The phases of normal wound healing 
Normal wound healing is governed by a series of overlapping sequences of events. Phases 
of wound healing begin with the initial platelet response, which occurs within minutes after 
trauma, and end in the final remodelling of the scar tissue, that can happen up to a year 
later. Diagram adapted from Nature Reviews Cancer 6; 702-713 (Bentzen, 2006). 
1.2.1 Immediate response  
The immediate response of wound repair launches as a consequence of both 
mechanical and chemical signals that are released en masse from the wound site. 
Damaged or stressed cells respond by activating and releasing various stress 
signals that can include signalling via the p38 mitogen activated protein kinases 
(MAPK), p44/42 MAPK and stress activated protein kinase / Jun N-terminal kinase 
SAPK/JNK pathways (Kobayashi et al., 2003, Yano et al., 2004). Phosphorylation of 
this cascade of signalling molecules starts a complex series of concurrent events 
that aim to restore normality in the damaged tissue. Endogenous molecules, such 
as damage associated molecular pattern molecules (DAMPs), are also released to 
further activate other cells in the damaged tissue area.   
Damage extending through the epidermis into the dermis generally results in 
bleeding and therefore one of the earliest responses to injury is the stemming of 
blood loss from the damaged vessels through the formation of a clot. Normally 
isolated underlying collagen within the dermis is exposed to circulating platelets from 
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damaged blood vessels which bind together in the initial stages of clot formation. 
This binding is strengthened by von Willebrand factor (vWF). The coagulation 
cascade follows and is governed by the extrinsic pathway enabling a mass release 
of thrombin that converts fibronectin into fibrogen, the building block of a 
haemostatic plug. The blood clot serves as a temporary shield, protecting the 
exposed wound while providing a provisional matrix which cells can migrate to and 
through, and to which growth factors can bind. These growth factors include platelet 
derived growth factor, basic fibroblast growth factor (bFGF) and transforming growth 
factor beta (TGF- β). TGF- β is a protein that controls proliferation and differentiation 
and its signalling pathways are multi-potent in all stages of wound healing. Its roles 
are explored in detail below. 
1.2.2 Inflammatory response 
Within minutes of wounding, the inflammatory response begins with the rapid 
activation of resident immune cells (such as Langerhans and mast cells) in the 
wounded tissue and surrounding area (Springer, 1994). These cells release a 
torrent of cytokines and other inflammatory mediators (such as IL-1 and 6) that 
stimulate circulating leukocytes to actively leak from the blood vessels into the 
wound site in a process called extravasation. This process can be divided into four 
key stages; rolling, activation attachment and migration. In the first few moments of 
wound healing it is thought that vasodilatation occurs at the site of inflammation and 
this slows down and disturbs the blood flow, ultimately allowing neutrophil 
leukocytes to bump and roll along the endothelium. Surface receptors are activated 
on both neutrophils and the endothelium layer which catch rolling leukocytes in 
preparation to migrate through the vasculature wall. These leukocytes then migrate 
between endothelial cells in the blood vessel wall and are subsequently recruited to 
the site of wound damage (Hübner et al., 1996). TGF- β is also released at the site 
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of tissue damage and recruits neutrophils and monocytes in a positive feedback 
loop (Faler et al., 2006). These inflammatory cells are the body’s first active 
defensive mechanism against infectious disease and foreign material. Neutrophils 
are activated and recruited into the wound and have primary roles in killing invading 
microorganisms using bursts of reactive oxygen species (Dovi et al., 2004). 
Monocytes drawn from the circulation later than neutrophils mature into 
macrophages (Martinez et al., 2006), a phagocytic cell whose role is to clear up 
matrix and cell debris. Unless the wound is particularly infected, the level of 
leukocytes falls after a few days and spent neutrophils are also phagocytised by 
macrophages (Haslett, 1992). Both neutrophils and macrophages serve as major 
producers of cytokines, chemokines and growth factors, amplifying earlier wound 
signals released by activated platelets and directing further cell and tissue migration 
(Theilgaard-Mönch et al., 2004). 
1.2.3 Re-epithelialisation 
Keratinocyte cells achieve re-epithelialisation through crawling and migrating along 
the edges of the wound while cutting a path through the fibrin clot. This process is 
regulated by the growth factors released by the inflammatory cells at the wound site 
and surrounding wounded tissue. Lower keratinocytes are anchored to the lamina 
by hemidesmosomes through integrin cell adhesions and in order for the cells to 
grasp hold of and crawl over the provisional wound matrix these attachments have 
to be dissolved and additional integrin proteins have to be formed (Cavani et al., 
1993, Haapasalmi et al., 1996). These alterations to cell-cell and cell-matrix 
adhesions allow the advancing and migrating keratinocyte cells to progress from the 
basal membrane through the fibrin clot. Once beyond the free edge of the basal 
lamina, keratinocyte cells release interstitial collagenase matrix metalloproteinase 1 
(MMP-1) enabling them to penetrate through the clot and along the interface 
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between the scab and the healthy dermis (Okada et al., 1997). A few hours after 
wounding and the onset of re-epithelialisation, the migrating keratinocyte cells 
experience a ‘proliferative burst’ which, although not crucial to the re-epithelialisation 
stage, can provide an extra reservoir of cells to aid in the wound healing process 
(Garlick and Taichman, 1994). New keratinocyte cells can also re-epithelise from 
hair follicle remnants if the wounding leaves a stump. Acting like a normal cut wound 
edge the cells will migrate into wound margins (Martin, 1997).  
1.2.4 Proliferation, migration and contraction 
Wound closure, through contraction, begins with the collective migration and 
proliferation of epidermal cells coupled with the recruitment of fibroblasts from the 
dermis. Fibroblasts are drawn in from several sources that can include the 
differentiation of circulating fibrocytes, bone marrow progenitor cells (Abe et al., 
2001) and migrating fibroblasts from nearby healthy dermis (Hinz, 2007). A new 
stroma is formed which replaces the temporary fibrin clot once re-epithelialisation 
has finished. TGF- β acts as a chemo attractant to help pull fibroblasts into the 
wound site and stimulating them to proliferate (Faler et al., 2006). 
In order for the migrating fibroblasts to crawl into the provisional matrix of the wound 
clot to lay down their own collagen-rich template, they must first down-regulate their 
own collagen receptors and up-regulate their own integrins that bind fibrin and 
fibronectin. Once in close proximity to the wound, TGF-β then drives differentiation 
of fibroblasts into α-SMA expressing myofibroblasts (Hinz et al., 2001a). The 
contractile bundles of actin within wound myofibroblasts enable tissue contraction 
and help draw the wound close. Actin also contributes to the synthesis, bundling and 
alignment of new collagen fibres with the capacity of generating strong contractile 
forces (Hinz et al., 2001b). 
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Angiogenesis is a critical component to successful wound repair that involves the 
generation of new blood vessels to supply the re-growing tissue with much needed 
nutrients and oxygen. The new microvascular network is apparent throughout the 
wound a few days after tissue damage. Known as granulation tissue due to its 
granular appearance, the growth of this wound connective tissue is promoted by 
FGF-2, vascular endothelial growth factor (VEGF) and TGF- β (Berse et al., 1992, 
Faler et al., 2006) 
1.2.5 Resolution 
Migrating and proliferating keratinocyte and fibroblast cells eventually meet their 
opposite counterparts as the wound completely closes. After several weeks the 
blood clot will have been shed (often leaving a depressed mark that indicates the 
site of injury) while dermal fibroblasts will continue to proliferate, gradually elevating 
the overlying epidermis and reducing the extent of the indentation. Normal 
architecture and complete resolution of the skin is rarely achieved in full. Dense 
collagen within the extracellular matrix will continue remodelling through a delicate 
balance of synthesis and degradation while the microvasculature within the scar 
tissue will refine and mature (Adams and Alitalo, 2007). Skin appendages, such as 
hair follicles and sebaceous glands which were damaged during the initial wounding, 
are not regenerated and are also replaced by fibrous tissue. The formation of non-
flexible fibrous scar tissue completes the repair process but ultimately fails to restore 
the tissue to its complete original condition. 
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Figure 1.4 Gap junctions 
 (A) Four transmembrane loops (M1-4), two extracellular loops (E1-2), one cytoplasmic loop 
(CL), an amino terminus (NT) and a carboxyl terminus (CT) form one connexin. Six connexin 
subunits form a connexon (or hemichannel) and partner connexons in the plasma membrane 
of neighbouring cells dock to generate a gap junction. (B) Hemichannels can be arranged by 
homomeric or heteromeric connexins and gap junctions can be arranged by homotypic or 
heterotypic hemichannels. Diagram adapted from Molecular Membrane Biology 19; 121-136 
(Evans and Martin, 2002a). 
1.3 Communication in the skin: gap junctions and connexins 
The highly complex sequence of events in skin wound healing relies heavily on the 
communication of signals released during the numerous, overlapping stages. Cell-
to-cell communication is crucial in order for tissues to co-ordinate their processes 
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and mounting evidence now supports the theory that gap junctions play a pivotal 
role in the communication of these signals. Gap junctions are specialised 
connections that provide a regulated pathway linking the cytoplasms of adjacent 
cells and allow molecular signals to pass freely between the two. Each gap junction 
is made of two connexons from opposing cells, which in turn are composed of six 
protein subunits called connexins (figure 1.4A). Twenty connexin genes have been 
identified in rodents and 21 in humans, with at least ten detectable within the skin. 
Several genetic disorders of the skin have been continually attributed to mutations 
and defects in connexin genes. Through this substantial research, it has become 
apparent that connexins play an integral role in the various stages of wound healing. 
1.3.1 History of gap junction research 
The emergence of gap junction research began in the 1950s when it became 
apparent that neighbouring cells could communicate with each other via electrical 
pathways. Loewenstein was among the first to detect low-resistant ionic pathways 
between salivary gland of mosquitoes (Loewenstein et al., 1967). Watanabe and 
Weidmann also noted fast interaction of electrical activity, through resistant junctions 
between myocardial cells (Watanabe, 1958, Weidmann, 1969). However research in 
this topic during this time was dismissed as being controversial as it challenged the 
established idea that cells were individual entities, surrounded by electrically 
insulating membrane,  that only communicated via the release of extracellular 
signals (Evans and Martin, 2002a).  
In the early 1960s research emerged describing how non-excitable cells could 
‘metabolically communicate’ between their neighbours, through what are now known 
to be gap junctions. Enzyme deficient cells would normally perish in culture but 
when grown together with wild type cells, forming gap junctions with each other, the 
mixed cultures survived and grew at the wild type rates (Sybalska and Szybalski, 
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1962, Subak-Sharpe et al., 1969). This original research generated much 
enthusiasm and speculation into what type of cell-cell communication was occurring. 
This mechanism for sharing genetic ability paved the way for an exciting decade of 
gap junction discovery, further supporting the argument of gap junction 
communication existence between cells (Pitts, 1998).  
Revel was the first to describe the hexagonal structure of junctions found between 
cells in the heart and the liver of mice (Revel and Karnovsky, 1967). Using electron 
microscopy, they eliminated their findings as being tight junctions (forming the 
closest contact between adjacent cells, mediating cell-cell adhesion and regulating 
transportation through the extra-cellular matrix) due to a 20 Å wide space found 
between these structures. Brightman further described the junctions in the 
vertebrate brain also noting that these structures were bisected by a median gap 
that was continuous with the rest of the interspace (Brightman and Reese, 1969). 
Through penetration of horse radish peroxidise into this gap, he further confirmed its 
polygon structure. It was from similar studies that the name ‘gap junction’ became 
common usage due to this unknown divide between neighbouring cells (figure 1.5).  
Continued development of electron microscopy research also led to the further 
discovery of gap junction structures in the smooth muscle cells of sheep ureter, 
guinea pig and mouse heart (Uehara and Burnstock, 1970) and mouse liver 
(Goodenough and Revel, 1970). Gap junctions have now been identified in most 
tissues and only erythrocytes, platelets and sperm do not use this type of cell-to-cell 
communication (Evans and Martin, 2002a). However, it wouldn’t be until 1986 that 
the biochemical structure of gap junctions would be identified (Paul, 1986). 
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Figure 1.5 Gap junctions viewed under an electron microscope 
High magnification of a longitudinal section from a block of mouse heart treated with 
lanthanum (Ai) or uranium (Aii) solutions. The normal intercellular space (ics) is reduced to a 
gap of about 20 Å wide (g) in the junctional area. Adjacent mouse astrocytic processes (B) 
connected by gap junctions (g). The gap is constant throughout the junctional area and is 
therefore unlikely to represent tight junctions. Diagrams from Journal of Cell Biology 33; C7-
C12 (Revel and Karnovsky, 1967) and Journal of Cell Biology 40; 648-677 (Brightman and 
Reese, 1969). 
1.3.2 Connexins, connexons and gap junctions 
Gap junctional intercellular communication is facilitated by clusters of gated 
intercellular channels called gap junctions. Spanning the plasma membrane of two 
neighbouring cells gap junctions connect their cytoplasms and typically allow a rapid 
exchange of molecules up to 1000 Daltons (Da) in size.  Gap junction subunits are 
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called connexins and at least 20 have been identified in vertebrates. All connexins 
share a common structure and have a highly conserved amino acid identity 
(Goodenough et al., 1996). 
Each connexin protein is arranged as four hydrophobic transmembrane barrels (M1-
M4), two extracellular (E1-E2) and three intercellular domains that include an amino-
terminus (NT), a cytoplasmic loop (CL) and a carboxyl-terminus (CT). The E1 and 
E2 domains are the segments of the connexin protein that are involved in 
intercellular interactions. Each domain has three conserved cysteine residues joined 
by at least one disulfide bond between the loops. 
By using specific anti-peptide antibodies to determine the topography of connexin 32 
(Cx32) Rahman and Evans were the first to describe how cysteine residues were 
linked by disulphide bonds, both within and between loops (Rahman and Evans, 
1991). Dahl, Werner and colleagues further suggested that the six cysteine residues 
found in the extracellular domain of gap junctions were crucial for gap junction 
formation (Dahl et al., 1992). Using mutational analysis in Xenopus oocytes they 
described that change of any of the conserved cysteine residues into serine 
residues resulted in an absolute loss of gap junction function. However further 
investigation using competing peptides against cysteine has shown no 
enhancement to the ability to delay gap junction formation (Warner et al., 1995) 
resulting in the theory that cysteine residues function is to maintain the extracellular 
loop topography within gap junctions instead of having a direct involvement in the 
docking process.  
Like most plasma membrane proteins, connexins are synthesised by ribosomes and 
are delivered via vesicular trafficking from the endoplasmic reticulum (ER) via the 
Golgi apparatus. Connexins oligomerize after exiting the ER, most likely within the 
trans-Golgi network, to form hexameric connexons called hemichannels (Falk et al., 
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1997, Diez et al., 1999, Musil and Goodenough, 1993). The hexameric structure of 
hemichannels was further suggested through calculating its molecular weight 
(Goodenough et al., 1996), as at the time the connexin molecular weight was 
thought to be between 26-27 kDa and the molecular weight of a hemichannel was 
between 140 and 170 kDa. 
Kumar and Gilula were the first to propose that the gap junction family could be 
divided into two major subclasses, α and β (Kumar and Gilula, 1992). This decision 
was based on the evolutionary considerations, primary sequences and overall 
predicted topologic organization of the gap junction family. These included the 
observation that the connexin family is fairly conserved among vertebrates and that 
the major connexin classes appear to have evolved by gene duplications (Bennett et 
al., 1994, Cruciani and Mikalsen, 2006). Since then three more connexin subfamilies 
have been identified (figure 1.6). However, there was no attempt to imply that the 
class subdivision was based on functional properties of these gap junctions. During 
oligomerization connexins will arrange into homomeric (hemichannels assembled 
from the same connexin subtype) or heteromeric (hemichannels assembled from 
different connexin subtypes) hemichannels. Gap junctions can then be arranged into 
homotypic (gap junctions assembled from hemichannels formed of the same 
connexins) or heterotypic (gap junctions assembled from hemichannels formed of 
different connexins) channels, see figure 1.4B for more detail. Generally, 
heteromeric assembly only occurs between connexins of the same class (Evans and 
Martin, 2002a), such as between Cxs 26 and 32. The hemichannel is then 
transported to the plasma membrane and incorporated into the periphery of a pre-
existing gap junction plaque.  
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Figure 1.6 Subclasses of gap junctions 
Diagram shows phylogenetic tree for several gap junctions. The branches indicate the 
relationships between and within the classes of α, β, γ, δ and ζ. Diagram adapted from 
Evolutionary analyses of gap junction protein families in Biochimica et Biophysica Acta 
Biomembranes 1828; 4-14 (Abascal and Zardoya, 2013). 
For many decades it was thought that hemichannels remained in a permanent 
closed state, until docked with their partner from a neighbouring cell, to avoid 
influencing cell death. However, in the last few years, research has shown how 
hemichannels can open in cultured cells and provide a signalling pathway between 
the cytoplasm of the cell and the extracellular environment (Evans et al., 2006). The 
first evidence that hemichannels could be in an open state was described in 
Xenopus oocytes (Paul et al., 1991). Cx46 hemichannels were opening, allowing 
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large permeability to cations and creating an osmotic imbalance that ultimately killed 
the cell. Hemichannels can open under several different external influences such as 
changes in pH (Trexler et al., 1999, Francis et al., 1999) but primarily open under 
stress. For example,  low calcium (DeVries and Schwartz, 1992), metabolic 
(Contreras et al., 2002, John et al., 1999), mechanical (Stout et al., 2002) and 
ischemic (Shintani-Ishida et al., 2007) stresses can influence the opening of 
hemichannels. 
It is still unclear as to whether surface hemichannels have different permeability 
properties to gap junctions formed of the same connexin (Saez et al., 2003). 
Hemichannels are known to be permeable to small fluorescent dyes such as Lucifer 
yellow and propidium iodide (Contreras et al., 2002, Kondo et al., 2000) so will be 
permeable to small molecules of the similar size and smaller. These include (NAD+) 
nicotinamide adenine dinucleotide (Bruzzone et al., 2001),  (ATP) adenosine-5'-
triphosphate (Stout et al., 2002), glutamate (Ye et al., 2003) and glutathione (Rana 
and Dringen, 2007). Through the release of small metabolites and secondary 
messengers, it is likely that open hemichannels have key roles in certain 
physiological and pathological conditions.  
ATP released from Cx43 hemichannels can mediate the propagation of calcium 
signals in astrocytes and non-excitable cells (Stout et al., 2002) but can also cause 
cell death by acting on purinergic P2X receptors. This will trigger cellular permeation 
pathways to large molecules and ultimately cause cell death through osmotic 
imbalance (Poornima et al., 2012). In ischemic stress conditions Cx43 hemichannels 
speed up the mechanisms involved in cell death. This topic will be explored in more 
detail below and in chapter five. 
In gap junction formation, the extracellular portions of connexons from opposing 
cells interact and dock to complete a fully formed channel. Successful connexon 
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docking occurs when non-covalent bonds seal the two opposing hemichannels and 
small molecules, passing through the channel, do not leak out into the extracellular 
space (Laird, 1996). Stability of a gap junction is correlated with the size of the gap 
junction plaque, which can grow to over 1 µm in diameter (Musil and Goodenough, 
1991). Gap junction plaque size can vary depending on their location, for example in 
the inner ear gap junction plaques are numerous, often covering over 25% of the 
plasma membrane supporting cells, comprising more than 100,000 gap junctions 
(Forge et al., 2003a). Gap junction assembly relies heavily on correct connexin 
trafficking and there are a number of genetically inherited channel disorders which 
are linked directly to problems in connexin trafficking and gap junction assembly. 
One of the most surprising early discoveries in gap junction research was that gap 
junction half life could be as short as five hours in vivo (Fallon and Goodenough, 
1981). This research was later re-visited and confirmed in vitro showing even 
shorter half lives of 1.5-3.5 hours in Cxs 32 and 43 (Traub et al., 1987). This 
evidence and more suggests how gap junctions are not ‘long-lived’ structures but in 
fact undergo a continual process of formation and degradation (Laird, 1996). One of 
the first theories proposed on how gap junctions were internalised was based on 
annular gap junctions. These double-membrane intracellular structures were 
identified using electron microscopes and thought to be entire gap junctions that had 
originated from the cell surface (Larsen and Tung, 1978). Immunogold labelling 
confirmed that these structures were rich in connexin protein (Naus et al., 1993). 
Jordan and colleagues built on this research by using cells fluorescently tagged with 
Cx43-GFP, confirming that one of the two partner cells internalised the gap junction 
formed from both cells (Jordan et al., 2001). The degradation of internalised 
connexins occurs through lysosomal and proteosomal pathways in an ubiquitin-
dependent fashion (Laing et al., 1997). 
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1.3.3 Innexins and pannexins 
Innexins are a group of proteins that create gap junctions in invertebrates. To date 
24 innexins have been identified in C-elegans but only eight in Drosophila (Phelan et 
al., 1998, Yen and Saier, 2007). Innexins exhibit gap junction like properties such as 
the ability to form intercellular channels in Xenopus oocytes and induce electrical 
coupling between oocyte pairs (Landesman et al., 1999). Like their connexin 
cousins, innexins have a common structure and are arranged as four 
transmembrane spanning segments, a cytoplasmic amino terminus and a carboxyl 
tail. Six innexin subunits create an innexon, a functional pore that links the 
cytoplasm of the cell with the extracellular environment (Bao et al., 2007). Stebbings 
and colleagues have shown through mRNA analysis that innexins can form hetero-
oligomerization structures (Stebbings et al., 2000). Two innexons from opposing 
cells dock to form a continuous pore, in a gap junction formation, permeable to ions 
and small molecules. 
Within the last 15 years, research within the gap junction field has become a little 
more complicated with the discovery of the pannexin. Being classed as a family 
within vertebrate and invertebrate proteins, pannexins can also create hydrophilic 
channels across a cell’s plasma membrane (Panchin, 2005). Pannexins have a 
moderate sequence homology with invertebrate innexins but are evolutionary 
distinct from connexins. However, pannexins are structurally similar to both 
connexins and innexins, possessing four transmembrane segments and cytoplasmic 
amino-terminal and carboxyl-terminal domains. To date, three pannexins have been 
identified; Pannexins 1, 2 and 3 (Baranova et al., 2004). 
Six pannexin subunits create a pannexon, connecting a cell’s cytoplasm with the 
extracellular space, although there is contradicting evidence as to whether 
pannexons have the ability to form gap junction channels between neighbouring 
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cells. With only a few exceptions known to date, there is little evidence to suggest 
that pannexons do form gap junctions in vivo (Dahl and Harris, 2009). Functional 
conductance between paired Xenopus oocytes in vitro (Bruzzone et al., 2003) and 
dye transfer between unspecified channels in pannexin transfected cells (Vanden 
Abeele et al., 2006, Lai et al., 2007) have been the only evidence of pannexin based 
functional gap junction formation. There has been no evidence of successful dye or 
electrical coupling in cell cultures expressing Pannexin 1 (Huang et al., 2007), 
neither has there been convincing evidence of punctate staining, found typical in 
immuno-analysis of gap junction plaques (Locovei et al., 2006). Hence the only 
indications that pannexin subunits can form gap junctions are in those cases where 
there is an over expression of the protein. Perhaps pannexons are not designed for 
binding to a partner in a neighbouring cell (Boassa et al., 2007, Dahl and Locovei, 
2006). Xenopus oocytes wouldn’t naturally pair in vivo, but within a forced 
expression environment there may be a weak tendency that would be enough to 
exert a functional role that would never occur in nature. 
On the other hand there is mounting evidence that suggests pannexins can form 
functional non-junctional plasma membrane channels (Dahl and Locovei, 2006).  
Along with their distant relative, the connexin hemichannel, the pannexon pore is 
highly permeable to ATP (Locovei et al., 2006, Ransford et al., 2009). This function 
is so strong in pannexons that ATP release in this manner has been shown to carry 
current (Dahl and Harris, 2009). The functional properties of pannexons overlap 
significantly with those of connexin hemichannels and to date there are no drugs to 
discriminate between the two. For this reason, care must be applied when 
interpreting data of specific conditions that may involve both protein classes. 
For the purpose of this investigation, this thesis will restrict its focus to the connexin 
family of proteins. 
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1.3.4 Function of gap junctions 
1.3.4.1 Gap junction communication 
Gap junctions allow the direct passage of secondary messengers, small metabolites 
and electrical signals between the cytoplasm of connected, neighbouring cells. In 
excitable cells, such as neurons and cardiomyocytes, gap junctions allow electrical 
coupling, allowing the generation of synchronized and rapid responses. In addition 
to the secondary messengers and metabolites that transfer through hemichannels 
as described above (including NAD+, ATP, glutamate and glutathione) other 
secondary messengers and metabolites that can transfer between non excitable 
cells via gap junctions include calcium (Ca2) ions (Sáez et al., 1989a), (IP3) inisitol 
triphosphate (Sáez et al., 1989a), (cAMP) cyclic adenosine monophosphate (Sáez 
et al., 1989b) and (ADP) adenosine diphosphate (Goldberg et al., 1998). 
While gap junctions all serve a common role in allowing these signals to pass freely 
between neighbouring cells, there is a diversity of function that can be attributed to 
the different connexins expressed in a gap junction, as a result of hereto-
oligomerization (White, 2003, Goldberg et al., 2004). For example cGMP and cAMP 
will pass equally well through homomeric channels of Cx32 but cGMP passes ‘more 
effectively’ through heteromeric channels of Cxs 32 and 26 (Bevans et al., 1998). 
This suggests preferential selectivity of Cx26 towards cAMP. Channels composed of 
Cxs 43 and 32 will allow the passage of glucose, glutamate, ADP and adenosine but 
generally homomeric channels of Cx43 will transfer these molecules better than 
channels of Cx32 and transfer ATP over 100-fold better than channels formed solely 
of Cx32 (Goldberg et al., 2004). Gap junctions have also been known to 
demonstrate charge selectivity as homomeric channels of Cx26 will favour cation 
transfer while homomeric channels of Cx32 prefer the passage of anion currents 
(Veenstra, 1996). 
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Functional assays of gap junction communication mainly fall into two categories; the 
first measures the transfer of molecules between neighbouring cells. This can be 
assayed through metabolic cooperation as described above or through monitoring 
the transfer of fluorescent dyes between communicating cells. Cells are injected with 
dyes with a typical weight of 500 Da (i.e. Lucifer yellow, MW = 443 Da) that will 
comfortably transfer through gap junctions. To establish whether the cells are 
functionally coupled by gap junctions, a time dependent diffusion of the molecules to 
neighbouring cells is monitored. A control would include the co-injection of a larger 
fluorescent dye such as rhodamine-dextran (MW = 10,000 kDa) which is too large to 
transfer between neighbouring cells via gap junctions. The second category of 
assays is designed to measure the electrical currents carried by ions and has been 
greatly improved through advancements in patch-clamp method technology 
(Goodenough et al., 1996). 
Gap junctions exist in nearly every mammalian cell (Saez et al., 2003) and have 
roles in several physiological functions, including excitable cell contraction, cell 
growth and differentiation, cell death under pathological conditions and wound 
closure. Connexin defects within any of these systems can often cause severe 
disease and death. Current literature reports at least eight human diseases that are 
caused by germline mutations in the connexin family (Laird, 2006). 
1.3.4.2 Gap junction mutations  
The first connexin mutation was discovered in the Charcot Marie-Tooth X syndrome, 
a peripheral neuropathy disease that causes severe limb weakness (Bergoffen et 
al., 1993). Using Southern and Northern blot analysis, Bergoffen and colleagues 
were the first to describe base change mutations in the gene coding for protein Cx32 
(GJB1). Since this first report, over 400 mutations in the gene GJB1 have been 
described that cause Charcot Marie-Tooth X syndrome. Many of these mutations 
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prevent normal Cx32 transfer to the membrane, whereas others can cause complete 
abolishment of Cx32 expression by affecting the promoter of the GJB1 gene or the 
translation of Cx32 mRNA (Scherer and Kleopa, 2012). These mutations ultimately 
lead to the disruption of Cx32 gap junction function in Schwann cells in peripheral 
nerves, leading to the failure of ion and small molecule transfer across the compact 
myelin. This results in myelin disruption, axonal degradation and progressive 
atrophy of distal muscles.  
Cardiac tissue relies heavily on gap junction facilitated action potential propagation, 
to ensure symmetrical rhythmicity of the heart. Having three key Cxs 40, 43 and 45, 
(Kanter et al., 1992)   it is not surprising that mutations in these  key cardiac proteins 
can cause fatal ventricular arrhythmias present in cardiac diseases of the heart. For 
example, mutations on the carboxyl tail of Cx43 can abolish left-right symmetry seen 
in the severe heart disease viscera-atrial heterotaxia (Dasgupta et al., 2001). Knock-
out mouse models of Cxs 40 (Simon et al., 1998, Bevilacqua et al., 2000), 43 
(Reaume et al., 1995) and 45 (Nishii et al., 2001) confirm that gap junctions play a 
crucial role in cardiac conduction. 
Freeze fracture studies have shown that gap junctions reside in large numbers 
within the inner ear epithelium in reptiles, birds and mammals (Forge et al., 2003a) 
and screening using reverse transcriptase polymerase chain reaction (RT-PCR), 
Western blots and immunohistochemistry has revealed four connexin subtypes in 
the mammalian inner ear (Cxs 26, 30, 31.1 and 43). The most abundant of these 
connexins, Cxs 26 and 30, co-localise to form heterotypic connexons in non-sensory 
epithelial cells (Forge et al., 2003b). One supposed function of gap junctions 
composed of Cxs 26 and 30 within the inner ear is to maintain the endocholear 
potential by recycling endolymphatic K+ ions from the sensory hair back to the 
endolymph (Kikuchi et al., 2000). Recessive mutations in the gene coding for Cx26, 
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GJB2, have been continually associated with non-syndromic hereditary deafness 
(Iossa et al., 2011). 
It is estimated that mutations in gene GJB2 are responsible for half of all non-
syndromic hereditary deafness. Two of the most common genetic mutations 
responsible for deafness include mutations in 35delG (30delG) and 16delT. The first 
introduces a premature stop codon within the amino terminus at amino acid position 
13, while the second introduces a premature stop codon within the first extracellular 
loop at amino acid position 56 (Martin et al., 1999). The properties of Cx26 
mutations have been examined in transfected HeLa cells (Marziano et al., 2003) and 
Xenopus oocytes (White et al., 1998) revealing impaired intracellular trafficking and 
electrical deficiency which results in non-syndromic hereditary deafness.  
Mutations that disrupt Cx26 are primarily confined to the inner ear (non-syndromic) 
but can occur with other clinical features (syndromic). One such clinical feature is 
hyper-thickening and increased roughness and browning of the epidermis that can 
be found in Keratitis-Ichthyosis Deafness (KID) and Hystrix-Like Ichthyosis 
Deafness (HID) syndromes (van Steensel, 2004, Richard, 2005). Both are clinically 
characterized by skin lesions (known as erythrokeratodermia), vascularising keratitis 
and mild to profound hearing loss. Another such disease is Vohwinkel's Syndrome 
that is characterised by disturbed epidermal differentiation, (manifested by 
hyperkeratosis on the soles of feet, palms of hands and knuckles) and 
pseudoainhum with spontaneous digital amputation. Like in KID and HID syndromes 
patients also suffer with moderate to profound hearing loss (van Steensel, 2004, 
Waller and Maibach, 2005, Richard, 2005).  
One well characterised, yet rare, disease that has been attributed to mutation of the 
gene coding for Cx31 is Erythrokeratodermia variabilis (EVK) (Gottfried et al., 2002, 
Di et al., 2002, Common et al., 2005). Sufferers of EVK experience transient 
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erythema coupled with generalised hyperkeratosis (figure 1.7). The erythema 
patches are usually of variable intensity (hence the name of the disease) and can 
arise on normal skin as well as on hyperkeratotic plaques. These red patches of skin 
can last anything between a few hours and a few days. However, the hyperkeratosis 
is persistent and EVK patients will suffer from yellow-brown thickening of their skin, 
which can sometimes scale and peel (Brown and Kierland, 1966, Vandersteen and 
Muller, 1971). Being autosomal dominant, EVK can affect entire families and has 
enabled extensive genetic research to have been carried out (Richard et al., 1997). 
The genetic mutation associated with EVK is on the gene GJB3, which encodes for 
Cx31 (Richard et al., 1998). In total six out of eight GJB3 mutations have been 
identified in the 20 families investigated. The mutations involve either disruption to 
the amino terminus or to the transmembrane domains and interfere with the 
assembly and functional properties of Cx31. Mutations of GJB3 have also been 
found in progressive high-tone hearing loss. This mutation interferes with the E2 
domain, preventing Cx31 connexons from docking to neighbouring partners 
(Richard, 2000).  
Currently 28 mutations of Cx43 (GJA1) have been identified but it is only one 
frameshift mutation within the c-terminus that results in the loss of many 
phosphorylation and protein-binding sites. The autosomal dominant mutations 
results in the pleiotropic development disorder oculodentodigital dysplasia (ODDD). 
The disease is clinically characterized by patients exhibiting soft tissue fusion of the 
digits, craniofacial abnormalities, small eyes with lens and cornea defects, loss of 
teeth enamel, brittle nails, hair abnormalities and skin disease. However, since Cx43 
is the most ubiquitous connexin in the human body, it is remarkable how patients’ 
symptoms are not more severe.  Sufferers appear to live long lives in relatively good 
health (Laird 2006, 2014). 
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Figure 1.7 Clinical and histological features of EVK 
 (A-C) Clinical features of Erythrokeratodermia variabilis (EVK). Sufferers experience 
hyperkeratotic plaques on their lower extremities (A-B) and palmoplantar keratoderma with 
peeling on soles of their feet (C). Histological section of EVK shows hyperkeratosis (D). 
Diagrams from Experimental Dermatology 9; 77-96 (Richard, 2000) and Acta Dermato 
Venereologica 90; 274-278 (Zhang et al., 2010b). 
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Connexins are expressed in all cells linked with tissue repair, with strong evidence 
indicating they mediate changes in migration, proliferation, inflammation and 
contraction (explored in further detail below). It is clear that defects in the connexins 
involved in these processes can give rise to sensorineural hearing loss and 
associated hyper-proliferative skin disorders. This shows that there is a complex 
relationship between the changes of the genotype and the phenotypic appearance 
of connexins and there is mounting evidence for a crucial role in connexin based 
communication in the skin   
1.3.5 Connexins in the intact skin  
In 1988, Salomon and colleagues were the first to describe how cells in normal and 
differentiated skin could communicate with each other through gap junctions 
(Salomon et al., 1988). By microinjecting keratinocyte and fibroblast cells with the 
gap junction permeant dye Lucifer yellow, they demonstrated that the fibroblast cell 
was the most communicative within the skin. However, cell-to-cell communication 
was not observed between the epidermal and dermal sub-units. Gap junction 
intercellular communication is governed by at least ten different connexin subtypes 
within the skin and although the spatial and differential expression pattern is similar 
(but not identical) between rodents and humans, experimental discoveries may not 
be comparable between the species. These include Cxs 26, 30, 30.3, 31, 31.1, 32, 
37, 40, 43 and 45. Only Cxs 26, 30, 31.1 and 43 will be described in greater detail 
below (figure 1.8). 
Using antibodies against different connexin epitopes, Western and Northern blots, 
and mRNA expression analysis, there is now an extensive map of connexins within 
the rodent and human skin (Guo et al., 1992, Butterweck et al., 1994, Kandyba et 
al., 2008). Cxs 26, 30, 31.1 and 43 are highly expressed in the differentiating strata 
spinosum and granulosum of the foetal rodent skin but only Cx43 can be found in 
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the stratum basal. Rodent hair follicles and sebaceous glands express Cxs 26 and 
43 whereas sweat glands express just Cx26. Dermal fibroblast cells predominantly 
express Cx43. During the maturation of rodent skin, Cx26 down-regulates in the 
upper epidermal layers, whereas Cx31.1 up-regulates. However, no difference in 
gap junctional communication is observed (Kamibayashi et al., 1993, Goliger and 
Paul, 1994). 
 
Figure 1.8 Connexin profiles in mature rodent and human skin 
Original diagram shows the skin labelled with key areas of interest. Connexin expression 
within the skin is divided into four key connexins (Cxs 26, 30, 31.1 and 43) which are further 
divided between rodents and human expression. Intensity of expression is indicated by *, 
increasing * indicates increasing expression of relevant connexin. Refer to text for 
references. 
Cx43 is the most widely expressed and ubiquitous connexin found in human skin 
(and indeed in the rest of the body). In the epidermis Cx43 is expressed throughout 
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the strata spinosum and granulosum and in a punctate and partly linear pattern, 
along the periphery of keratinocytes, in the stratum basal. Cx43 is also found in the 
sebaceous glands and abundantly in both the lower regions of the hair follicles and 
the dermal fibroblasts (Guo et al., 1992, Salomon et al., 1994, Tada and Hashimoto, 
1997). Cx30 can be found in all layers of the epidermis (Brandner et al., 2004). Cx26 
is barely detectable in the epidermis, except in the stratum basal (Locke et al., 
2000), although staining can be ‘patchy’ and mainly in the skin of palms and soles. 
However, it is found in copious amounts within sweat glands and the base of hair 
follicles.  
1.4 Connexin dynamics in normal wound healing 
There are several stages during wound healing that rely heavily on the 
communication of signals to successfully complete wound closure. Gap junctions 
provide specialised connections between neighbouring cells that allow molecular 
signals to pass freely between the two. At least ten gap junction protein subunits 
have been found within the skin and at least four (Cxs 26, 30, 31.1 and 43) play 
integral roles during the wound healing process. Golgier and Paul were the first to 
describe connexin location and intensity in developing and mature rat skin (Goliger 
and Paul, 1994) and subsequently, among others, went on to describe the dynamics 
of these key connexins during the wound healing response (Goliger and Paul, 1995, 
Saitoh et al., 1997, Coutinho et al., 2003). Generally using Western blots and 
immunofluorescence, these researchers have described, in detail, the dynamics of 
the four key connexins during wound healing, linking their changes in expression 
and intensity with particular stages of the wound healing process (figure 1.9).   
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Figure 1.9 Dynamics of connexins during wound healing 
Summary diagram that shows connexin dynamics in rodent skin during wound healing. 
Distribution of Cx26 (blue), Cx30 (red), Cx31.1 (green) and Cx43 (purple) are shown in 
normal, wounded and healing skin. Shading is used to indicate the level of expression, with 
darker shaded indicated higher levels of expression. Connexin expression within the hair 
follicles is also shown. Connexin expression is shown one, four and seven days after 
wounding. C = stratum corneum, g = stratum granulosum, us = stratum upper spinosum, ls = 
stratum lower spinosum, b = stratum basal, hf = hair follicle, bv = blood vessel. Diagram 
adapted from Cell Biology International 27; 525-541(Coutinho et al., 2003). 
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1.4.1 Connexin response in the epidermis during wound healing 
In 1978, Gabbiani and colleagues were the first to observe a significant increase in 
the number of gap junctions present at the epidermal cell surface in wounded rat 
skin (Gabbiani et al., 1978). Using the same electron microscopy technology, 
Andersen and partners also noticed a large number of gap junctions in wounded 
guinea pig palate epithelium, when compared to non-wounded tissue (Andersen, 
1980). They linked this increase in gap junction number with the process of 
epidermal differentiation. During the initial wound healing response, epidermal 
keratinocytes undergo dynamic processes as a result of the stress signals released 
during wounding. These include the disassembly of desmosomes, the redistribution 
of integrin receptors and the formation of actin bundles in the early stages of wound 
healing and hyper-proliferation during the later stages.  
Cx26 is normally found in the stratum granulosum and stratum spinosum in 
relatively low levels in non-wounded rodent tissue. Within hours of wounding these 
levels of Cx26 decrease further at the wound edge, however Cx26 remains at a 
detectable level in the strata granulosum and upper spinosum near, but not at, the 
site of the wound. Approximately 24 hours after wounding Cx26 is greatly up-
regulated in the middle and upper stratum spinosum and strata granulosum at the 
wound edge, but not in the stratum basal. This elevated expression is maintained 
throughout the migration of epidermal keratinocyte cells into the wound, linking 
heavily with the process of re-epithelialisation and the hyper-proliferation of the 
epidermis. Cx26 expression returns to pre-wounding levels between 7 and 12 days 
after wounding in rodent skin. It has been noted how Cx30 expression follows a very 
similar dynamic to Cx26 expression during rodent wound healing (Coutinho et al., 
2003). 
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Expression of Cx31.1 can typically be found in very low levels, within the stratum 
spinosum and stratum granulosum in non-wounded epidermis in rodent skin. 
Following wounding in rodents, the expression of this connexin drops at the wound 
edge in a similar pattern to Cxs 26 and 30. However, unlike the significant up-
regulation of Cxs 26 and 30 in migrating epidermal keratinocyte cells a day after 
wounding, Cx31.1 remains very low in proliferating and regenerating areas. Cx31.1 
remains almost undetectable until six to seven days after wounding, where its 
expression significantly rises in intensity in the strata granulosum and spinosum 
(Coutinho et al., 2003). Nagata and colleagues note that in guinea pig epidermis, 
cells undergo apoptosis at a similar time, suggesting a role of Cx31.1 in terminal 
differentiation of keratinocyte cells (Nagata et al., 1999). Cx31.1 returns to pre-
wound levels approximately 12 days after initial wounding.  
Cx43 is moderately expressed in the strata basal and spinosum in non-wounded 
rodent tissue. Similar to the above connexins, Cx43 expression drops at the wound 
edge within the first hours after wounding in rodents. Cx43 expression remains 
absent in all proliferative and regeneration areas within the epidermis, similar to 
Cx31.1, until four days after wounding. Cx43 expression then significantly up-
regulates in the proliferating epidermis and remains elevated until six to seven days 
after wounding, when expression returns to pre-wounding levels (Coutinho et al., 
2003). It has also been noted in rodents that Cx43 expression is dynamic in dermal 
fibroblast cells and blood vessels during the wound healing process (Mori et al., 
2006).  
1.4.2 Connexin response in the dermis during wound healing 
During the early inflammatory response, within hours of initial wounding, circulating 
leukocytes, prompted by a cascade of inflammatory signals, invade the wound site. 
This process of extravasation requires blood vessels to become more permeable to 
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the inflammatory molecules and ultimately causes dermal tissue to swell. Cx43 
significantly up-regulates in wound edge blood vessel epithelium as inflammatory 
signals attract Cx43 expressing neutrophils (Coutinho et al., 2003). This up-
regulation seen in blood vessels is maintained throughout the inflammatory 
response within the dermis and expression doesn’t reduce until two days after 
wounding, returning to normal levels by day 12.  The leukocyte-leukocyte and 
leukocyte-endothelial cell communication, facilitated by hemichannels and gap 
junctions composed of Cx43, is crucial for the transmigration of inflammatory cells 
from the vasculature to the wound site. 
Gap junctions, hemichannels and connexins have been identified in leukocytes and 
vasculature endothelial cells and there is mounting evidence of functional 
communication in homotypic and heterotypic populations of these cell types 
(Oviedo-Orta and Howard Evans, 2004). Cxs 37, 40 and 43 have been identified in 
the vascular endothelium in both in vitro and in vivo settings (Polacek et al., 1993, 
Polacek et al., 1997, van Kempen and Jongsma, 1999). Intracellular communication 
between aggregated lymphocytes was first established in the early 1970s as shown 
by ion flow and intracellular communication through low resistance junctions (Hülser 
and Peters, 1971, Hülser and Peters, 1972). Levy and colleagues also reported that 
in a linear orientation, macrophages communicated via cytoplasmic bridges and 
possessed electrical coupling properties (Levy et al., 1976). Several years later, 
hamster leukocytes were seen to express Cx43 when treated by inflammatory 
stimuli (Jara et al., 1995). Human PMNs were also reported to express Cx43 when 
stimulated by inflammatory molecules and form functional gap junctions (Branes et 
al., 2002). Similar results were observed in human monocytes and macrophages 
when activated with lipopolysaccharides (LPS). Not only did these cells create 
functional gap junctions formed of Cx43 but their gap junction communication was 
inhibited by 18α-Glycyrrhetinic acid, a known gap junction communication inhibitor 
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(Eugenín et al., 2003). Time dependent and bi-directional cross talk between 
populations of PMNs and human umbilical vein endothelial cells (HUVECs) have 
also been observed (Zahler et al., 2003). Oviedo-Orta, Evans and colleagues were 
the first to observe Cx43 expression in non-activated lymphocytes (Oviedo-Orta et 
al., 2000). Using mRNA analysis they reported Cx43 expression in peripheral blood 
lymphocytes, tonsil lymphocytes and tonsil derived T and B lymphocytes. Activation 
using in vitro inflammatory stimuli resulted in T and B lymphocytes expressing more 
Cx43. Functional analysis studies using dye transfer confirmed gap junction 
communication between both homologous and heterologous co-cultures of T and B 
lymphocytes. Incubation with gap junction communication blockers decreased dye 
transfer and therefore confirmed gap junction based communication between these 
cells. These results suggest that gap junctions and their connexins have a heavy 
involvement in the complex sequence of events of the early inflammatory response. 
Two key factors play important roles in the movement of cells during extravasation. 
The first is adhesion of leukocytes to endothelial cells before migration. The second 
is the role chemokines play in controlling where leukocytes travel to once they have 
left the bloodstream. In the research discussed here it is clear that PMNs, 
macrophages, monocytes, lymphocytes and endothelial cells of vascular walls 
express connexins and form functional gap junctions to enable cross talk between 
homologous and heterologous populations of these cells (Polacek et al., 1993, Jara 
et al., 1995, Polacek et al., 1997, van Kempen and Jongsma, 1999, Branes et al., 
2002, Coutinho et al., 2003, Zahler et al., 2003, Sarieddine et al., 2009).   
In an elegant study, conducted by Ovieda-Orta, Evans and colleagues, trans-
endothelial migration was investigated using an in vitro model of heterotypic 
populations of endothelial cells and lymphocytes in a chamber system (Oviedo-Orta 
et al., 2002). HUVECs were grown on tissue culture inserts as a monolayer and 
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loaded with the dye Calcein-AM. Once confluent, the HUVEC tissue inserts were 
placed in a new plate containing a monocyte culture supernatant and an upper 
chamber was filled with a suspension of a mixed lymphocyte population. Attracted 
by the chemokines released by the monocyte culture, lymphocytes transmigrated 
through the monolayer of HUVECS to the lower chamber. Fluorescence-activated 
cell sorting (FACS) analysis was then carried out on the transmigrated cells and it 
was reported that lymphocytes had communicated with the endothelial monolayer 
and had accepted dye transfer. In a similar study using PMNs and HUVECS, 
conducted by Zahlar and colleagues, it was also reported that there was a bi-
directional cross talk between populations of PMNs and HUVECS while PMNs 
transmigrated through a layer of HUVECs in a chamber system (Zahler et al., 2003).  
Once neutrophils have left the bloodstream, they are governed by chemo-kinetic 
migration to determine where they next move to. Upon wounding, tissue 
macrophages release a torrent of cytokines such as IL-1, IL-6 and TNFα that have 
roles in vasodilatation, increasing vascular permeability and crucially recruiting 
monocytes and neutrophils to the wound site. Work carried out Oviedo-Orta, Evans 
and colleagues has shown that human T and B lymphocytes express Cx43 and 
incubation with gap junction communication blockers significantly reduced the 
synthesis of key chemokines IL-2, IL-10 and IFNγ, and immunoglobulin’s IgA, IgG 
and IgM (Oviedo-Orta et al., 2001). It was thought that the reduction in 
immunoglobulins was linked to the reduction in IL-2 synthesis as lymphocytes 
stimulated with IL-2 will release theses antibodies.  
Gabbiani first described gap junctions between myofibroblasts (Gabbiani et al., 
1978) and Salomon further described extensive coupling existed between dermal 
fibroblasts (Salomon et al., 1988). Using rodent models it has also been shown that 
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dermal wound edge fibroblasts naturally down-regulate Cx43 as they become 
migratory and lay down granulation tissue (Mori et al., 2006). 
Brandner and colleagues compared murine wound healing connexin profiles with 
those of human and demonstrated that in acute wound healing there was an initial 
down regulation of Cxs 26, 30 and 43 (Brandner et al., 2004) confirming the work of 
Coutinho (Coutinho et al., 2003). Subsequently, one to two days after wounding, 
Cx26 and 30 were found in the regenerating epidermis whereas Cx43 remained low, 
following a similar pattern to the murine model (Coutinho et al., 2003). The lack of 
Cx43 at the wound margin in the early stages of healing seems to play an important 
role irrespective of species. It is clear that without the regulation of these connexin 
proteins, the natural system of wound healing stages would not progress and 
consequently it has come to light in recent years of research that connexins within 
the skin could play a vital role when wounds do not heal in a normal and timely 
manner (Becker et al., 2012).  
1.5 Connexin dynamics in abnormal wound healing 
1.5.1 Introduction to chronic wounds  
Chronic wounds are those that do not heal in an orderly set of phases, nor in a 
predictable amount of time, the way in which most acute wounds do. Chronic 
wounds are clinically described as wounds that do not heal within 1-2 months or that 
have not shown a 20-40% reduction in wound area after one month of wounding 
(Flanagan, 2003). Non–healing wounds are characterized by prolonged 
inflammation, re-epithelialisation failure and defective re-modeling of a wound. A 
large percentage of chronic wounds fall into three main etiological categories; 
diabetic foot ulcers, venous leg ulcers and pressure ulcers (figure 1.10). A smaller 
fourth group covers ulceration caused by arterial deficiency or radiation damage 
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(Mustoe, 2004). As chronic wounds take a long time to heal, do not heal completely 
or constantly re-occur, independence and quality of life of the sufferer is 
compromised.  
The three main types of chronic wounds are causing a major threat to the public 
health services and global economy, significantly contributing to the growing 
escalation in health care costs. The average age of a patient that develops a chronic 
wound is over 60 (Mustoe, 2004) and with the aging population in both Europe and 
the United States is expected to increase by 13-15% in the coming years (Sen et al., 
2009), the global care costs for chronic wounds has been predicted to rise to $13-
15bn annually (Siddiqui and Bernstein, 2010). In the UK alone, treatment and after-
care of chronic wounds costs the government £2-3.1bn per year, amounting to 3% 
of National Health Service (NHS) expenditure (Harding and Queen, 2010). This 
burden will only increase as the nation continues to make poor lifestyle choices, 
such as a lack of physical activity and poor diet, which will result in a rise in obesity 
and diabetes – some of the key precursors to the development of a chronic wound. 
1.5.1.1 Diabetic foot ulcers 
Diabetes mellitus is a metabolic disease in which a person suffers from elevated 
glucose levels, either due to inadequate production of insulin or because tissue no 
longer responds to the insulin produced. Chronic diabetic foot ulcers (figure 1.10A) 
arise from complications of the disease (such as peripheral neuropathy) causing 
arterial damage and decreased sensation to the extremities of the body. Abnormal 
forces or accidental trauma to the toes and feet can lead to broken skin. Coupled 
with tissue ischemia, continued trauma and poor management of the wound, chronic 
diabetic foot ulcers form which are very slow and difficult to heal. Estimates suggest 
that more than 15% of diabetic sufferers will develop a diabetic foot ulcer, frequently 
debilitating and often requiring amputation (Jeffcoate and Harding, 2003). The 
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prevalence of diabetes is on the rise prompting warnings from global health experts 
who predict a diabetic epidemic if changes do not occur.  
Early studies estimated that by the year 2000, diabetes would be diagnosed in 2.8% 
of the global population and forecasted that by 2030 over 4% of the world would be 
diabetic (Wild et al., 2004). However, worldwide prevalence of diabetes in 2010 was 
6.4% (Farag and Gaballa, 2011), already greatly exceeding previous projections, 
and new forecasts now predict global incidence of diabetes to reach nearly 440 
million people by 2030, nearly 8% of the predicted global population (Shaw et al., 
2010, Bruno and Landi, 2011). As the estimates continually increase the only 
explanation is that prevalence of diabetes is also generally increasing. Although 
diabetic foot ulcers are the least common chronic wound, 12% of global health 
expenditure is already spent on diabetes and its complications (Zhang et al., 2010c). 
At least 24,000 people in the UK are diagnosed with a diabetic foot ulcer annually, 
costing the NHS millions of pounds each year (Harding et al., 2002). 
1.5.1.2 Venous leg ulcers 
Venous leg ulcers (figure 1.10B) are caused by low blood circulation, due to 
damaged leg veins. Compromised blood vessels and valves cause blood to flow 
backwards, ultimately causing high blood pressure in leg veins, which become 
leaky. Subsequently the fluid causes swelling and damage, leading to hardened and 
inflamed skin that develop into painful venous leg ulcers. Leg ulcerations are 
common, accounting for 85% of all lower extremity ulcers (McGuckin et al., 2002) 
with 70,000-190,000 individuals in the UK suffering with a venous leg ulcer at any 
one time (NHS, 2013). They are more prevalent in the elderly population and as with 
all chronic wounds, as the elderly population rises, so will their frequency.  
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Improvements in Western civilization health care, living standards and socio-
economic status means that more and more people are now living to an old age 
(Wicke et al., 2009). Relative to the general population, both the number and 
proportion of the older populous is increasing. For example, it has been estimated 
that in the 17 years between 2008 and 2025 the European population will grow by 
just 1%, however in the same time, population of the over 65s will grow by 13% 
(Sen et al., 2009). By 2050, it is predicted that the European population growth will 
be static or declining whereas the number of the over 65s will be reaching 50 million; 
approximately 59% of the total European population. Current global estimates 
suggest $3bn is spent each year on treatment of venous leg ulcers with a further 
$2bn attributed to work days lost. This staggering financial burden will only get 
bigger. 
1.5.1.3 Pressure ulcers 
Pressure ulcers (figure 1.10C) can be caused by either prolonged or repeated 
pressure to the skin and are often found on bony prominences. Currently, there are 
an estimated 7.4 million pressure ulcers in the world and over 400,000 people in the 
UK will develop a pressure ulcer this year. Vulnerable patients generally include 
those who suffer from impaired mobility or sensation, such as the elderly, wheelchair 
bound or bedridden, and pressure ulcers are often seen in hospitalised patients. 
Approximately 25% of people resident in long-term geriatric wards will have a 
pressure ulcer and the prevalence of pressure ulcers in hospitals has risen by 63% 
in the past 10 years (Sen et al., 2009). As pressure ulcers are a major source of 
infection, leading to septicaemia and often death, there have been 60,000 avoidable 
deaths in that same time period and as the global elderly population grows so will 
the global nursing home population. Pressure ulcers also come with their own 
economic burden, with estimates suggesting treatment of pressure ulcers could cost 
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the NHS £2bn per year (Bennett et al., 2004). Pressure ulcers and their possible 
treatments will be explored in more detail in chapters five and six. 
 
Figure 1.10 Chronic ulcers 
(A) Diabetic foot ulcer found in a typical position under the second metatarsal head on the 
sole of the patient’s foot. (B) Venous leg ulcer in a typical location, above the above the 
patient’s ankle. (C) Pressure ulcer on the heel of a patient’s foot. Note that all the wounds 
have irregular boarders and have a yellow, fibrinous base. Diagrams from The Lancet 361; 
1545-1551 (Jeffcoate and Harding, 2003), Journal of American Academy of Dermatology 44; 
401-421 (Valencia et al., 2001) and Wounds International 1 (Murando and Dealey, 2013). 
1.5.2 Connexin dynamics in chronic wounds 
As connexins, hemichannels and gap junctions play such integral roles within intact 
skin and the wound healing process, it is no surprise that connexins have been 
flagged to have possible roles in the failure of wound closure found in chronic, non-
healing wounds. Current research pins this responsibility on Cx43 as it is the most 
ubiquitous connexin in rodent and human skin. 
1.5.2.1 Cx43 in diabetic foot ulcers 
The onset of diabetes can cause significant changes in connexin expression in 
tissues of the human body, including the skin (Wright et al., 2012, Mendoza-Naranjo 
et al., 2012b). Abdullah and colleagues have reported that human diabetic dermal 
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fibroblasts demonstrated significantly greater gap junction communication when 
compared to normal dermal fibroblasts (Abdullah et al., 1999). Investigations into the 
connexin profiles of human diabetic foot ulcers, which supported the above 
discovery, found that there was no loss of Cx43 in fibroblasts at or near the wound 
margins of the chronic wounds investigated but it was upregulated (Mendoza-
Naranjo et al., 2012b). The key absence of normal down-regulation of this protein, 
which occurs in normal wound healing, may be a crucial factor in a wound’s failure 
to heal normally in a diabetic foot ulcer (Becker et al., 2012). 
Experimentally it is challenging to re-create a model of chronic wounds in vivo, as 
chronic wounds do not naturally occur in animals. This is primarily due to the 
absence of truly aged animals, neuropathy or chronic debility (Mustoe, 2004). 
Nonetheless, Wang, Becker and partners improved upon an FDA approved animal 
model in which it is known that normal wound healing is impaired. Delayed wound 
healing occurs in rat models of diabetes induced by streptozotocin (STZ). Wang and 
colleagues were the first to map the profiles of Cxs 26 and 43 in intact non-wounded 
skin and skin undergoing wound healing in this model (Wang et al., 2007). They 
discovered that, in comparison to normal intact skin, diabetes reduced the 
expression of Cxs 43 and 26 in the intact epidermis and increased Cx43 in the intact 
dermis. Diabetes also dramatically altered connexin dynamics during wound 
healing. Similar to human diabetic foot ulcers, Cx43 was significantly up-regulated in 
the wound edge epidermis, resulting in a thickened bulb of non-migrating 
keratinocytes.  Over a day later than normal wound healing, Cx43 finally down-
regulated in the epidermis and triggered the migration of keratinocytes into the 
wound. Although the dynamics of Cx26 did not change in diabetic rat skin, its 
distributions at the wound edge were abnormal and more widespread. 
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Further analysis by the same group confirmed that fibroblasts at the wound edge of 
human chronic foot ulcers had a 10 fold elevated expression of Cx43 in comparison 
to non-wounded skin, and that STZ-induced diabetic rats had an excess of Cx43 in 
their dermal fibroblasts (Mendoza-Naranjo et al., 2012b). Using an in vitro model of 
diabetes, where fibroblast cells were cultured in elevated glucose levels, it was 
found that Cx43 expression was significantly more elevated than in normal 
fibroblasts. Gap junction communication had significantly increased in these 
‘diabetic’ fibroblasts and migration rates in scratch wound assays had significantly 
decreased. The results support the theory that increased fibroblast Cx43 expression 
in vitro, in diabetic rat and in human diabetic foot ulcer skin, may be fundamental to 
the impaired healing found in diabetic foot ulcers. 
1.5.2.2 Cx43 in venous leg ulcers and pressure ulcers 
Research relating connexin dynamics to the failure of wound closure in human 
venous leg ulcers is sparse. However, Raffetto has described reduced motility in 
human dermal fibroblasts in patients with chronic venous insufficiency (a precursor 
to the development of venous leg ulcers) and Mendoza-Naranjo has noted that the 
same fibroblasts have significantly more Cx43 than their dermal counterparts in 
intact skin (Raffetto et al., 2001, Mendoza-Naranjo et al., 2012a).  
To date, there have been no published investigations (human or rodent based) into 
the role of connexins in the pressure ulcer. However, there has been progressive 
development on the design of an in vitro pressure ulcer model.  Primarily using 
metal plates and/or magnets, models of cyclic ischemia-reperfusion injury on the 
back of rodents has been refined to mimic chronic pressure ulcers (Peirce et al., 
2000, Reid et al., 2004). The models successfully mimic pressure sores, by creating 
tissue necrosis, hyper-thickened wounds and an increase in the inflammatory 
response.  
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1.5.3 Transient knockdown of Cx43 in wound healing 
It is clear (at least in diabetic foot and venous leg ulcers) that Cx43 plays a 
significant role in the failure of wound healing leading to a potential therapeutic 
target to be developed. 
1.5.3.1 Transient knockdown of Cx43 in acute wound healing 
Cx43 dynamics during acute wound healing is tightly regulated to ensure successful 
closure of the wound. After several years of development and research from the 
Becker group, a promising therapeutic that could enhance the rate of acute and 
chronic wound healing has emerged. A number of years ago a Cx43 specific 
antisense oligodeoxynucleotide (Cx43 asODN) was developed (Law et al., 2006); a 
30mer unmodified backbone antisense that targets to Cx43 mRNA and induces a 
Cx43 protein knockdown. This ODN has been demonstrated to promote accelerated 
wound healing (Qiu et al., 2003, Mori et al., 2006, Wang et al., 2007).  However, 
being unmodified, this ODN will rapidly break down in cells (half life of 20-30 
minutes) and break down even faster in blood (half life of fewer minutes), so will only 
act effectively where it is topically applied (Wagner, 1994). Exonucleases within 
serum are also known to break down unmodified oligodeoxynucleotides (Shaw et 
al., 1991). To counteract this short half-life and rapid breakdown, the therapeutic has 
been formulated within a Pluronic™ F-127 gel. This gel has thermo-reversible 
properties, (can be liquid on ice and gels at body temperature) that acts as a slow 
release reservoir and enables a constant topical delivery of Cx43 asODN over 
several hours. 
When immediately applied to a rodent skin wound, Cx43 asODN rapidly reduces 
Cx43 expression in wound edge keratinocytes, fibroblasts and blood vessels within 
two hours, nearly a whole day faster than in nature (Qiu et al., 2003, Mori et al., 
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2006). Early application of Cx43 asODN to acute wounds dampens tissue swelling 
and the inflammatory response, promotes early keratinocyte and fibroblast cell 
migration and closes the wound gap earlier than wounds left un-treated. Wounds 
treated with Cx43 asODN appear less red and swollen and rapidly reduce in size, 
resulting in smaller and thinner scar tissue (Qiu et al., 2003). Targeting the early 
stages of wound closure using Cx43 asODN appears to ‘jump-start’ the subsequent 
phases of wound healing. 
1.5.3.2 Transient knockdown of Cx43 in diabetic ulcers 
As described in much detail above, in both human diabetic foot ulcers and STZ- 
diabetic rat lesions, Cx43 fails to down-regulate at the wound edge, as seen in 
normal acute wounds 24h after wounding. Application of Cx43 asODN to acute 
wounds significantly reduces Cx43 at the wound edge and promotes an early wound 
healing response. Therefore application of Cx43 asODN to STZ-induced diabetic rat 
wounds should promote a better wound healing rate. Wang and colleagues 
confirmed this was the case, showing that a single application of Cx43 asODN on 
the wound immediately after wounding was sufficient enough to prevent Cx43 up-
regulation at the wound site (Wang et al., 2007). This single topical application was 
able to prevent the formation of a bulb of non-migratory keratinocyte cells, restoring 
the healing rate back to normal. As early research has suggested that human 
diabetic foot ulcers show a similar Cx43 profile to STZ-induced diabetic rat lesions, 
there is promise for Cx43 asODN as a therapeutic to promote healing in these 
debilitating wounds. 
1.6 Connexin mimetic peptides in wound healing 
Although it is now certain that Cx43 plays integral roles in both acute and chronic 
wound healing, it is still unclear whether these responses are attributed to the 
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connexin hemichannels or gap junctions. Long term hemichannel down-regulation 
can be achieved through topical application of Cx43 asODN; however the 
differences between gap junction communication and hemichannel signaling can be 
teased out by application of small connexin mimetic peptides. Acting on the 
extracellular loops of connexins, these peptides can rapidly block hemichannels and 
prevent gap junction formation. However, with longer or more concentrated 
incubation periods, connexin mimetic peptides have been reported to inhibit gap 
junctional communication.  
1.6.1 History of connexin mimetic peptides 
There are many compounds that can block gap junctional communication but their 
mechanisms of action frequently lead to unwanted and non-specific effects. For 
example, aliphatic alcohols, such as octanol (Cotrina et al., 1998b) and heptanol 
(Guan et al., 1997) and anesthetics, such as halothane (Boitano et al., 1992) act to 
disrupt gap junctional communication through the mechanism of ‘squeezing’; 
dissolving into the cell membrane and leading to the contraction of gap junctions. 
However, this action is likely to modify other non-gap junction channels in the area 
and therefore cannot be defined as a specific gap junctional communication limiter. 
Other methods to disrupt gap junction communication can be achieved by using 
lipophilic aglycones, such as 18α-Glycyrrhetinic acid which does not act directly on 
the gap junction. Instead they act indirectly via the activation of G proteins, protein 
kinases and ATPases, leading to the phosphorylation of the connexin, which will 
ultimately disrupt the gap junction assembly and channel gating (Taylor et al., 1998, 
Chaytor et al., 1999). 
The development of a specific and reversible inhibitors of gap junction 
communication began shortly after the deduction of the complete amino acid 
sequences of Cxs 32 and 43 (Evans et al., 2012). Through understanding the 
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involvement of gap junctions in mouse embryo development, Becker, Evans and 
colleagues were among the first to raise antibodies that would interfere with gap 
junctional communication (Becker et al., 1995). Antibodies for Cx43 were raised 
against the amino terminus, cytoplasmic loop and the carboxyl tail, whereas 
antibodies for Cx32 were raised against the cytoplasmic loop and the first 
extracellular loop. Predicted amino acid sequence homology confirmed that the 
antibody towards Cx32 first extracellular loop was recognized by both Cxs 32 and 
43. This particular antibody would not stain intact gap junctions. Parallel work 
carried out by Evans, Boitano and colleagues developed further antibodies towards 
Cx32 that would disrupt calcium waves in primary airway epithelial cells, propagated 
by gap junctions (Boitano et al., 1998). 
Although the development of specific antibodies towards connexins was a major 
step forward in the pursuit to find a specific inhibitor of gap junction communication, 
these antibodies were deemed too large. Although useful tools in blocking the 
docking of hemichannels during gap junction assembly, due to their size, they had 
limited access to the gap between docked hemichannels. Their size could also 
ultimately compromise their specificity. 
One of the key experimental studies that marked the beginning of the development 
of connexin mimetic peptides was conducted by Warner and colleagues (Warner et 
al., 1995). They developed and screened the efficiency of 15 short extracellular loop 
sequences that shared homology to amino acids in the first and second extracellular 
loops of Cx32. By testing the synchronization of the beating of embryonic chick 
heart myocytes, this group showed that all of the short peptides designed delayed 
gap junction formation. This work was successfully complimented in Xenopus 
oocytes that had been transfected with the mRNA of Cx32 (Dahl et al., 1994). 
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The potential of short mimetic peptides to disrupt gap junction communication had 
been realized and it was noted that Warner paid particular attention to two motifs on 
the two extracellular loops; SHVR on the first and SRPTEK on the second. As Cx43 
is the most ubiquitous gap junction protein, two synthetic short connexin mimetic 
peptides were designed to encompass these motifs. Gap26 corresponded to the first 
extracellular loop (amino acid sequence VCYDKSFPISHVR) and Gap27 to the 
second (amino acid sequence SRPTEKTIFII). The names corresponded to the 26th 
and 27th synthesized connexin mimetic peptides that were designed by Evans in the 
Medical Research Council for gap junction projects. 
1.6.2 The benefits of connexin mimetic peptides in wound healing 
In recent years it has been realized that connexin mimetic peptides show a huge 
potential in tackling connexin-based maladies and show promise in translational and 
therapeutic possibilities. These prospects include enhancing the rate of wound 
repair in acute and chronic wounds and reducing the spread of damage caused in 
tissue ischemia reperfusion. 
Early work conducted by the Martin group has not only shown that both Gap26 and 
Gap27 reduce gap junction communication in human keratinocyte and fibroblast 
cells but also that it has great potential in the wound healing environment (Wright et 
al., 2009, Pollok et al., 2011). Using scratch wound assays (creating an in vitro 
‘wound’ across a confluent layer of cells) it was shown in both keratinocytes and 
fibroblasts that connexin mimetic peptides could increase the rate of migration 
across these scrapes (Wright et al., 2009). Further encouraging ex vivo work using 
3D organotypic porcine wound models demonstrated that Gap27 could accelerate 
wound closure through an increase in keratinocyte re-epithelialisation and enhanced 
proliferation rates (Pollok et al., 2011). This work will be built upon and explored in 
further detail in chapters three and four of this thesis. 
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Tissue ischemia is a major medical problem that plagues a number of organs and is 
caused by a restriction of blood supply to tissue, causing a severe shortage of 
oxygen, glucose and other nutrients needed for cell survival. Tissue ischemia is 
common in cardiac (heart attacks), cerebral (strokes) and skin (pressure ulcers) 
tissue, however, the real damage often occurs upon reperfusion. This is when the 
blood supply returns in a restoration of circulation and causes inflammation and 
oxidative damage to the tissue that has been denied oxygen flow for a period of 
time. Often this damage spreads beyond the initial ischemic area and this spread of 
damage and cell death has recently been attributed to increased gap junction and 
hemichannel communication (García-Dorado et al., 2004, Cotrina et al., 1998a, 
Thompson et al., 2006, Orellana et al., 2010). 
There is already potential therapeutic promise that connexin mimetic peptides could 
provide cardiac and neuronal protection during ischemia reperfusion. O’Carroll, 
Green and colleagues pioneered in showing that during an in vitro spinal cord injury 
model, treatment with connexin mimetic peptides could significantly reduce the cell 
damage that occurs (O'Carroll et al., 2008). Building on this research, using a model 
of cerebral ischemia in foetal sheep, Davidson and colleagues demonstrated that 
connexin mimetic peptide treatment could not only increase the survival rate of cells 
during ischemia reperfusion but also reduce seizure activity (Davidson et al., 
2012b). Cardiac protection has also been noted when rat models of myocardial 
infarction are treated with connexin mimetic peptides (Hawat et al., 2012). 
Treatment significantly reduced the infarct size by over 60%. 
To date, there has been no published work indicating that connexin mimetic 
peptides could reduce the extensive progressive damage often seen in pressure 
ulcers. Continued cyclic periods of pressure and relief during pressure ulcer 
formation causes severe tissue ischemia reperfusion damage in the skin, similar to 
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the damage formed in cerebral and cardiac ischemia reperfusion. There are 
currently no effective treatments for this irreversible pressure ulcer damage caused 
by ischemia reperfusion injury and understanding how cell death occurs and 
spreads will help in the discovery of a treatment to reduce the impact of ischemia 
reperfusion damage. This topic will be greatly explored in chapters five and six of 
this thesis. 
1.7 General aim of this thesis 
The potential therapeutic implications of the wound healing properties of connexin 
mimetic peptides are exciting, novel and promising. It has recently become apparent 
that gap junctions and their connexins play an integral and crucial role in wound 
healing. The overall aims of this PhD thesis are to further explore the role and 
potential therapeutic implications of the connexin mimetic peptide Gap27 in both in 
vitro and in vivo models of wound healing and to use Gap27 to investigate the 
mechanism of cell death and damage during ischemia reperfusion injury. 
Hypotheses will be addressed in individual research chapters. 
Aims and objectives 
1) To characterize the effect of Gap27 on connexin expression in fibroblast and 
keratinocyte cells, while exploring the effects of the connexin mimetic peptide in cell 
communication and in vitro models of wound healing. 
2) To investigate the ability of connexin mimetic peptides to enhance wound closure. 
An examination of the potential enhanced wound healing properties of Gap27 will be 
carried out using a well-documented in vivo wound healing model. Detailed analysis 
will be executed on the effect of Gap27 treatment during the early stages of wound 
healing. This will include an assessment on the inflammatory response and re-
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epithelialisation, while special attention will be given to the connexin profiles in 
treated and non-treated tissue to establish the importance of connexins during 
wound healing. 
3) To investigate the mechanism of spread of cell death and damage during 
ischemia reperfusion injury in vitro by probing this with mimetic peptides. Connexin 
mimetic peptides have a unique dose response; at low doses, Gap27 has been 
shown to block hemichannels but can target gap junctional intercellular 
communication at higher doses and for longer periods of incubation. Using this tool, 
I plan to dissect out the relative contributions of the connexin based communication 
involved in the spread of cell death and damage during ischemia reperfusion during 
pressure ulcer formation. 
4) Finally, using an in vivo model of pressure ulcers developed by Thomas Mustoe 
the role of Cx43 based hemichannels and gap junctions will be examined during 
ischemia reperfusion in the skin. 
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2. Materials and methods 
This chapter covers all materials, reagents and protocols in detail and which are 
referred back to in the results chapters. 
2.1 Reagents, antibodies and mimetic peptides 
All chemicals and reagents were purchased from Sigma-Aldrich (Gillingham, UK) 
unless otherwise stated. Tissue culture reagents were purchased from Gibco 
(Paisley, UK) unless otherwise stated. Details of antibodies, connexin mimetic 
peptides and anti sense oligodeoxynucleotide (asODN) used in experiments are as 
follows. 
Table 2-1 Primary antibodies used in this investigation 
 
The table details all primary antibodies used in either cell culture (immuno), in mouse tissue 
(immuno) or in Western blots (WB). The table includes information regarding the name of the 
antibody, at what dilution the antibody was used at and for what incubation period.                
* Rabbit anti connexin hemichannel antibody (rb anti Cx HC) is a custom made affinity 
purified antibody against a highly conserved portion of the 1st ECL of Cx43. Sequence: 
ESAWGDEQSAFRCNTQQPGC. This antibody will only bind to E1 and prevent gap junction 
formation and therefore will only stain for non-docked hemichannels.  
Name Protocol Host Reactivity Dilution Incubation Manufacturer Catalogue #
Immuno 1 in 4000 1 hour at RT
WB 1 in 4000 Overnight at 4°C
rb anti Cx26 Immuno Rabbit Cx26 1 in 200 Overnight at 4°C Life Tech, UK 51-2800
rb anti Cx30 Immuno Rabbit Cx30 1 in 200 1 hour at RT Life Tech, UK 71-2200
rb anti Cx HC* Immuno Rabbit Cx HC 1 in 1000 Overnight at 4°C Custom made n/a
rt anti α tubulin Immuno Rat alpha tubulin 1 in 2000 1 hour at RT Abcam, UK ab64332
rb anti Cx43 Sigma, UK C6219Rabbit Cx43
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Table 2-2 Secondary antibodies used in this investigation 
 
The table details all secondary antibodies used in conjunction with the primary antibodies, 
used in either cell culture (immuno), in mouse tissue (immuno) or in Western blots (WB). The 
table includes information regarding the name of the antibody, at what dilution the antibody 
was used at and for what incubation period. 
Table 2-3 Sequences of connexin mimetic peptides 
 
The table details mimetic peptides used in this investigation. Connexin mimetic peptide 
Gap27 (sequence SRPTEKTIFII) was designed against a portion of the second extracellular 
loop of Cx43 that leads into the fourth transmembrane domain (figure 2.1). The highly 
conserved sequence SRPTEK is found on Cxs 43, 26 and 30. Scrambled peptide (sequence 
RFKSPSLCTTDEV) was designed by Colin Green and includes a scrambled portion of the 
highly conserved sequence (RFKSPSLCTTDEV). 
  
Name Protocol Host Reactivity Dilution Incubation Manufacturer Catalogue #
gt anti rb AF 488 Immuno Goat Rabbit 1 in 500 1 hour at RT Life Tech, UK A-11008
gt anti rb AF 568 Immuno Goat Rabbit 1 in 500 1 hour at RT Life Tech, UK A-11009
gt anti rb HRP WB Goat Rabbit 1 in 1000 1 hour at RT Life Tech, UK G-21234
gt anti rt HRP WB Goat Rat 1 in 1000 1 hour at RT Life Tech, UK A-10549
Name Sequence Connexin Residue # MW Purity Custom made by Reference
Gap27 SRPTEKTIFII 43 204-214 1304 g/mol 95%  Thermo Scientific, Germany Chaytor et al., 1997
Scrambled RFKPSLCTTDEV none none 1396 g/mol 95% Peptide2.0, USA Danesh-Meyer et al. 2011
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Figure 2.1 Connexin 43 with Gap27 and antibodies 
Diagram shows Cx43 sequence of rat. Connexin mimetic peptide Gap27 shares homology to 
the second extracellular loop that leads into the fourth transmembrane domain of the protein 
Cx43. Gap27 sequence: SRPTEKTIFII. Primary antibody for Cx43 corresponds to the C-
terminal segment of the cytoplasmic domain (amino acid 363-382). Primary antibody for Cx 
HC corresponds to 1st ECL. Sequence: ESAWGDEQSAFRCNTQQPGC 
Table 2-4 Sequence of antisense oligodeoxynucleotide 
 
The table details Cx43 specific antisense oligodeoxynucleotide used in this investigation. 
Cx43 asODN (sequence 5′-GTA ATT GCG GCA GGA GGA ATT GTT TCT GTC-3′) is a 
30mer that targets to Cx43 mRNA and induces a Cx43 protein knockdown. 
Name Sequence Custom made by
Cx43 asODN 5′-GTA ATT GCG GCA GGA GGA ATT GTT TCT GTC-3′  Sigma, Poole, UK
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2.2 In vitro 
2.2.1 Cell culture 
2.2.1.1 Fibroblast and keratinocyte cell culture 
Immortal fibroblast cells derived from mouse (NIH 3T3) were cultured in Dulbecco’s 
Modified Essential Medium (DMEM; 4.5 g/l D-glucose, L-glutamine, pyruvate, 
phenol red) supplemented with 10% donor bovine calf serum (DBS), 100 U/ml 
penicillin and 100 µg/ml streptomycin. This complete medium is abbreviated to 
fibroblast DMEM.  
Immortal keratinocyte cells derived from human (HaCaT) were a kind donation from 
J.Sutcliffe and cultured in 43.5% DMEM (4.5 g/l D-glucose, L-glutamine, pyruvate, 
phenol red) and 43.5% DMEM F-12 (L-glutamine) supplemented with 10% heat-
inactivated foetal  bovine serum (FBS), 1% GlutaMAX®, 1% RM plus supplement 
(final concentration of  5 µg/ml transferrin, 0.4 µg/ml hydrocortisone, 5 µg/ml insulin, 
10 ng/ml EGF, 2x10-11 liothyronine and 10-10 M cholera toxin), 50 U/ml penicillin and 
50 µg/ml streptomycin (Aasen and Izpisúa Belmonte, 2010). This complete medium 
is abbreviated to keratinocyte DMEM. 
Fibroblast and keratinocyte cells were cultured in separate humidified incubators 
with atmospheres of 5% CO2 and 95% air, at 37°C. Cell growth and health was 
regularly monitored and cell medium was changed every 2-3 days in both cell types. 
If cells reached 80% confluence and were not needed for experiments, they were 
split down 1 in 3 to reduce overcrowding.  
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2.2.1.2 Retroviral constructs and transduction 
Fibroblast cells were transduced with a Cx43 specific shRNA construct (sequence 
5’-GGTGTGGCTGTCAGTGCTC-3’; a gift from W. H. Moolenaar) or a retroviral 
empty vector (pSuppressor; Imagenx Co. San Diego, USA).  The GP2-293 
packaging cell line (Clonetech) was transfected by calcium phosphate precipitation 
with 5 µg pMD.G envelope plasmid, 10 µg pBSII SK-carrier plasmid (Stratagene) 
and 15 µg retroviral plasmid containing either Cx43shRNA or the empty vector. The 
viral medium was collected and used to infect NIH 3T3 cells growing in fibroblast 
DMEM at 37C in 5% CO2. Viral medium was replaced every 12 hours for 48 hours. 
Resistance to 2 µg/ml puromycin (Cx43shRNA) or 500 µg/ml geneticin (empty 
vector) was used to select transduced cells. 
The first three passages of transduced pSuppressor (PSupp) and transduced 
Cx43shRNA (shRNA) NIH 3T3 fibroblast cells were used in all experiments. All cells 
were cultured in fibroblast DMEM at 37C in a humidified incubator with an 
atmosphere of 5% CO2 and 95% N2, at 37°C. All experiments were carried out when 
cultures reached 80% confluence. 
2.2.2 Mimetic peptide incubation 
During in vitro experiments the connexin mimetic peptide Gap27 and scrambled 
mimetic peptide (refer to table 2.3) were prepared in reduced serum medium Opti-
Minimal Essential Medium (OptiMEM) supplemented with 1% DBS. This complete 
medium is abbreviated to OptiMEM. As a modification of DMEM, OptiMEM allowed 
cells to continue to grow and proliferate successfully in a heavily reduced serum 
environment. This enabled the fragile peptide to incubate optimally while preventing 
its breakdown by proteases that reside within the serum. Control cells were also 
cultured in OptiMEM during experiments for direct comparison.  
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In dose response experiments, mimetic peptide incubation was the same for 
fibroblasts and keratinocytes, in immunostaining and in Western blots. For two hour 
incubation periods, cultures were treated with a single dose of Gap27 (10, 30, 100 
or 300 µM) scrambled peptide (100 µM) or left untreated (naive OptiMEM). For six 
hour incubation periods, cultures were treated with Gap27 (10, 30, 100 or 300 µM) 
scrambled peptide (100 µM) or left untreated (naive OptiMEM) and medium was 
replaced every two hours with fresh medium containing peptide. Details of mimetic 
peptide incubation times and concentration in assays is detailed in the relevant 
sections below and addressed in individual research chapters. 
2.2.3 Oxygen glucose deprivation re-oxygenation 
Fibroblast cells were subjected to hypoxic conditions before reperfusion in an 
oxygen-glucose deprivation-reoxygenation (OGDR) insult. Cell medium was 
replaced with glucose and serum free medium (0 g/l D-glucose, L-glutamine, phenol 
red) that had been effervesced with 5% CO2 and 95% N2 for one hour. This medium 
is abbreviated to OGDR DMEM. Hypoxia was induced by placing the cultures inside 
a sealed chamber with an atmosphere of 5% CO2 and 95% N2 for 1.5 hours. Cells 
were then exposed to reoxygenation through medium change (OptiMEM) at 37°C in 
5% CO2 and 95% air for progressive periods of time (0, 1.5, 4 and 24 hours). 
2.2.3.1 Measuring oxygen levels in the media 
Partial pressure of oxygen within OGDR DMEM was measured using the fibre optic 
oxygen (FOXY) probe (Ocean Optics, Florida, USA), to confirm hypoxic conditions. 
Oxygen levels of fibroblast DMEM were measured as a control. FOXY probe tips are 
covered with a layer of ruthenium compound trapped in a matrix of a hydrophobic 
gel. When excited by an LED, the ruthenium compound fluoresces and if the excited 
ruthenium comes into contact with an oxygen molecule, the excess energy will 
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quench the ruthenium fluorescent signal. This intensity or phase shift of 
fluorescence is measured by a spectrometer (Ocean Optics, Florida, USA) and is 
then related to the partial pressure of oxygen.  
Before sample measurements were taken, the FOXY probe was calibrated using 0% 
oxygen and 21% oxygen standards. The zero oxygen standard was prepared by 
dissolving one gram of sodium hydrosulphite in 20 ml of 1X phosphate buffered 
saline (PBS) and warming to 37 °C in a waterbath before being read with the probe. 
Sodium hydrosulphite is a strong reducing agent that removed all oxygen from the 
solution. The atmospheric oxygen standard was prepared using 1X PBS and 
warming to 37 °C before being read. A standard curve was created using the 
program OOISensors (Ocean Optics, Florida, USA). OGDR and fibroblast DMEM 
were also read at 37 °C.  
2.2.4  Immunostaining cells 
Cells were grown to confluence in 8-well chamber slides (Millicell EZ slide, Millipore, 
Watford, UK) and subjected to treatment as described above (OGDR insult and/or 
mimetic peptide incubation). At required time points, cells were fixed in 4% 
paraformaldehyde (PFA) in 1XPBS for 5 min, incubated with a blocking solution (1M 
lysine, 1X PBS, 0.05% Triton X-100) for a further 30 min and immunolabeled with a 
primary antibody diluted in blocking solution (refer to table 2.1 for dilutions and 
incubation periods). Negative controls were incubated overnight in blocking solution 
containing no primary antibody for the same time. Following removal of the primary 
antibody solution, cells were washed in triplicate using 1X PBS before incubation for 
one hour at room temperature with the secondary antibody (refer to table 2.2 for 
dilutions) diluted in blocking solution. A counter stain of Höechst 33258 and 33342 
(1:50,000) diluted in dH2O was applied as a nuclear indicator. After a further three 
1X PBS washes, the culture chamber slides were mounted onto microscope 
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coverslips using Citiflour™ mounting medium and viewed under a confocal 
microscope (Upright SPE, Leica, Milton Keys, UK).  All images were acquired using 
identical parameters and camera settings to allow for direct comparison of staining 
intensity. Images were uploaded to ImageJ™ (version 1.46r, Wayne Rasband, NIH, 
USA) to analyse connexin profiles. A threshold was set to ensure maximum 
connexin expression was measured while taking care to eliminate the background. 
Nuclei count was achieved by creating a binary image of the nuclei and counting 
solid nuclei structures. All parameters were kept constant for all measurements 
while connexin pixel area per cell was quantified.  
2.2.5 Western blots 
2.2.5.1 Protein collection, quantification and preparation 
Cells were grown to confluence in 6-well plates and subjected to treatment as 
described above (OGDR insult and/or mimetic peptide incubation). Cultures were 
washed in 1X PBS and lysed with ice cold radio immunoprecipitation (RIPA) buffer 
(0.05 M Tris pH 8.0, 0.15 M NaCl,  1% Triton X-100, 0.5% sodium deoxycholate and 
0.1% SDS) with complete protease and phosphatase inhibitor cocktail tablets; one 
tablet of each per 10 ml RIPA buffer (Roche, Hertfordshire, UK). Cells were scraped 
and total cell protein was collected on ice. Lysates were sonicated for 30 min and 
centrifuged at 4°C for 10 min before the purified supernatant was collected. Cell 
homogenates were stored at -20°C until required for blotting. 
Protein content of the samples was determined using a BSA assay (Thermo 
Scientific, Northumberland, UK) in a 96-well format according to the manufacturer’s 
instructions. Equal amounts of protein were denatured using reducing Laemmli 4X 
buffer (Bio-Rad, Hertfordshire, UK) at 100°C for 10 min. Samples were allowed to 
cool before gel loading. 
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2.2.5.2 Gel electrophoresis, transfer and blocking 
Protein samples were run on a precast 10% SDS-PAGE resolving gel (Bio-Rad, 
Hertfordshire, UK) for one hour at 150V. Samples were then transferred onto 
nitrocellulose membrane for one hour at 100V. Protein transfer was confirmed using 
Ponceau Red solution (1% acetic acid, 0.5% Ponceau Red) in dH2O and 
membranes were subsequently washed thoroughly with PBS-Tween (1X PBS, 1% 
Tween20) to remove Ponceau Red stain. Following successful protein transfer the 
membrane was blocked in 1% non-fat milk diluted in PBS-Tween, for one hour at 
room temperature, under gentle agitation. 
2.2.5.3 Antibody incubation and detection 
The membranes were incubated with a primary antibody (refer to table 2.1 for 
dilutions and incubation periods) diluted in blocking solution, under gentle agitation.  
The following day the antibody solution was removed and membranes were washed 
in triplicate using PBS-Tween. The membranes were subsequently incubated with a 
secondary antibody (refer to table 2.2 for dilutions) conjugated with horseradish 
peroxidise (HRP), diluted in blocking solution, for one hour at room temperature, 
under gentle agitation. The secondary antibody was then removed and the 
membranes were washed in triplicate using PBS-Tween. 
To visualise the immunoreactivity, ECL (West Pico chemiluminescent substrate, 
Thermo Scientific, Northumberland, UK) was used according to the manufacturer’s 
instructions. Detection and visualisation of the proteins on the membranes were 
achieved through exposure using a ChemiDoc™ (Bio-Rad, Hertfordshire, UK). 
Digital images were collected and then loaded onto ImageJ for protein band 
intensity analysis. The intensity of the protein of interest was measured relative to 
the intensity of the housekeeping protein. Alpha tubulin was used as a 
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housekeeping protein (refer to tables 2.1 and 2.2 for dilutions and incubation 
periods). All protein collection for Western blots was repeated in triplicate. 
2.2.6 Detailed assays using cell cultures 
2.2.6.1 Migration assays – scratch wound 
Scratch wound assays were used to investigate mimetic peptide effects on cell 
migration rates. Cells were cultured and grown to confluence in 24-well plates that 
had been pre-treated with an attachment factor. This prevented the cells from 
ruffling upon scratching. An in vitro model of wounding was performed by drawing a 
200 µl pipette tip across confluent cells in each well. Cultures were rinsed of any cell 
debris and incubated with a single dose of 10, 30, 100 or 300 µM Gap27, 100 µM 
scrambled peptide or left untreated (naive OptiMEM). Images of migrating cells were 
taken on an Olympus inverted microscope (Olympus 1X81) on an XYZ stage (Prior 
XYZ stage, Cambridge, UK), in a temperature and gas controlled chamber (5% CO2 
and 95% air at 37°C). An image of a defined area at the edge of each scratch 
wound was taken and subsequent images were taken every hour of the same 
location, for six hours. The rate of migration was quantified by measuring the 
movement of the leading edge over time.  
2.2.6.2 Communication assays - fluorescent recovery after photobleaching 
Fluorescent Recovery after Photobleaching (FRAP) was used to investigate the 
connectivity of neighbouring cells, through gap junction communication, by 
monitoring the diffusion of a flurophore between the two. FRAP was used to assess 
connexin mimetic peptide effect on communication between fibroblast cells and to 
assess communication between fibroblast cells during OGDR insult. Both 
experiments were subject to the same FRAP procedure (described in more detail 
below). 
Chapter 2 Materials and methods 
76 
 
Communication of fibroblasts continuously incubated with Gap27 for 2 hours 
Fibroblast cells were cultured on glass bottom 35 mm2 dishes and grown to 
confluence. Cultures were washed in 1X PBS before undergoing continuous 
incubation for two hours with Gap27 (30 or 300 µM) or scrambled peptide (300 µM) 
prepared in OptiMEM. A control of non-treatment (naive OptiMEM) was used. After 
two hours of incubation in mimetic peptide, calcein acetoxymethyl ester, (calcein-
AM; 1 µl/1000 µl of medium) was added to the cells for a 20 min incubation period. 
The medium was then removed and cultures were washed in triplicate using 1X 
PBS. Cultures were then replaced with fresh medium containing connexin mimetic 
peptide (or naive OptiMEM) and propidium iodide (PI; 1 µl/1000 µl of medium) 
before FRAP was carried out. 
Communication of fibroblasts subjected to OGDR and treated with continuous 
incubation of Gap27 for 4 hours 
Fibroblast cells were cultured on glass bottom 35 mm2 dishes and were grown to 
confluence. Cultures were washed in 1X PBS before being subjected to OGDR 
insult as described above. After 1.5 hours of oxygen-glucose deprivation, cells were 
subjected to reperfusion. Cells were either continuously incubated with Gap27 (100 
or 300 µM) or left un-treated (naive OptiMEM). A control of no OGDR and no 
treatment was used. After four hours of incubation in mimetic peptide, calcein-AM 
was added to the cells for 20 min. The medium was then removed and cultures were 
washed in triplicate using 1X PBS. As described above, cultures were then replaced 
with fresh medium containing connexin mimetic peptide (or naive OptiMEM) and PI 
before FRAP was carried out. 
FRAP images were taken on a confocal microscope, with a temperature and gas 
controlled chamber (5% CO2 and 95% air at 37°C). Using a 63X water immersion 
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apochromatic objective lens (NA, 0.9), optical sections were scanned in xyt mode. A 
zoomed region of interest (ROI) covering a connected cell was bleached of its 
flurophore with increased laser power before being allowed to recover at a rate of 
1.635 seconds per frame. Communication was monitored through fluorescent 
recovery; by timing how long it took for cells to transfer fluorescent calcein to their 
neighbouring bleached cell through gap junctions. Fluorescent recovery was 
measured by loading the images of recovery frames onto ImageJ. The average 
image intensity of the ROI was measured in every frame over the same time period. 
Calcein-AM is commonly used in cell communication assays as the acetomethoxy 
(AM) ester segment and allows the diffusion of calcein through the cellular 
membrane. Once inside the cell, intracellular esterases cleave the AM group, 
hydrolysing calcein into a hydrophilic charged derivative. Calcein then becomes 
trapped within the cytoplasm and becomes fluorescent. Now at a MW of 622.55 
g/mol, calcein is free to move between communicating cells via their gap junctions. 
Dead and dying cells lack active esterases and therefore only live cells are labelled. 
PI is a charged dye which is membrane impermeant and is often used as a dead cell 
indicator, although live cells with open hemichannels can also label with this dye. 
The role of PI in these experiments was to ensure imaging did not kill cells and give 
false results.  
2.2.6.3 Cell viability assay - MTT 
An MTT reduction assay was used to assess cell viability index in fibroblast cells 
subjected to an OGDR insult. Cell viability in wild-type, PSupp or shRNA fibroblast 
cells was measured. In subsequent experiments wild-type fibroblasts were either 
treated with Suramin or Gap27 after reperfusion before their cell viability was 
measured. All experiments were subject to the same MTT assay described in more 
detail below. 
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Cell viability in wild-type, PSupp and shRNA fibroblast subjected to OGDR 
Wild type, PSupp or shRNA fibroblast cells were cultured in 96-well plates at a 
density of 10,000 cells per well and allowed to grow to 60-70% confluence. Cells 
were subjected to OGDR insult and cell viability was measured at progressive time 
points after 1.5 hours after reoxygenation (0, 4 and 24 hours) using an MTT assay. 
Cell viability in fibroblasts subjected to OGDR then treated with Suramin  
Wild type fibroblast cells were cultured in 96-well plates at a density of 10,000 cells 
per well and allowed to grow to 60-70% confluence. Hypoxia was induced as 
described above and cells were exposed to reoxygenation 1.5 hours after oxygen 
glucose deprivation. Cultures were treated with a single dose of 100 µM Suramin in 
fibroblast DMEM or left untreated (naive fibroblast DMEM). A control of no OGDR 
was used. Suramin is a general, non specific P2Y and P2X purinergic receptor 
antagonist. Cell viability was measured at progressive time points after 
reoxygenation (0, 4 and 24 hours) using an MTT assay. 
Cell viability in fibroblasts subjected to OGDR then treated with Gap27 
Wild type fibroblast cells were cultured in 96-well plates at a density of 10,000 cells 
per well and allowed to grow to 60-70% confluence.  Hypoxia was induced as 
described above and cells were exposed to reoxygenation 1.5 hours after oxygen 
glucose deprivation. Cultures were treated with a single dose of 30 or 300 µM 
Gap27 in OptiMEM or left untreated (naive OptiMEM). A control of no OGDR was 
used. Cell viability was measured at progressive time points after reoxygenation (0, 
4 and 24 hours) using an MTT assay. 
Chapter 2 Materials and methods 
79 
 
Cell viability index was measured using the MTT reduction assay and was 
performed according to the manufacturer’s instructions (Millipore, Watford, UK). Ten 
ml of 1X PBS was added to 50 mg of MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyl tetrazolium bromide) and 10 µl of MTT solution was added to the culture 
medium in each well.  Mitochondrial and cytosolic dehydrogenases reduced the 
yellow tetrazolium salt (MTT) to a dark blue formazan dye capable of 
spectrophotometric detection. This process required active mitochondria from living 
cells and therefore dead cells do not cleave MTT. After four hours of incubation at 
37°C, 100 µl of isopropanol with 0.04N hydrochloric acid (HCl) was added to each 
well. The isopropanol dissolved the formazan to give a homogenous blue solution 
suitable for absorbance. Absorbance was measured on a microplate 
spectrophotometer (Spectra Max 340; Molecular Devices, Berkshire, UK) at a test 
wavelength of 570 nm and a reference wavelength of 630 nm. Absorbance is 
directly proportional to the number of live cells and was normalized to the untreated 
control cultures which represented 100% viability, zero hours after reperfusion. 
Percentage of viability was measured by dividing the mean absorbance of the 
sample by the mean absorbance of control, multiplied by 100. 
2.2.6.4 Hemichannel activity assay during OGDR 
In order to monitor cells for hemichannel activity, PI uptake was observed and 
measured in low confluence fibroblast cells. As PI is membrane impermeant it is 
often used as a dead cell indicator, although live cells with open hemichannels will 
also label with this dye. Cells were cultured and grown to low confluence in 24-well 
plates to ensure cell to cell contact was not achieved and therefore any 
hemichannels at the plasma membrane remained undocked. Cultures were 
subjected to OGDR insult as described above and after 1.5 hours of oxygen-glucose 
deprivation, cells were subjected to reperfusion. Calcein-AM was added to the cells 
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for a 20 min incubation period. The medium was then removed and cultures were 
washed in triplicate using 1X PBS. Cultures were then treated with a single dose of 
30, 100 or 300 µM Gap27 in OptiMEM or left untreated (naive OptiMEM). This was 
to ensue ‘plugging’ of open hemichannels and not continuous disruption of Cx43. A 
control of no OGDR was used. Images of a defined area of low confluence were 
taken on an Olympus inverted microscope (Olympus 1X81) on an XYZ stage (Prior 
XYZ stage, Cambridge, UK),  in a temperature and gas controlled chamber (5% CO2 
and 95% air at 37°C). Further images of the same region of interest were taken 
every 30 min for five hours in each group. PI uptake was measured as a percentage 
of calcein-AM labelled cells in the first frame taken.  
2.2.6.5 Bystander effect assay during OGDR 
In order to monitor gap junction communication activity, PI uptake and transfer to 
neighbours in confluent fibroblast cells was observed. PI will enter cells through 
open hemichannels and is therefore small enough to pass to neighbouring cells via 
gap junction communication. Cells were grown to confluence to ensure gap 
junctions had the best possible chance of forming between neighbouring cells. 
Cultures were subjected to OGDR insult as described above and after 1.5 hours of 
oxygen-glucose deprivation, cells were subjected to reperfusion. Cells were either 
incubated with Gap27 (10, 30, 100, 300 or 1000 µM), 100 µM scrambled peptide or 
left un-treated (naive OptiMEM). A control of no OGDR and no treatment was used. 
After four hours of incubation in mimetic peptide, calcein-AM was added to the cells 
for a 20 min incubation period. The medium was then removed and cultures were 
washed in triplicate using 1X PBS. As described above, cultures were then replaced 
with fresh medium containing connexin mimetic peptide in OptiMEM (or naive 
OptiMEM) and PI. Images of a defined area of confluent cells were taken on an 
Olympus inverted microscope (Olympus 1X81) on an XYZ stage (Prior XYZ stage, 
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Cambridge, UK), in a temperature and gas controlled chamber (5% CO2 and 95% 
air at 37°C). Further images of the same region of interest were taken every hour for 
24 hours in each group. PI uptake was measured as a percentage of calcein-AM 
labelled cells in the first frame taken. Total PI uptake over 24 hours was measured.  
The protocol was repeated using shRNA fibroblast cells and total PI uptake over 24 
hours was measured.  
The protocol was also repeated under Brilliant blue G (BBG) treatment. As 
described above, fibroblast cells were subjected to 1.5 hours of oxygen glucose 
deprivation followed by reperfusion. Cells were incubated with 2 or 20 µM BBG, 300 
µM Gap27 or left untreated (naive OptiMEM). BBG is an antagonistic P2Y purinergic 
receptor blocker. After four hours of incubation in BBG or mimetic peptide, calcein-
AM was added to the cells for a 20 min incubation period. The medium was then 
removed and cultures were washed in triplicate using 1X PBS. As described above, 
cultures were then replaced with fresh medium containing BBG, connexin mimetic 
peptide or naive OptiMEM, and PI. . Images of a defined area of confluent cells were 
taken on an Olympus inverted microscope (Olympus 1X81) on an XYZ stage (Prior 
XYZ stage, Cambridge, UK), in a temperature and gas controlled chamber (5% CO2 
and 95% air at 37°C). Further images of the same region of interest were taken 
every hour for 24 hours in each group. PI uptake was measured as a percentage of 
calcein-AM labelled cells in the first frame taken. Total PI uptake over 24 hours was 
measured.  
  
Chapter 2 Materials and methods 
82 
 
2.3 In vivo 
Three sets of animal experiments were carried out and all procedures conformed to 
UK Home Office regulations under project licence PDL70/6778. 
2.3.1 Animals 
Six week old male mice from the Institute of Cancer Research (ICR, UK) were used 
in all experiments. These animals were individually housed in an environmentally 
controlled room (temperature 21±3°C, humidity 50±20%, a light/dark cycle of 12 
hours) and allowed free access to food and water. All mice were 30-35 g in weight. 
2.3.2 General surgical procedures 
All mice received anaesthesia and analgesic before surgical procedures were 
carried out.  Individual mice were initially placed in a sealed chamber and 
anaesthesia was administered via isoflurane (3-4% isoflurane in 100% oxygen) at 
an air flow rate of two litres per minute. During this time a large patch of fur was 
shaved from the mouse dorsum (covering the area of interest to be wounded). The 
mouse was then injected subcutaneously, in the scruff of the neck, with 0.1 mg/kg 
analgesic buprenorphine (Vetergesic™). The anaesthetised mouse was then 
transferred to a heated mat and laid on its ventral side, while isoflurane was 
continually administered through a nose cone at the same concentrations and rates 
described above. The mouse pad or ear was pinched to gauge the response to 
anaesthesia and analgesic. Wounding was only carried out on unresponsive mice.  
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Figure 2.2 Diagrams of surgical procedures 
 (A) Gap27 effect in vascular permeability. Mice were subjected to four 6mm wounds. Two 
wounds were treated with a single 25 µl dose of either 100 or 300 µM Gap27, one wound 
was treated with 300 µM Cx43 asODN (positive control) and the final wound was left 
untreated (negative control). Four hours after wounding, a 200 µl FITC-BSA was injected 
into the tail vein of each mouse. Mice were then euthanized 30 min after injection. (B) Gap27 
effect in wound healing. Mice were subjected to four 6mm wounds. Three wounds were 
treated with a single 25 µl dose of 100, 300 or 1000 µM Gap27 and the final wound was left 
untreated (negative control). Mice were then euthanized 24 hours after wounding.  
2.3.2.1 Gap27 effect in vascular permeability during wound healing  
A total of seven mice were wounded and treated with the investigational products; 
Gap27 (100 and 300 µM) and Cx43asODN (300 µM). The drugs were dissolved in 
molecular grade water to make 1 mM stock before being formulated in 30% 
Pluronic™ gel. This delivery substance has thermo-reversible properties (can be 
liquid between 0 and 4°C and gels above 4°C) that enabled a constant and stable 
topical delivery of the drugs. Four circular 6mm full thickness punch wounds were 
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made on either side of the dorsal midline of each mouse. A single 25 µl application 
of either 100 or 300 µM Gap27 or 300 µM Cx43 asODN were then applied to the 
wounds as detailed in figure 2.2A.  Each mouse was kept anesthetised for a further 
30 min to allow the investigational products to absorb into the wound. The mice 
were then placed in a heated animal holding container, for recovery, before being 
returned to its home cage.  
Three hours after wounding, each mouse was injected with 1.5% FITC-BSA via the 
tail vein. FITC-conjugated with Bovine Serum Albumen is used for vascular 
permeability measurements in inflammatory and oedema models. In order to see the 
delicate tail vein each mouse was warmed to 40°C in a heated chamber that caused 
vasodilatation. By using a clamp device to hold the mouse in place, 200 µl of 1.5% 
FITC-BSA was injected directly into the base of the tail vein. Successful injections 
were indicated by observing the yellow dye travel up the tail vein towards the mouse 
torso. The FITC-BSA was given thirty minutes to travel around the mouse 
vasculature before the mouse was euthanized. 
2.3.2.2 Gap27 effect in wound healing 
A total of six mice were wounded and treated with three doses of Gap27 (100, 300 
and 1000 µM). The fourth wound was left untreated. Gap27 was formulated in 30% 
Pluronic™ gel. Four circular 6mm full thickness punch wounds were made on either 
side of the dorsal midline of each mouse. A single 25 µl application of either 100, 
300 or 1000 µM Gap27 was then applied to the wounds as detailed in figure 2.2B.  
Each mouse was kept anesthetised for a further 30 min to allow the investigational 
products to absorb into the wound. The mice were then placed in a heated animal 
holding container, for recovery, before being returned to its home cage. Twenty-four 
hours after wounding the mice were euthanized. 
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2.3.2.3 Ischemia reperfusion injury model  
The following surgical procedure was adapted from a protocol developed by 
Thomas Mustoe (Reid et al., 2004). In this experiment a total of 20 mice were 
randomly divided into two equal groups. The first would undergo a single ischemic 
reperfusion cycle that would last 5.5 hours (1.5 hours ischemia; 4 hours reperfusion) 
whereas the second would undergo a single ischemic reperfusion cycle that would 
last 25.5 hours (1.5 hours ischemia; 24 hours reperfusion). Equal numbers within 
each timed group would receive 300 µM of Cx43 asODN or would be left untreated; 
equalling to five mice within each group. 
After the mouse dorsum had been shaved, it was cleaned with sterile water and 
disinfected with 70% ethanol (EtOH).  A 1 cm transverse incision through the full 
thickness of the skin was made approximately 1 cm below the right shoulder.  A 12 
mm neodymium gold plated magnet was tunnelled under the skin and held in place. 
The incision was closed using a suture. An external gold plated neodymium magnet 
of the same size and strength was placed on the skin over the internal magnet for 
1.5 hours (figure 2.3). After which the external magnet was removed and the 
pressure sites were either subcutaneously injected with 300 µM Cx43 asODN 
formulated in 30% Pluronic™ gel or left untreated. The left side of the midline of the 
dorsum was considered as control skin within the mouse. 
Thirty minutes before the mice were euthanized, 200 µl of 1.5% FITC-BSA was 
injected into the tail vein of each mouse, as described above, to assess vascular 
permeability of the pressure site. The FITC-BSA was given thirty minutes to travel 
around the mouse vasculature before the mouse was euthanized. 
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Figure 2.3 Ischemia reperfusion injury model 
(A) Ischemia reperfusion model. The ischemic phase of the model is accomplished by 
applying a neodymium magnet over a region of skin in which another neodymium magnet 
has been subcutaneously implanted. The reperfusion phase occurs 1.5 hours after and is 
achieved by removing the external magnet. (B) Cross-sectional view of the pressure model 
created using magnetic force. 
2.3.3 Tissue processing and cryosectioning 
Immediately after euthanasia, the tissue of interest was carefully excised from the 
back of the mouse and laid on waxy cardboard to prevent the edges of the skin from 
rolling. The tissue was quartered into four separate wounds (figure 2.4A) before 
being submerged in 4% PFA at room temperature overnight.  On the following day, 
the tissue was thoroughly washed with 1X PBS (minimum of three times for 1-2 
hours) before being transferred into sucrose solution at 4°C overnight; 20% sucrose 
(VWR, Leicestershire, UK) with 0.1% sodium azide in 1X PBS. 
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Figure 2.4 Tissue processing 
 (A) Back tissue from each mouse was removed and laid on waxy cardboard to prevent the 
skin edges from curling. Wounds are coloured grey. Scalpel lines are depicted as dashed 
black lines. The four wounds were quartered so that each wound could be carefully excised 
before being bisected. This was to ensure that the two wound edges in each wound would 
be visible when sectioning (B). 
Before embedding, the circular back wounds or pressure sites were bisected (figure 
2.4A). Half of the wound tissue was then placed in cryomolds in the same 
orientation before being embedded in OCT (Tissue Tek, Sakura Finetek, USA). The 
orientation would ensure that the two edges in each wound would be visible during 
cryosectioning (figure 2.4B). OCT is a well established medium for frozen 
specimens. Formulated of water soluble glycols and resins, OCT provides a 
convenient specimen matrix for cryostat sectioning at temperatures of -20°C. OCT is 
a viscous liquid at room temperature and a solid at temperatures of -10°C and 
below. The second half of the wound was kept for contingency and stored at -80°C. 
Tissues were cooled using dry-ice and stored at -80°C until cryosectioned.  
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Tissue samples were sectioned using a Leica Cryostat CM 1900 UV, (Leica, Milton 
Keys, UK) and mounted onto gelatine coated slides. Tissue samples destined for 
histology processing were cut at 5 µm thick, whereas tissue specimens for 
immunostaining were sectioned at 12 µm thick. Sectioned slides were stored at -
20°C until processed. 
2.3.4 Histology assay - Haematoxylin and Eosin stain 
Slides were placed in the same orientation in a slide rack and allowed to acclimatise 
to room temperature for 5-10 min, before being rinsed well with dH2O for 5 min. This 
was to ensure any excess OCT was rinsed away. Slides were then immersed in 
Haematoxylin stain for 30-45 sec followed by immediate rinse in continuous running 
tap water for 5 min to remove excess stain. Slides were then observed under a light 
microscope to assess over-staining (nuclei should be blue/purple whereas the 
cytoplasm should be clear). If the staining was too strong, the slides were dipped 
once into 0.3% acid alcohol (HCl in dH2O), rinsed in running tap water and checked 
again. If the staining was too weak, the Haematoxylin staining run was repeated. 
Once the optimal stain had been achieved, slides were immersed in Eosin for 1 min. 
After a quick dip into tap water, the slides underwent a dehydration process (1 min 
in 70% EtOH, 2 min in 100% EtOH, a further 2 min in fresh 100% EtOH, 5 min in 
Xylene and a further 5 min in fresh Xylene). This is a delicate process and the 
timings are crucial. Too much dehydration will remove the Eosin stain, whereas too 
little dehydration will cause the tissue sample to fall apart. Slides were mounted onto 
glass coverslips using DePeX mounting medium (VWR, Leicestershire, UK) and 
allowed to dry at room temperature for at least 12 hours. 
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2.3.5 Immunostaining tissue 
Slides were placed in a humidified, light protected, slide chamber and allowed to 
acclimatise to room temperature for 5-10 min. Tissue samples on the slides were 
subsequently covered with a few drops of 1X PBS for 5-10 min, to remove excess 
OCT. Slides were then placed in the same orientation in a slide rack and immersed 
in ice cold acetone for 5 min to fix and permeabilise the tissue. On removal, excess 
acetone was carefully wiped away and the tissue samples were circled using a wax 
pen. Tissue samples were covered with blocking solution (1M lysine, 1X PBS, 
0.05% Triton X-100) and incubated. After 30 min, tissue was immunolabeled with a 
primary antibody diluted in blocking solution (refer to table 2.1 for dilutions and 
incubation periods). Negative controls were incubated overnight in blocking solution 
containing no primary antibody for the same time. Following removal of the primary 
antibody solution, cells were washed in triplicate using 1X PBS before incubation for 
one hour at room temperature with the secondary antibody (refer to table 2.2 for 
dilutions) diluted in blocking solution. A counter stain of Höechst 33258 and 33342 
(1:50,000) diluted in dH2O was applied as a nuclear indicator. After a further three 
1X PBS washes, the slides were coversliped using Citiflour™ mounting medium and 
viewed under a confocal microscope (Upright SPE, Leica, Milton Keys, UK).  All 
images were acquired using identical parameters and camera settings to allow for 
direct comparison of staining intensity. 
2.3.6 Detailed analysis 
2.3.6.1 Blood vessel leakiness 
In order to assess whether Gap27 has an effect on the early immune response, 
blood vessel leakiness was analysed. Tissue samples were observed under a 
confocal microscope (Upright SPE, Leica, Milton Keys, UK). For each animal, at 
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least three optical section images were taken adjacent to the wound edge (site I), 
200-400 nm away from the wound edge (site II) and 600-1000 nm from the wound 
edge (site III); see figure 2.5 for further details. Images were then uploaded to 
ImageJ for analysis. Total percentage of blood vessel leakiness in each field of view 
was measured. This data was then normalised within each animal back to the non-
treated site as uniform FITC-BSA was not guaranteed.  
 
Figure 2.5 Regions of interest in blood vessel leakiness analysis 
The cross section diagram of skin details the regions of interest measured in blood vessel 
leakiness analysis. Site I covers the dermis from the wound edge to 200 nm beyond the 
wound site. Site II covers the dermis 200-400 nm away from the wound edge. Site III covers 
the dermis 600-1000 nm away from the wound edge. 
2.3.6.2 Inflammatory response 
Haematoxylin and Eosin stained slides were used to access the inflammatory 
response. Using identical parameters and camera settings images were taken with a 
light microscope (DMRE, Leica, Milton Keys, UK) before being uploaded onto 
ImageJ for analysis. Tissue was observed at the wound edge, distal to the wound 
edge and at blood vessels. Polymorphonuclear leukocytes were identified through 
high powered imaging of the tissue and leukocyte count per 1000 µm2 was 
quantified.  
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2.3.6.3 Re-epithelialisation 
Haematoxylin and Eosin stained slides were used to access the re-epithelialisation 
rate. Using identical parameters and camera settings images were taken with a light 
microscope (DMRE, Leica, Milton Keys, UK) before being uploaded onto ImageJ for 
analysis. Re-epithelialisation was noted by measuring the distance from the top of 
the junctions between new and old epithelium to the leading edge of new epithelial 
growth on both sides of the wound in the epidermis. Measurements from both sides 
were averaged. 
2.3.6.4 Connexin expression 
Slides were immunolabeled for Cxs 26, 30, 43 and hemichannels to assess Gap27 
effects during the early wound healing stages and slides were immunolabeled for 
Cx43 and hemichannels to assess Cx43 asODN effects on pressure wounds. Using 
identical parameters and camera settings images were screened using a light 
microscope (DMRE, Leica, Milton Keys, UK). Images were then taken for 
measurement using a confocal microscope (details below) before being uploaded 
onto ImageJ for analysis. In Gap27 dose response experiments, connexin profiles 
were measured within blood vessels, at the wound edge or adjacent to the wound 
edge, approximately 200-400 µm away from the wound (figure 2.6A). In pressure 
ulcer wound models, connexin profiles were measured at the pressure site, in tissue 
adjacent to the pressure site and in distal tissue (figure 2.6B). Connexin profiles 
were measured per nuclei within the epidermis and per 1000 µm2 in the dermis.  
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Figure 2.6 Regions of interest in connexin profiling 
 (A) Punch biopsy wound. The cross section diagram of skin details the regions of interest 
measured in Gap27 dose response experiments. The red box indicates the wound edge 
whereas the blue box indicates an area adjacent to the wound edge, approximately 200-400 
µm away from the wound. (B) Ischemia reperfusion skin injury. Diagram of a pressure site 
viewed from above indicates the areas of interest in connexin profiling. PS = Pressure site, 
AT = Adjacent tissue, DT = Distal tissue/non treated control site.  
2.3.7 Confocal microscopy 
In connexin profiling (in vitro and in vivo) single optical section images were taken 
using a Leica SPE confocal microscope using a 40X 1.2NA oil objective (in vitro) or 
a 60X 1.4NA oil objective (in vivo). Fluorophores were excited sequentially (Höechst 
using a 405 nm wavelength lasers, Alexa 488 using a 488nm wavelength laser and 
Alexa 568 using a 532 laser).  
In blood vessel analysis single optical section images were taken using a Leica SPE 
confocal microscope using a 63X 1.4NA oil objective. Fluorophores were excited 
sequentially (Höechst using a 405 nm wavelength lasers, FITC-BSA using a 488nm 
wavelength laser and Alexa 568 using a 532 laser).  
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In FRAP analysis optical sections images, scanned in xyt mode, taken using a 
confocal microscope using a 63X water immersion apochromatic objective lens (NA, 
0.9). FITC flurophore was excited using a 488 nm wavelength. 
All mages were 8-bit greyscale at 1024 x 1024 pixels. Images were captured using a 
z-series frame average of four. All image acquisition setting remained identical 
between images in order to allow comparisons in image analysis.   
2.3.8 Statistics 
Statistical comparisons were made using either a one-way analysis of variance 
(ANOVA) or independent-samples t-test using SPSS Statistics™ (version 21, IBM). 
Data was tested for normality (Shapiro-Wilk test) and equal variances (Levene test) 
before statistical comparisons were carried out. In time-lapse experiments, the null 
hypothesis was rejected using a multivariate analysis of variance (MANOVA), The 
Dunnett post hoc test (against the control sample) or Tukey post hoc test were 
performed if data proved significant. All experiments were performed at least in 
triplicate. All data are presented as means ± S.E.M. and n represents the number of 
repeats for each experiments indicated below each graph. 
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3. Gap27 mechanisms in vitro 
3.1 Introduction 
Gap junctions provide an essential route of communication that occurs in the 
majority of cells, tissues and organs in vertebrates. The exceptions to these cases 
include non-nucleated units such as platelets, red blood cells and skeletal muscle 
(Evans and Martin, 2002a). Previous work has consistently shown how gap 
junctions play fundamental roles in communication during the wound healing 
process (Goliger and Paul, 1995, Saitoh et al., 1997, Coutinho et al., 2003). A 
variety of cell types (including keratinocytes, fibroblasts and neutrophils) and tissue 
rely on complex communication through gap junctions and their connexins to ensure 
completion of wound healing (Coutinho et al., 2003, Brandner et al., 2004, Mori et 
al., 2006). By directly coupling neighbouring cells gap junctions provide a signalling 
highway for ions, small molecules and messages that are crucial in co-ordinating 
cellular activities during the stages of wound healing. Gap junctions are expressed 
in all cells linked with tissue repair and three key connexins (Cxs 26, 30 and 43) 
undergo dynamic changes to regulate the stages of wound closure (Coutinho et al., 
2003). It has been noted in recent research that in chronic, non healing wounds 
Cx43 fails to down regulate at the wound edge and follow the natural sequence of 
events during wound closure (Brandner et al., 2004, Wang et al., 2007). Inhibiting 
Cx43 expression, using specific Cx43 asODN, can achieve significant improvement 
in wound repair (Qiu et al., 2003, Mori et al., 2006, Wang et al., 2007).  
However, there are still very few pharmacological reagents that externally block this 
communication pathway in an acceptably specific manner without unwanted and 
non-specific effects. These include aliphatic alcohols (Guan et al., 1997, Cotrina et 
al., 1998b) and anaesthetics (Boitano et al., 1992), that although successfully 
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disrupt gap junction communication, do so by ‘squeezing,’ which is likely to modify 
other non-gap junction channels in the membrane. Other methods to disrupt gap 
junction communication involve using lipophilic aglycones (Taylor et al., 1998, 
Chaytor et al., 1999), which act indirectly to disrupt gap junction communication. The 
therapeutic answer to specific and external inhibition of hemichannel and gap 
junction based communication could lie in the development of the short synthetic 
connexin mimetic peptide Gap27 (Warner et al., 1995). Designed against Cx32 but 
also possessing homology to the second extracellular loop of Cx43, Gap27 has 
been extensively used to quickly and reversibly inhibit communication in gap 
junctions constructed of Cx43. 
Connexin mimetic peptides, such as Gap27, have consistently been identified as 
effective inhibitors of gap junction based communication; however there is still some 
uncertainty on its mechanism of action. Several in vitro experimental studies into 
gap junction communication across a broad range of cells and tissues have resulted 
in three key theories on how connexin mimetic peptides can interrupt or inhibit this 
communication. These include the connexin mimetic peptide interacting with an 
unpaired connexon in the plasma membrane and therefore preventing connexons 
docking (figure 3.1A); interacting via the intracellular space within a gap junction 
resulting in its dissociation and ultimately leading to its internalisation (figure 3.1B); 
or interacting directly with a gap junction and altering its gating (figure 3.1C) 
(Berthoud et al., 2000, Evans and Boitano, 2001). 
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Figure 3.1 Proposed mechanisms of action of connexin mimetic peptides 
(A) Diagram illustrating inhibition of docking. Gap junction channels are formed by docking of 
hemichannels from two neighbouring cells (arrow 1). In the presence of connexin mimetic 
peptide (depicted by red ~), docking is prevented (arrow 2). (B) Diagram illustrating 
dissociation of formed gap junctions. The presence of connexin mimetic peptides induces 
destabilization of established gap junction channels, leading to the undocking of 
hemichannels. (C) Diagram illustrating altered gating. Connexin mimetic peptides rapidly 
diffuse into the extracellular confines of gap junctions where the two hemichannels interact 
and alter channel gating. Diagrams adapted from American Journal of Physiology Lung 
Cellular and Molecular Physiology 279; L619-L622 (Berthoud et al., 2000) and Biochemical 
Society Transactions 29; 606-612 (Evans and Boitano, 2001). 
Nonetheless in recent research it has been realized that connexin mimetic peptides 
show a huge potential in tackling connexin-based maladies and show promise in 
translational and therapeutic possibilities. For example, O’Carroll, Green and 
colleagues demonstrated that during an in vitro spinal cord injury, treatment with 
connexin mimetic peptides could significantly reduce the cell damage that occurs 
(O'Carroll et al., 2008) and more recently, cardiac protection has been noted when 
rat models of myocardial infarction are treated with connexin mimetic peptides 
(Hawat et al., 2012). Early work conducted by the Martin group has not only shown 
that connexin mimetic peptide Gap27 reduces gap junction communication in 
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human keratinocytes and fibroblast cells but has great potential in the wound 
healing environment (Wright et al., 2009, Pollok et al., 2011). The advantage of 
using connexin mimetic peptides such as Gap27 over Cx43 asODN (that specifically 
disrupts Cx43 protein production), is the unique time dependent properties that 
connexin mimetic peptides possess when disrupting either hemichannel or gap 
junction based communication.  
Using skin cell cultures (immortal fibroblast cells derived from mouse; NIH 3T3 and 
immortalized keratinocyte cells derived from human; HaCat) the work presented in 
this chapter aims to build upon the current theories of Gap27 mechanism of action. 
This was achieved by characterizing the effect of Gap27 on connexin expression in 
these cells while exploring the mechanical effects of the connexin mimetic peptide in 
cell communication and in vitro models of wound healing.  
Hypothesis – Gap27 will reduce communication and increase the migration rates in 
fibroblast and keratinocyte cells. There is no assumption that Gap27 will reduce 
connexin expression in these cell types.  
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3.2 Results 
Gap27 incubation significantly reduced communication 
between fibroblast cells 
For two hours confluent immortal NIH 3T3 fibroblast cells were treated with Gap27 
(30 or 300 µM), scrambled peptide (300 µM) or left untreated (naive) prepared in 
complete OptiMEM. Cells were subsequently incubated with Calcein-AM and PI 
before FRAP was carried out. Fluorescence recovery was significantly reduced in 
cultures incubated in high (300 µM) concentrations of Gap27 in comparison to 
untreated (naive) cultures. There was no change in fluorescence recovery in 
cultures incubated in low (30 µM) concentrations of Gap27 or in scrambled peptide 
(figure 3.2) 
Gap27 incubation significantly increased the rate of migration 
in fibroblast cells 
Confluent NIH 3T3 fibroblast cells were subjected to an in vitro model of wound 
healing. Cultures were scratched before being treated with a single dose of Gap27 
(10, 30, 100, 300 µM), scrambled peptide (100 µM) or left untreated (naive) 
prepared in complete OptiMEM. The rate of cell migration across the scratch wound 
increased in cultures incubated with high (100-300 µM) concentrations of Gap27 in 
comparison to untreated (naive) cultures. Incubation with scrambled peptide did not 
increase the rate of migration (figure 3.3). 
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Figure 3.2 High concentrations of Gap27 significantly reduced gap junction 
communication in fibroblast cells 
(A) The panels show representative images of Fluorescence Recovery after Photobleaching 
(FRAP). Cultures were incubated with Gap27 (30 or 300 µM) or 300 µM scrambled control 
peptide for two hours. A control of non-treatment was used. (B) Graph shows the recovery 
profiles of fluorescence. During incubation gap junction communication was significantly 
reduced between cells in 300 µM Gap27. Statistical comparisons were made using a one-
way analysis of variance (ANOVA). The null hypothesis was rejected using a multivariate 
analysis of variance (MANOVA) before statistical comparisons were carried out. The data is 
shown as the means ± S.E.M. (Between non-treated cells and cells treated with 300 µM 
Gap27 n=3, **p<0.01). Scale bar = 20 µm, t= time. 
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Figure 3.3 High concentrations of Gap27 significantly increased the rate of 
fibroblast cell migration 
 (A) The panels show representative images of scratch wounds during a migration assay. 
Confluent fibroblast cells were scratched and rinsed of any cell debris before being 
incubated with a single dose of 10, 30, 100 or 300 µM Gap27, 100 µM scrambled peptide or 
left untreated. The dashed black line indicates the leading edge of the scratch wound 1 hour 
after scratching. The dashed white line indicates the leading edge of the scratch wound 6 
hours after scratching. (B) Graph shows the velocity of migration for all the aforementioned 
conditions. Cells incubated with higher (100-300 µM) concentrations of Gap27 migrated 
faster over the scratch wound. Statistical comparisons were made using a one-way analysis 
of variance (ANOVA). The data is shown as the means ± S.E.M. (n=4, *p≤0.05). Scale bar = 
100 µm. SP = Scrambled peptide. 
Gap27 incubation significantly reduced Cx43 and connexin 
hemichannel expression in fibroblast cells  
For two hours confluent NIH 3T3 fibroblast cells were treated with Gap27 (10, 30, 
100 or 300 µM) scrambled peptide (100 µM) or left untreated (naive) prepared in 
complete OptiMEM. For six hour incubation periods, confluent NIH 3T3 fibroblast 
cells were treated with Gap27 (10, 30, 100 or 300 µM) scrambled peptide (100 µM) 
or left untreated (naive) prepared in complete OptiMEM and medium was replaced 
every two hours with fresh medium containing Gap27, scrambled peptide or naive 
OptiMEM. Cells were fixed and immunolabeled for Cx43 and nuclei before total pixel 
area per cell was quantified. Incubation of high (100-300 µM) concentrations of 
Gap27 for two hours and incubations with both low (10-30 µM) and high (100-300 
µM) concentrations of Gap27 for six hours of continuous incubation significantly 
reduced Cx43 expression in fibroblast cells in comparison to untreated naive 
cultures. Incubation with scrambled peptide did not reduce Cx43 expression (figure 
3.4). 
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Further analysis of Cx43 protein expression by Western blotting confirmed that Cx43 
and phosphorylated isoforms of Cx43 decreased in confluent NIH 3T3 fibroblast 
cells after Gap27 treatment. Incubation of high (100-300 µM) concentrations of 
Gap27 for two hours and incubations with both low (30 µM) and high (100-300 µM) 
concentrations of Gap27 for six hours of continuous incubation significantly reduced 
Cx43 expression in fibroblast cells in comparison to untreated naive cultures (figure 
3.5) 
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Figure 3.4 Effect of Gap27 on Cx43 expression in fibroblast cells; 
immunofluorescence analysis 
 (A) The panels show representative images of non-treated fibroblast cells and those that 
have been incubated with 100 µM scrambled control peptide or increasing doses of Gap27 
for either 2 hours or for 6 hours of continuous incubation (Gap27 replaced every 2 hours). A 
control of non-treatment was used. Cells were immunolabeled for Cx43 (green) and nuclei 
(blue), (B) Total pixel area per cell was quantified and the graph shows that higher doses 
(100-300 µM) of Gap27 significantly reduced Cx43 expression in fibroblast cells after just 
two hours of incubation. (C) Total pixel area per cell was quantified and the graph shows that 
in continuous incubation both low (10-30 µM) and high (100-300 µM) doses of Gap27 
significantly reduced Cx43 expression in fibroblast cells over 6 hours. Incubation with 
scrambled control peptide did not reduce Cx43 expression. Statistical comparisons were 
made using a one-way analysis of variance (ANOVA). The data are shown as the means ± 
S.E.M. (n=3, **p<0.01, ***p<0.001 against non-treated cells). White arrows indicate Cx43 
expression. Scale bar = 50 µm. NT = No treatment, SP = Scrambled peptide. 
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Figure 3.5 Effect of Gap27 on Cx43 expression in fibroblast cells; Western blot 
analysis 
 (A) Cx43 protein and phosphorylated isoforms (p-Cx43) expression in fibroblast cells during 
incubation with Gap27 was confirmed through Western blot analysis. The panels show 
representative blots. Alpha tubulin serves as a loading control housekeeping protein. (B) The 
intensity of the total protein was measured relative to the intensity of the housekeeping 
protein. The graph shows that higher doses of Gap27 (100-300 µM) significantly reduced 
Cx43 protein expression in fibroblast cells after just two hours of incubation. (C) The graph 
shows that during 6 hours continuous incubation both low (30 µM) and high (100-300 µM) 
doses of Gap27 significantly reduced Cx43 expression in fibroblast cells over 6 hours. 
Statistical comparisons were made using a one-way analysis of variance (ANOVA). The data 
are shown as the means ± S.E.M. (n=3, *p<0.05 against NT cells). NT = No treatment. 
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As above, for two hours confluent NIH 3T3 fibroblast cells were treated with Gap27 
(10, 30, 100 or 300 µM) or left untreated (naive) prepared in complete OptiMEM. For 
six hour incubation periods, confluent NIH 3T3 fibroblast cells were treated with 
Gap27 (10, 30, 100 or 300 µM or left untreated (naive) prepared in complete 
OptiMEM and medium was replaced every two hours with fresh medium containing 
Gap27 or naive OptiMEM. Cells were fixed and immunolabeled for connexin 
hemichannels and nuclei before total pixel area per cell was quantified. Connexin 
hemichannel antibody is a custom made affinity purified antibody against a highly 
conserved portion of the first extracellular loop of Cx43. Incubation of high (30-300 
µM) concentrations of Gap27 for two hours and incubations with both low (10-30 
µM) and high (100-300 µM) concentrations of Gap27 for six hours of continuous 
incubation significantly reduced connexin hemichannel expression in fibroblast cells 
in comparison to untreated naive cultures (figure 3.6). 
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Figure 3.6 Effect of Gap27 on connexin hemichannel expression in fibroblast 
cells; immunofluorescence analysis 
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 (A) The panels show representative images of non-treated fibroblast cells and those that 
have been incubated with increasing doses of Gap27 for 2 hours. A control of non-treatment 
was used. Cells were immunolabeled for hemichannels (green) and nuclei (blue). (B) Total 
pixel area per cell was quantified and the graph shows that mid to high doses (30-300 µM) of 
Gap27 significantly reduced hemichannel expression after just two hours of incubation. (C) 
The panels show representative images of non-treated cells and those that have been 
incubated with increasing doses of Gap27 for 6 hours of continuous incubation (Gap27 
replaced every 2 hours). A control of non-treatment was used. Cells were immunolabeled for 
hemichannels (green) and nuclei (blue). (D) Total pixel area per cell was quantified and the 
graph shows that in continuous incubation both low (10-30 µM) and high (100-300 µM) 
doses of Gap27 significantly reduced hemichannel expression over 6 hours. Statistical 
comparisons were made using a one-way analysis of variance (ANOVA). The data are 
shown as the means ± S.E.M. (n=3, *p<0.05, **p<0.01 against NT cells). White arrows 
indicate hemichannel expression. Scale bar = 50 µm. NT = No treatment. 
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Gap27 incubation significantly increased the rate of migration 
in keratinocyte cells 
Confluent HaCaT keratinocyte cells were subjected to an in vitro model of wound 
healing as described above. Cultures were scratched before being treated with a 
single dose of Gap27 (10, 30, 100, 300 µM), scrambled peptide (100 µM) or left 
untreated (naive) prepared in complete OptiMEM. The rate of cell migration across 
the scratch wound significantly increased in cultures incubated with high (100-300 
µM) concentrations of Gap27 in comparison to untreated (naive) cultures. Incubation 
with scrambled peptide did not increase the rate of migration (figure 3.7) 
Gap27 incubation significantly reduced Cx43 expression in 
keratinocyte cells 
As described above, for two hours confluent HaCaT keratinocyte cells were treated 
with Gap27 (10, 30, 100 or 300 µM) scrambled peptide (100 µM) or left untreated 
(naive) prepared in complete OptiMEM. For six hour incubation periods, confluent 
HaCaT keratinocyte cells were treated with Gap27 (10, 30, 100 or 300 µM) 
scrambled peptide (100 µM) or left untreated (naive) prepared in complete OptiMEM 
and medium was replaced every two hours with fresh medium containing Gap27, 
scrambled peptide or naive OptiMEM. Cells were fixed and immunolabeled for Cx43 
and nuclei before total pixel area per cell was quantified. Incubation of high (100-300 
µM) concentrations of Gap27 for two hours and incubations with both low (10-30 
µM) and high (100-300 µM) concentrations of Gap27 for six hours of continuous 
incubation significantly reduced Cx43 expression in keratinocyte cells in comparison 
to untreated naive cultures. Incubation with scrambled peptide did not reduce Cx43 
expression (figure 3.8). 
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Figure 3.7 High concentrations of Gap27 significantly increased the rate of 
keratinocyte cell migration 
 (A) The panels show representative images of scratch wounds during a migration assay. 
Confluent keratinocyte cells were scratched and rinsed of any cell debris before being 
incubated with a single dose of 10, 30, 100 or 300 µM Gap27, 100 µM scrambled peptide or 
left untreated. The dashed black line indicates the leading edge of the scratch wound 1 hour 
after scratching. The dashed white line indicates the leading edge of the scratch wound 6 
hours after scratching. (B) Graph shows the velocity of migration for all the aforementioned 
conditions. Cells incubated with higher (100-300 µM) concentrations of Gap27 migrated 
faster over the scratch wound. Statistical comparisons were made using a one-way analysis 
of variance (ANOVA). The data is shown as the means ± S.E.M. (n=4, *p<0.05, **p<0.01). 
Scale bar = 100 µm. NT = No treatment, SP = Scrambled peptide. 
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Figure 3.8 Effect of Gap27 on Cx43 expression in keratinocyte cells; 
immunofluorescence analysis 
 (A) The panels show representative images of non-treated keratinocyte cells and those that 
been incubated with 100 µM scrambled control peptide or increasing doses of Gap27 for 
either 2 hours or for 6 hours of continuous incubation (Gap27 replaced every 2 hours). A 
control of non-treatment was used. Cells were immunolabeled for Cx43 (green) and nuclei 
(blue), (B) Total pixel area per cell was quantified and the graph shows that higher doses 
(100-300 µM) of Gap27 significantly reduced Cx43 expression in keratinocyte cells after just 
two hours of incubation. (C) Total pixel area per cell was quantified and the graph shows that 
in continuous incubation both low (10-30 µM) and high (100-300 µM) doses of Gap27 
significantly reduced Cx43 expression in keratinocyte cells over 6 hours. Incubation with 
scrambled control peptide did not reduce Cx43 expression. Statistical comparisons were 
made using a one-way analysis of variance (ANOVA). The data are shown as the means ± 
S.E.M. (n=3, **p<0.01 against NT cells). White arrows indicate Cx43 expression. Scale bar = 
50 µm. NT = No treatment, SP = Scrambled peptide. 
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Further analysis of Cx43 protein expression by Western blotting confirmed that Cx43 
expression decreased in confluent HaCaT keratinocyte cells after Gap27 treatment. 
Incubation of high (100-300 µM) concentrations of Gap27 for two hours and 
incubations with both low (30 µM) and high (100-300 µM) concentrations of Gap27 
for six hours of continuous incubation significantly reduced Cx43 expression in 
keratinocyte cells in comparison to untreated naive cultures (figure 3.9) 
Continuous incubation with Gap27 significantly reduced Cxs 26 
and 30 expressions in keratinocyte cells 
For two hours confluent HaCaT keratinocyte cells were treated with Gap27 (10, 30, 
100 or 300 µM) scrambled peptide (100 µM) or left untreated (naive) prepared in 
complete OptiMEM. For six hour incubation periods, confluent HaCaT keratinocyte 
cells were treated with Gap27 (10, 30, 100 or 300 µM) scrambled peptide (100 µM) 
or left untreated (naive) prepared in complete OptiMEM and medium was replaced 
every two hours with fresh medium containing Gap27, scrambled peptide or naive 
OptiMEM. Cells were fixed and immunolabeled for either Cx26 or Cx30 and nuclei 
before total pixel area per cell was quantified. Two hours of incubation in Gap27 did 
not significantly reduce Cx26 Cx30 in keratinocyte cells (figure 3.10). Incubation in 
both low (10-30 µM) and high (100-300 µM) concentrations of Gap27 for six hours of 
continuous incubation significantly reduced both Cx26 and Cx30 expression in 
keratinocyte cells in comparison to untreated naive cultures. Incubation with 
scrambled peptide did not reduce Cxs 26 and 30 expressions (figure 3.11). 
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Figure 3.9 Effect of Gap27 on Cx43 expression in keratinocyte cells; Western 
blot analysis 
 (A) Cx43 protein expression in keratinocyte cells during incubation with Gap27 was 
confirmed through Western blot analysis. The panels show representative blots. Alpha 
tubulin serves as a loading control housekeeping protein. (B) The intensity of the protein of 
interest was measured relative to the intensity of the housekeeping protein. The graph 
shows that higher doses of Gap27 (100-300 µM) significantly reduced Cx43 protein 
expression in keratinocyte cells after just two hours of incubation. (C) The graph shows that 
during 6 hours continuous incubation (Gap27 replaced every 2 hours) both low (30 µM) and 
high (100-300 µM) doses of Gap27 significantly reduced Cx43 expression in keratinocyte 
cells over 6 hours. Statistical comparisons were made using a one-way analysis of variance 
(ANOVA). The data are shown as the means ± S.E.M. (n=3, *p<0.05, **p<0.01 against NT 
cells). NT = No treatment.  
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Figure 3.10 Effect of Gap27 on Cx26 expression in keratinocyte cells; 
immunofluorescence analysis 
 (A) The panels show representative images of non-treated keratinocyte cells and those that 
been incubated with 100 µM scrambled control peptide or increasing doses of Gap27 for 
either 2 hours or for 6 hours of continuous incubation (Gap27 replaced every 2 hours). A 
control of non-treatment was used. Cells were immunolabeled for Cx26 (green) and nuclei 
(blue), (B) Total pixel area per cell was quantified and the graph shows that a short 
incubation period with Gap27 did not reduce Cx26 expression per cells. Incubation with 
scrambled peptide did not reduce Cx26 expression per cell. (C) Total pixel area per cell was 
quantified and the graph shows that in continuous incubation both low (10-30 µM) and high 
(100-300 µM) doses of Gap27 significantly reduced Cx26 expression in keratinocyte cells 
over 6 hours. Incubation with scrambled control peptide did not reduce Cx26 expression. 
Statistical comparisons were made using a one-way analysis of variance (ANOVA). The data 
are shown as the means ± S.E.M. (n=3, *p<0.05, **p<0.01 against NT cells). White arrows 
indicate Cx26 expression. Scale bar = 50 µm. NT = No treatment, SP = Scrambled peptide. 
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Figure 3.11 Effect of Gap27 on Cx30 expression in keratinocyte cells; 
immunofluorescence analysis 
 (A) The panels show representative images of non-treated keratinocyte cells and those that 
been incubated with 100 µM scrambled control peptide or increasing doses of Gap27 for 
either 2 hours or for 6 hours of continuous incubation (Gap27 replaced every 2 hours). A 
control of non-treatment was used. Cells were immunolabeled for Cx30 (green) and nuclei 
(blue), (B) Total pixel area per cell was quantified and the graph shows that a short 
incubation period with Gap27 did not reduce Cx30 expression per cells. Incubation with 
scrambled peptide did not reduce Cx30 expression per cell. (C) Total pixel area per cell was 
quantified and the graph shows that in continuous incubation both low (10-30 µM) and high 
(100-300 µM) doses of Gap27 significantly reduced Cx30 expression in keratinocyte cells 
over 6 hours. Incubation with scrambled control peptide did not reduce Cx30 expression. 
Statistical comparisons were made using a one-way analysis of variance (ANOVA). The data 
are shown as the means ± S.E.M. (n=3, *p<0.05, **p<0.01 against NT cells). White arrows 
indicate Cx30 expression. Scale bar = 50 µm. NT = No treatment, SP = Scrambled peptide. 
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3.3 Discussion 
Gap27 reduced gap junction communication  
Functional assays of gap junctional communication mainly fall into two categories; 
the first measures the transfer of dye molecules between neighbouring cells 
whereas the second is designed to measure electrical currents carried by ions. 
FRAP was used to investigate the connectivity of neighbouring cells incubated in 
Gap27 by monitoring the diffusion of the flurophore calcein between the connected 
cells. High concentrations of Gap27 significantly reduced gap junction 
communication in fibroblast cells after two hours of incubation (figure 3.2).  
Fibroblast cells left untreated or treated with either scrambled peptide or a tenfold 
lower dose of Gap27 showed no significant difference in communication.  
Similar studies using dye transfer assays (where cells are injected with dyes with a 
typical weight of 500 Da that will comfortably transfer through communicating gap 
junctions) have shown that Gap27 significantly reduces communication in fibroblast 
like COS-7 cells (Dora et al., 1999, Chaytor et al., 1999) Schwann cells 
(Mambetisaeva et al., 1999) leukocyte cells (Oviedo-Orta et al., 2000), alveolar cells 
(Isakson et al., 2003) and HeLa cells transfected with Cx43-GFP (Berman et al., 
2002).  Incubation periods ranged from 15 minutes to a couple of hours in these 
studies but a consistent feature throughout was a high concentration of Gap27 
(typically ranging between 130-500 µM). As shown in the chapter, it is primarily high 
concentrations of Gap27 that will reduce gap junction communication.  
Reduction in cell to cell gap junction communication was also seen in tracheal 
airway epithelial cells (Boitano and Evans, 2000) and primary ATII cells (Isakson et 
al., 2001) where high concentrations of Gap27 significantly reduced calcium waves 
in stimulated cells. Again, similar results were observed in rabbit mesenteric arterial 
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cells (Dora et al., 1999) and rat aortic smooth muscle cells (Kwak and Jongsma, 
1999) where high concentrations of Gap27 reduced cellular conductance.  
Gap27 increased the rate of migration 
An in vitro model of wound healing was used to investigate mimetic peptide effects 
on cell migration rates and again it was the higher concentrations of Gap27 (100-
300 µM) that had significant effects on increasing the rate of migration in both 
fibroblast (figure 3.3) and keratinocyte (figure 3.7) cells. Fibroblast and keratinocyte 
migration into the wound are crucial steps during the wound healing stages. 
Fibroblasts are recruited from several sources including circulating fibrocytes, bone 
marrow cells (Abe et al., 2001) and migrating fibroblasts from nearby unwounded 
dermis (Hinz, 2007). Within the maturing granulation tissue fibroblasts differentiate 
into α-SMA expressing myofibroblasts whose actin enable tissue contraction and 
help contract down the granulation tissue (Hinz et al., 2001a). Whereas keratinocyte 
cells achieve re-epithelialisation of the wound by crawling and migrating along the 
wound edge and aiding in ultimate wound closure. It was observed in the research 
presented in this chapter how both fibroblast and keratinocyte cell rates of migration 
were clearly increased by high concentrations of Gap27 and those cells left 
untreated or treated with either scrambled peptide or a lower dose of Gap27 had no 
significant difference in the rate of migration.  
Conversely, studies of wound closure using rat fibroblast cells have shown that 
treatment using non-specific gap junction blockers heptanol and endosulpan led to a 
reduction in both fibroblast migration and collagen production (Ehrlich and Diez, 
2003). However, as discussed previously, the use of non-specific blockers of gap 
junction communication can frequently lead to unwanted and non-specific effects. 
Using NIH 3T3 fibroblast cells that have been transduced with Cx43 specific shRNA 
construct in an in vitro scratch wound model, Mendoza-Naranjo and colleagues 
have shown that reducing Cx43 and Cx43 based gap junction communication 
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significantly increases the migration rate (Mendoza-Naranjo et al., 2012a). Further 
supportive studies carried out by the Martin group have shown how Gap27 
incubation can significantly increase the rate of migration in a range of fibroblast and 
keratinocyte cell types. In both an in vitro organotypic culture (Kandyba et al., 2008) 
where primary mouse keratinocyte cells were seeded onto primary mouse dermal 
cells, and in primary human fibroblast and keratinocyte cells (Wright et al., 2009) 
Gap27 increased the rate of cell migration and the rate of in vitro wound closure. An 
acceleration of Gap27 migration was also observed in human fibroblast and 
keratinocyte cells that had their proliferation rates inhibited through pre-treatment by 
x-ray radiation (Pollok et al., 2011).   
Typical total rates of migration, observed in cells involved in the studies carried out 
by the Martin group, ranged between 8-10 µm per hour in fibroblast cells and 
between 6-15 µm per hour in keratinocyte cells. Work presented in this research 
chapter (where migration rates were approximately 18-30 µm per hour in fibroblasts 
and 15-30 µm per hour in keratinocytes) highlight a difference in migration rates. 
However a closer observation into the scratch wound studies carried out by the 
Martin group reveal faster rates of migration in the first few hours of observation. 
Typically 20-25% of in vitro wounds had already closed in the first 6-12 hours of a 
48-72 hours study.  This initial burst of migration in the first few hours of observation 
supports the results I have presented in this chapter where migration rates were 
only observed for a six hour window, when migration rates in scratch wound assays 
are at their peak. Furthermore it was noted that peptide replenishment was only 
executed every 12 hours. Work carried out by Wright and colleagues have shown 
through dye transfer assays that the mimetic peptide Gap26M has a peak level of 
effectiveness 90 minutes post application, remaining at a similar level of 
effectiveness 5 hours post application before dropping significantly to control levels 
8 to 24 hours post application (Wright et al., 2009). Although Gap26 aligns to a 
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region in the first extracellular loop of Cx43, whereas Gap27 aligns to a region within 
the second, one would expect the breakdown rate of a similar number of amino 
acids to be relatively comparable. One note of interest is that Gap26M is an 
amended version of Gap26 that has an acylated N-terminus to provide the connexin 
mimetic peptide with greater solubility and stability. Therefore the peak effectiveness 
level of unmodified connexin mimetic peptides may be sooner and last for less time. 
Thereby if the mimetic peptide effectiveness is thought to drop significantly 8 to 24 
hours post application, this could explain the slower rates of migration seen in the 
work carried out by the Martin group. This is particularly noted in Wright and 
colleagues work where migration rates of human fibroblast cells appear to increase 
and plateaux in turn over 72 hours which would correspond to reapplication of 
peptide every 12 hours (Wright et al., 2009).  These periods of migration when 
peptide is replenished could correspond to a reduction in gap junction 
communication that is encouraging an increase in cell migration rates. 
Gap27 reduced Cx43 and connexin hemichannel expression 
Previous research discussed above together with work presented in this research 
chapter supports the consistent claim that connexin mimetic peptides are effective 
inhibitors of gap junction based communication. Novel work presented in this 
chapter also suggests that it is higher concentrations of Gap27 that effectively 
reduced this communication. However there is still some uncertainty on connexin 
mimetic peptide’s mechanism of action and there are currently three key theories on 
how peptides can interrupt or inhibit gap junction communication as discussed in 
detail above (Berthoud et al., 2000, Evans and Boitano, 2001). The first includes the 
assumption that mimetic peptides may be interacting with unpaired connexons in the 
plasma membrane, ultimately preventing the docking of complementary 
hemichannels from neighbouring cells and thereby reducing the number of 
operational gap junction channels and gap junction communication. As connexins 
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have a rapid turnover, between 1 and 4 hours (Fallon and Goodenough, 1981, 
Traub et al., 1987), this mechanism of disruption can be achieved in a relatively 
short time. The second theory suggests that connexin mimetic peptides interact via 
the extracellular space within a gap junction resulting in the dissociation or 
‘undocking’ of the channel and leading to its internalization and breakdown. This 
would also cause a reduction in the number of operational gap junction channels 
and ultimately reduce gap junction communication. Finally, the third theory 
hypothesises that mimetic peptides interact directly with gap junctions and alter their 
chemical gating, thus reducing gap junction communication. 
In a novel discovery reported in this research chapter, it was observed that 
incubation with Gap27 significantly reduced Cx43 expression in both 3T3 fibroblast 
and HaCaT keratinocyte cells. This was shown by both immunostaining (figure 3.4 
and figure 3.8) and in Western blot protein quantification assays (figure 3.5 and 3.9). 
A key observation made throughout these results was that in the short incubation 
period of two hours, only higher concentrations of Gap27 significantly reduced Cx43 
expression. In the six hour incubation period, where Gap27 was replaced every two 
hours, both lower and high concentrations significantly reduced Cx43 expression.  
A comparable report was made by O’Carroll, Green and colleagues when incubating 
ex vivo spinal cord segments in ‘Peptide 5’; a 12 amino acid long short connexin 
mimetic peptide that corresponds to the second extracellular loop of Cx43 and 
overlaps with Gap27 by seven amino acids (O'Carroll et al., 2008). A markedly 
reduced expression of Cx43 was observed in cultures as shown by Western blot 
when compared to cells incubated in a control peptide. However until now there 
have been no more reports that support the claim that mimetic peptides have the 
ability to reduce Cx43 expression.  
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Berman and colleagues were the first to claim that connexin mimetic peptides 
decrease gap junction communication without disrupting their intrinsic structure 
(Berman et al., 2002). Using HeLa cells stably transfected with Cx43-GFP incubated 
in Gap27 for 90 minutes, they observed that Lucifer yellow dye transfer was reduced 
between connected cells, yet there was no significant difference in plaque number of 
Cx43 between untreated and treated cells.  However, it should be noted that cells 
were also treated with sodium butyrate 18 hours before experiments were carried 
out to enhance protein expression and therefore cannot be fairly compared to 
natural Cx43 expression in cells. A similar study was carried out using an immortal 
smooth muscle cell line transfected with Cx43-GFP (Martin et al., 2005) to visualise 
trafficking of the protein to the cell membrane in cells treated with Gap26 or Gap27, 
or left untreated. Punctate staining of Cx43 was apparent in both sets of cells; 
however there was no visual difference in Cx43 expression.  On the other hand, it 
must be mentioned that quantification was carried out 12 hours after Gap27 
incubation and that during quantification there was no measurement of plaque area 
or number, only overall fluorescence. As detailed above, Gap27 is unlikely to be 
effective 12 hours after application due to its fragile structure and ease of 
degradation. In addition, quantification took place past the natural turnover time of 
connexins. Both studies claim that Gap27 doesn’t reduce Cx43 expression but 
neither observed this in cells that naturally express this connexin. 
Rat aortic smooth muscle cells, that do naturally express Cx43, were incubated in 
Gap27 for 4 hours before immunocytochemical analysis to determine Cx43 
expression (Martin et al., 2005).  Although it was reported that gap junction plaques 
in the plasma membrane remained intact with levels of fluorescence not differing 
significantly from control cells, there was an observed reduction in Cx43 expression 
shown in the fluorescent images and graphical data of this result.  In this study, cells 
were incubated in complete DMEM supplemented with 10% foetal bovine serum and 
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it has been well documented how proteases within serum can rapidly digest and 
break down peptides, greatly reducing their half life. It is highly likely that after four 
hours of incubation, the peptide will no longer have an optimal effect on Cx43 
expression in cells, as the peptide has been degraded in this serum supplemented 
medium.  Another group, using primary keratinocyte cells, observed that although 
Gap27 significantly reduced gap junction communication as shown by reduction in 
dye transfer, the mimetic peptide did not reduce Cx43 expression. However, there 
was no quantification of Cx43 expression and only an illustrative observation was 
made (Wright et al., 2013).  
This is the first detailed report exploring the dynamics of time and concentration 
effects of Gap27 on Cx43 expression. Research presented in this chapter has 
shown for the first time, using 3T3 fibroblast and HaCaT keratinocyte cells (that 
naturally express Cx43) in a time and concentration dependent protocol, that a high 
concentration of connexin mimetic peptide Gap27 significantly reduced Cx43 
expression. This was coupled with high concentrations of Gap27 reducing gap 
junction communication and increasing the migration rate of cells.  
It is unlikely that Gap27 reduced Cx43 through dissociation of already formed gap 
junctions, as once hemichannels have docked with their neighbouring hemichannels 
and accreted latterly in the plasma membrane, they are very difficult to tear apart 
(Evans and Boitano, 2001).  The first and second extracellular loop domains of 
connexin proteins are the segments that are primarily involved in intercellular 
interactions during docking. Each domain has three conserved cysteine residues, 
joined by at least one disulfide bond between the loops. Docking between opposed 
hemichannels involves the interactions between the extracellular loops to complete 
a fully formed channel. This interaction subsequently provides a continuous wall of 
protein, functioning as a tight electrical and chemical seal (Unger et al. 1999). The 
construction of this sealed bridge is difficult to break and it is doubtful that Gap27 is 
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able to disrupt this connection. Indeed, it has been shown in research that explores 
the trafficking of connexin proteins using cells that are transfected with connexin-
fluorophores that one of the two partner cells internalises a fully formed gap junction 
from both cells (Jordan et al., 2001) confirming that once formed, gap junctions are 
not likely to pull apart. 
Because of the strong interaction between connexons and the difficulty to disrupt 
this link, early theories developed by Evans and Berthoud proposed that the primary 
action of mimetic peptides such as Gap27 was to mimetically bind to undocked 
hemichannels, before preventing the docking of connexons to form functional gap 
junctions (Berthoud et al., 2000, Boitano and Evans, 2000). Connexin mimetic 
peptide’s high affinity to its counterpart sequence on the extracellular loop would 
compete with and prevent the docking of two connexin hemichannels, causing 
disruption to gap junction coupling. This would suggest an early effect of Gap27 was 
to inhibit hemichannel based communication before a later effect was to reduce or 
inhibit gap junction formation. This theory was supported by the results of a study 
using intravenous injections of fluorescently tagged Gap26 in a rat model of 
myocardial infarction. It was observed how the connexin mimetic peptide was able 
to reach the lateral membranes of cardiomyocytes and co-localise with Cx43, but 
remained absent from intercalated discs where gap junctions were formed. This 
demonstrated how Gap26 was able to interact with unopposed hemichannels but 
was unable to access the binding sites of connexons, on connexin extracellular 
loops, due to their engagement with their docked counterparts (Boengler et al., 
2005). 
Further work by Desplantez and colleagues, using an electrophysiological 
experiment with HeLa cells expressing Cx43 (Desplantez et al., 2012), 
demonstrated that Gap26 applied to non-contacting single cells inhibited 
hemichannel based currents whereas Gap26 applied to paired cells for a longer 
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incubation period inhibited gap junction communication, suggesting prevention of 
hemichannel docking. Recent work by Wang and colleagues, using patch clamp 
studies in HeLa cells transfected with Cx43 and pig ventricular myocytes 
endogenously expressing Cx43, has shown that incubation with connexin mimetic 
peptides can inhibit Cx43 hemichannel currents within minutes (Wang et al. 2013). 
These results further support that the primary function of connexin mimetic peptides 
are to interact with the extracellular loops of connexins, creating an inhibitory effect 
on hemichannel communication, before further incubation prevents these 
hemichannels from docking to their neighbours and ultimately inhibiting gap junction 
communication.   
I propose an additional branch to this hypothesis that explains how both Cx43 and 
hemichannel expressions are reduced in two types of cells after Gap27 incubation. 
The theory proposes that after Gap27 has bound to the extracellular surface of a 
connexin, an increased rate of internalisation is triggered. However this theory 
needs further testing to validate its assumptions. One way in which this could be 
achieved is to use fluorescently tagged connexins together with fluorescently tagged 
mimetic peptides to view in real time the effects of connexin mimetic peptides on 
connexin turnover. The design of the experiments needs to take into consideration 
the short lifespan of a connexin and the degradation rate of connexin mimetic 
peptides. 
Already there are successfully transfected cell lines with Cx43-GFP, that form 
functional gap junctions when compared to non-transfected cells of the same type 
(Jordan et al., 2001, Martin et al., 2001b, Martin et al., 2001a). These studies 
observe the trafficking and turnover of connexins from new connexin proteins into 
docked functional gap junctions before they are internalized at the end of their 
lifespan. However, there is no discretion in these observations between the new, 
forming connexins and the old, internalized connexins.  FlAsH (Fluorescein 
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Arsenical Hairpin) – ReAsH (Resorufin-derived red fluorescent Arsenical Hairpin) 
FlAsH-ReAsH (Gaietta et al., 2002, Evans and Martin, 2002b) or DENDRA (derived 
from Dendronephthya sp.) (Bejarano et al., 2012) may provide alternatives to tackle 
this observation obstacle. FlAsH-ReAsH as connexin tags allows the distinction 
between old and new connexins. As a pulse labelling experiment, cells expressing a 
Cx43 tetracysteine (Cx43-TC) chimera are initially exposed to the membrane 
permeant non-fluorescent biarsenical derivative FLASH-EDT2, resulting in a rapid 
binding to the tetracysteine motif before emitting light between 508-528 nm. As a 
result, trafficking of connexins labelled in this first hour can be monitored for the next 
4-8 hours. Cell exposure to REASH-ED2 creates a similar binding between the 
derivative and Cx43-TC, emitting light between 593-608 nm and will not stain the 
older connexins. Thus, a discrepancy between older and new connexins is 
achieved. Cells transfected with cDNA encoding Cx43-DENDRA will show Cx43 as 
green. Photo-switching using light pulses will convert this green into red and thereby 
also distinguish from new forming connexins in green. Thereby one could observe in 
real-time the potential docking of Gap27 onto old connexin plaques and monitor 
levels of possible internalized connexins from this incubation.  
In all of the research reports discussed above, it has been thought that initially 
connexin mimetic peptides primarily interact with undocked hemichannels and at 
later incubation periods, prevent the docking of connexons to form functional gap 
junctions. The research presented in this chapter further enhances this theory by 
suggesting that in short incubation periods of two hours, only higher concentrations 
of Gap27 significantly reduced Cx43 expression and gap junction communication, 
whereas in six hour incubation periods, where Gap27 was replaced every two hours, 
both lower and high concentrations significantly reduced Cx43 expression. This 
suggests that continually incubating cells in Gap27 will result in the lower 
concentrations having similar effects in reducing connexin expression and perhaps 
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reducing gap junction communication, observed in cells incubated at higher 
concentrations. Further work using communication assays could further support this 
theory.  
Using Gap27 to understand the conformation of connexons  
Although substantial research in the gap junction field has confirmed that during gap 
junction formation the extracellular portions of connexons from opposing cells 
interact and dock to complete a fully formed channel (Laird 1996), the conformation 
of the connexons is still unknown. During connexon docking, it is still unclear as to 
whether extracellular loops line up heterotypic (ECL1 to ECL2) or homotypic (ECL1 
to ECL1) as shown in more detail in figure 3.12A and B. 
 
Figure 3.12 Conformation of gap junction connexons 
(A) Figure depicting connexon docking in heterotypic conformation; ECL1 to ECL2. (B) 
Figure depicting connexon docking in homotypic conformation; ECL1 to ECL1. (C) Gap27 
competing out the hemichannel domain in ECL1 thereby reducing connexin hemichannel 
staining. ECL = Extracellular loop. HC ab = Hemichannel antibody.  
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In this chapter, a custom made affinity purified antibody against a highly conserved 
portion of the 1st ECL of Cx43 was used to detect connexin hemichannels. One of a 
group of large antibodies that were raised against the first extracellular loop of Cx32 
by Becker and colleagues (that were recognised by both Cxs 32 and 43) not only 
reduced gap junction communication but would also fail to immunostain gap 
junctions (Becker, Evans et al. 1995, Warner, Clements et al. 1995). These 
antibodies, larger in size but having a similar function to connexin mimetic peptides, 
delayed gap junction formation and reduced dye transfer between neighbouring 
cells.  
The results presented here have shown that incubation in Gap27 reduced 
hemichannel expression as shown by immunofluorescence. This would suggest that 
Gap27 has competed out the hemichannel antibody domain in ECL1 and therefore 
connexons are docking in a heterotypic fashion (figure 3.12A and C). Results 
presented here further supports the theory of rotational staggers developed by 
Unger and colleagues (Unger et al. 1999). By using electron microscope and image 
analysis to examine gap junction formation, they noticed a 30° displacement 
between the rings of opposing alpha helices on two connexons forming a channel. 
They assumed that if the rough shape for a connexin is circular, this displacement 
proposes that the two hemichannels forming the channel were likely to be 
rotationally staggered with respect to each other. Further work is needed to confirm 
these observations, perhaps repeating the experiment using Gap26, the mimetic 
peptide that shares homology to the first extracellular loop of Cx43. 
Gap27 reduced Cx26 and Cx30 expression in keratinocyte cells  
Research presented in this chapter, has shown for the first time, using immortal 
keratinocyte cells, that naturally express Cxs 26 and 30 and can form functional gap 
junctions (Fitzgerald et al., 1994, Choung et al., 2011, Lee et al., 2012) in a time and 
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concentration dependent protocol that continuously incubating these cells in Gap27 
can significantly reduce Cx26 and 30 (figure 3.10 and figure 3.11).  
Connexin mimetic peptides Gap26 and Gap27 have mainly been used to inhibit 
Cx43 based communication; however there has been some question on their 
specificity. Work carried out by Martin and colleagues has shown that Gap27 can 
inhibit both Cxs 43 and 37 based communication, although Gap27 does share 100% 
homology with both these connexins (Martin et al., 2005). Gap26 incubation in HeLa 
cells transfected with single Cxs 43, 40 and 26 can significantly reduce dye transfer 
in these cells (Wright et al., 2009) when there is at a least three amino acid 
differences between Cxs 40 and 26 and Gap26. However Gap27 incubation with 
these cells only reduced Cx43 based communication suggesting that Gap27 is more 
Cx43 specific. Yet, these cells were only incubated in 50 µM for 90 minutes and this 
low dose experiment may not reflect the results presented in this research chapter 
that continuous Gap27 incubation significantly reduced Cxs 26 and 30 in immortal 
keratinocyte cells. There are only three amino acid differences between Gap27 and 
human Cx26 and only two differences between Gap27 and human Cx30. This 
supports the results shown here as there is only a small divergence between the 
connexins and the connexin mimetic peptide. Further work using Western blot 
analysis could support these results. 
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Figure 3.13 Sequence alignments 
Diagram shows the topology of Cxs 43, 26 and 30 between amino acid numbers 181 and 
200. Connexin mimetic peptide Gap27 is given below each sequence. Amino acids coloured 
in red are non-alignments. 
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In recent research it has been realized that connexin mimetic peptides show a huge 
potential in tackling connexin-based maladies. As Gap27 has unique time and 
concentration dependent properties when disrupting either hemichannel or gap 
junction based communication, this connexin mimetic peptide shows promise in 
translational and therapeutic possibilities in wound repair. The next chapter explores 
the potential of Gap27 in the wound healing environment using an in vitro model of 
wound healing.  
Conclusions 
 Gap27 reduced communication in 3T3 fibroblast cells and increased 
migration rates in 3T3 fibroblast and HaCaT keratinocyte cells. 
 Gap27 significantly reduced Cx43 expression in both 3T3 fibroblast and 
HaCaT keratinocyte cells. 
 Gap27 also significantly reduced connexin hemichannel expression in 
3T3 fibroblast cells. 
 Continuous incubation with Gap27 significantly reduced Cxs 26 and 30 
expressions in HaCaT keratinocyte cells. 
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4. Gap27 in wound healing 
4.1 Introduction 
Wound healing begins immediately after the body’s protective barrier has become 
damaged and there are three classic stages of wound repair involved in its closure; 
the immediate inflammatory response, new tissue formation and remodelling. The 
immediate inflammatory response begins within moments of initial injury with a 
series of platelet aggregation, vasoconstriction and a release of pro-inflammatory 
signals. This is promptly followed by the recruitment of neutrophil leukocytes whose 
main role is to defend the host from the invasion by microbes. The migration of 
keratinocyte cells in the re-epithelialisation process and the migration of fibroblast 
cells and collagen deposition in granulation tissue formation govern the stage of 
tissue formation. This stage ultimately brings the wound margins closer together. 
Collagen continues to be synthesised (exceeding the rate of collagen degradation) 
in the tissue remodelling stage before the final process of scar resolution. This final 
stage can take between 6-12 months to complete fully, depending on the size and 
depth of the initial wound (Martin, 1997, Gurtner et al., 2008, Shaw and Martin, 
2009).The highly complex sequence of events in skin wound healing relies heavily 
on the communication of signals released during the numerous, overlapping stages. 
Cell-to-cell communication is crucial in order for tissues to co-ordinate their 
processes and mounting evidence has shown that gap junctions and their connexin 
sub units play a pivotal role in the communication of these signals.  
Gap junction communication within the skin is governed by at least ten different 
connexin subtypes. Within rodents, Cx43 is highly expressed in the differentiating 
strata spinosum, granulosum and basal in the epidermis and expressed in 
sebaceous glands, hair follicles and fibroblasts within the dermis. Both Cxs 26 and 
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30 are highly expressed in the differentiating strata spinosum and granulosum of 
rodent epidermis, whereas only hair follicles, sebaceous glands and sweat glands 
express Cx26 (Guo et al., 1992, Salomon et al., 1994, Butterweck et al., 1994, Tada 
and Hashimoto, 1997, Locke et al., 2000, Brandner et al., 2004, Kandyba et al., 
2008).  
These key connexins undergo dynamic changes and play integral roles during the 
wound healing process. In the immediate response of wound repair Cx43 protein 
expression is up-regulated in blood vessels, yet significantly down-regulated in 
leading edge tissue within the first day of wound closure. This protein switch-off is 
accompanied by a significant increase in the expression of Cxs 26 and 30 in the 
leading edge tissue, corresponding to the onset of re-epithelisation of epidermal 
keratinocytes and the migration of dermal fibroblasts. Upon the resolution of the 
wound, the expression profiles of these connexin proteins return to their normal pre-
wound levels (Goliger and Paul, 1995, Saitoh et al., 1997, Coutinho et al., 2003).  
In work developed by the Becker lab, it has been shown that transiently reducing 
Cx43 expression in acute wounds enhances the rate of wound closure in rodent 
models of wound healing (Qiu et al., 2003, Mori et al., 2006). Using a Cx43 specific 
asODN, a 30mer unmodified backbone antisense that targets to Cx43 mRNA and 
induces a Cx43 protein knockdown, it has been demonstrated that reducing this 
protein significantly accelerates the rate of wound closure. By comparing both 
physiological and cell biological aspects of tissue repair, it was confirmed how a 
single early application of Cx43 asODN to acute wounds dampened tissue swelling 
and the inflammatory response, promoted early keratinocyte and fibroblast cell 
migration and closed the wound gap earlier than wounds left un-treated.  Wounds 
treated with Cx43 asODN showed rapid angiogenesis, increased myofibroblast 
differentiation, enhanced granulation tissue deposition and increased wound 
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contraction. These events occurred 2-3 days before normal wound healing stages 
and resulted in the wounds appearing less red and swollen with smaller and thinner 
scar tissue. Treated wounds also had a markedly reduced neutrophil and 
macrophage recruitment and decreased leukocyte infiltration. This was coupled with 
a reduction in mRNA expression of pro inflammatory chemokines ligand 2 and TNF-
α in treated wounds. Both studies demonstrated that by targeting the early stages of 
wound closure using Cx43 asODN ‘jump-started’ the subsequent phases of acute 
wound healing. 
In a similar study using Cx43 asODN in a rodent acute mechanical scrape corneal 
wound model, it was also demonstrated that a transient knockdown of Cx43 
increased the rate of wound healing (Grupcheva et al., 2012). In comparison to 
control wounds, Cx43 asODN treatment decreased the wound area, reduced the 
inflammatory response and tissue oedema while increasing the rate of keratinocyte 
re-epithelialisation.  In a further optic model of wound repair it was also shown that 
Cx43 asODN treatment increased the rate of wound repair in comparison to control 
wounds (Danesh-Meyer et al., 2008). Ischemia reperfusion injury was observed in 
this model, together with an increase in Cx43 expression that resulted in an increase 
in inflammation, capillary break down and cell death. Transiently knocking down 
Cx43 reduced the responses observed in ischemic reperfusion damage and 
increased cell viability. This healing response was also recorded in human eye 
injury, where as a result of severe ocular surface burns, corneal epithelial wounds 
can lead to blindness (Ormonde et al., 2012). Treatment with Cx43 asODN 
significantly reduced inflammation in injured eyes and complete and stable corneal 
re-epithelialisation was observed in all treated patients. 
In another model of thermal injury, treatment with Cx43 asODN was tested in 
limiting burn extension damage (Coutinho et al., 2005). Using a rodent model, acute 
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thermal injuries were applied to the backs of these animals. Often burn damage 
spreads beyond the initial site of injury and this was noted with an increase in Cx43 
expression within the surrounding tissue. A single application of Cx43 asODN 
significantly reduced this elevation of Cx43 and limited the extension of burn 
damage. This was achieved through reducing neutrophil infiltration, increasing 
keratinocyte re-epithelialisation and wound closure, ultimately resulting in reduced 
scarring and granulation tissue deposition and increased dermal appendage 
survival. This study demonstrated how initial thermal injury can rapidly spread to 
neighbouring cells via gap junctions and by reducing this communication through 
transient Cx43 knockdown, thermal damage extent is significantly reduced.  
A comparable story was described in reports of rodent spinal cord injury (Cronin et 
al., 2008). In both models of compression injury and partial spinal cord transection, 
application of Cx43 asODN increased the rate of recovery. This was observed in 
treated animals scoring higher in behavioural tests of locomotion, having a reduction 
in tissue swelling and a decrease in blood vessel leakiness around the injury site. A 
more detailed investigation carried out by the same group using an ex vivo model of 
spinal cord trauma, revealed that Cx43 asODN treatment significantly reduced cell 
death and inhibited inflammation spreading from the site of injury to the 
neighbouring healthy tissue (Zhang et al., 2010a). These studies have supported the 
theory that in injured tissue gap junction protein Cx43 is transiently upregulated and 
spreads tissue damage to neighbouring healthy cells. Treatment with Cx43 asODN 
reduces this communication through transient Cx43 knockdown and maintained 
tissue viability.  
Transient knockdown of Cx43 has also seen benefits in the chronic wound 
environment. In both human diabetic foot ulcers and STZ-induced diabetic rat 
lesions, Cx43 fails to down-regulate at the wound edge, as seen in normal acute 
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wounds 24 h after wounding.  This sustained increase in Cx43 protein expression 
may be fundamental to the impaired healing found in diabetic foot ulcers. A single 
application of Cx43 asODN to a wound on STZ-induced diabetic rats was sufficient 
enough to prevent Cx43 up-regulation at the wound site. Treatment with Cx43 
asODN was also able to prevent the formation of a bulb of non-migratory 
keratinocyte cells, restoring the healing rate back to normal and in some cases 
exceeding the rate of control re-epithelialisation (Wang et al., 2007).  
Although it is becoming increasingly certain that Cx43 plays integral roles in both 
acute and chronic wound healing, it is still unclear whether these responses are 
attributed to the connexin hemichannels or gap junctions. Long term hemichannel 
and gap junction down-regulation can be achieved through topical application of 
Cx43 asODN; however the differences between gap junction communication and 
hemichannel signaling can be teased out by application of small connexin mimetic 
peptides.  Synthetic connexin mimetic peptide Gap27 is currently being considered 
as a candidate to improve the rate of wound healing. As shown in the previous 
chapter, Gap27 has unique time and concentration dependent properties when 
disrupting gap junction based communication or reducing Cx43 expression in 
immortal fibroblast and keratinocyte cells. Gap27 can rapidly block hemichannels 
and prevent gap junction formation in short or low concentration periods, however, 
with longer or more concentrated incubation periods, Gap27 can inhibit gap 
junctional communication and reduce Cx43 expression. In recent research it has 
been realized that connexin mimetic peptides show a huge potential in tackling 
connexin-based maladies and increasing the rate of wound repair. However, this 
research has been limited to 2D cultures, 3D organotypic or ex vivo models of 
wound healing and to date, there have been no studies executed on in vivo models 
of wound healing to elucidate the potential of Gap27 as a wound healing remedy 
(Kandyba et al., 2008, Pollok et al., 2011).  
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Using a murine in vivo model of wound healing, the work presented in this chapter 
aims to investigate the ability of connexin mimetic peptide Gap27 to enhance the 
rate of wound closure. Detailed analysis was carried out on the effect of Gap27 
during the initial stages of wound healing. This included an assessment on the 
inflammatory response and re-epithelialisation, while special attention was given to 
the connexin profiles in treated and non-treated tissue. Using Gap27 as a tool, a 
detailed exploration was carried out to determine the importance of hemichannel 
and gap junction based communication during wound repair. 
Hypothesis – By reducing connexin based communication, Gap27 will enhance the 
early stages of wound closure. 
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4.2 Results 
Gap27 significantly reduced blood vessel leakiness four hours 
after wounding 
In order to assess whether Gap27 has an effect on the extravasation process during 
the early immune response, blood vessel leakiness was assessed as described in 
detail in the methods section. Blood vessel leakiness was more pronounced at the 
wound site (figure 4.1B) and significantly reduced further away from the wound 
edge. Total blood vessel leakiness was then quantified in all four wounds in site 1 
(figure 4.1B) but as uniform FITC-BSA injection was not guaranteed, the data was 
normalised within each animal back to the non-treated site (figure 4.1E).  Gap27 
effects on blood vessel leakiness were compared with a positive control of Cx43 
asODN (which has already been shown to reduce leakiness in wounded tissue). 
Application of Cx43 asODN and Gap27 significantly reduced the extent of blood 
vessel leakiness.  
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Figure 4.1 Gap27 significantly reduced blood vessel leakiness at the wound 
site, four hours after wounding 
 (A) The panels show representative images from site 1 of treated and non-treated wounds. 
FITC-BSA (green) Dashed white line indicated wound edge. (B) Total leakiness of the blood 
vessels was quantified in three sites relative to the wound and significantly reduced further 
away from the wound edge. (C) Diagram depicting sites of interest in blood vessel leakiness 
analysis. (D) Total leakiness of blood vessels was quantified in site 1. (E) This data was 
normalised within each animal back to the non-treated site as uniform injection of FITC-BSA 
was not guaranteed. Application of Cx43 asODN and Gap27 to the wound site significantly 
reduced the extent of blood vessel leakiness. Statistical comparisons were made using a 
one-way analysis of variance (ANOVA). Data was tested for normality (Sharpiro-Wilk test) 
and equal variances (Levene test) before statistical comparisons were carried out. The data 
are shown as the means ± S.E.M. (n=7, *p<0.05, **p<0.01 against Site 1 in B and NT tissue 
in E). Scale bar = 50 µm. NT = No treatment, asODN = Cx43 antisense 
oligodeoxynucleotide, G27 = Gap27, SI = Site 1, SII = Site 2, SIII = Site 3 
  
Chapter 4 Gap27 in wound healing 
143 
 
Gap27 significantly reduced Cx43 expression in blood vessels, 
four hours after wounding 
Tissue slices were immunolabeled for Cx43 to assess what effect Gap27 had on this 
connexin’s expression within and around leaking blood vessels. Gap27 significantly 
reduced Cx43 expression in and around the vasculature at the wound site four 
hours after wounding (figure 4.2). 
Gap27 significantly reduced Cx43 and hemichannel expression 
at the wound edge, four hours after wounding 
Tissue slices were immunolabeled for Cx43 and connexin hemichannels before 
being imaged at the wound edge and adjacent to the wound site, four hours after 
wounding. Within the epidermis, high concentrations of Gap27 significantly reduced 
Cx43 expression at the wound edge, whereas a lower concentration of Gap27 only 
markedly reduced Cx43 expression at the wound edge (figure 4.3B). Within the 
dermis, Cx43 expression significantly increased at the wound edge of non-treated 
tissue in comparison to sites adjacent to the wound. Treatment with Gap27 
significantly reduced this expression at both the wound edge and adjacent to the 
wound (figure 4.3C). Similar results were observed in hemichannel expression. Both 
high and lower concentrations of Gap27 significantly reduced hemichannel 
expression within the epidermis at the wound edge (figure 4.4B). Within the dermis, 
hemichannel expression also significantly increased at the wound edge of non 
treated tissues in comparison to sites adjacent to the wound. Treatment with Gap27 
significantly reduced this expression at both the wound edge and adjacent to the 
wound (figure 4.4C). 
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Figure 4.2 Gap27 significantly reduced Cx43 expression in blood vessels, four 
hours after wounding 
 (A) The panels show representative z series images of nuclei (blue) FITC-BSA (green) and 
Cx43 (red), in treated and non-treated tissue 4 hours after wounding. The images are 
merged in the lower panels. Blood vessels are indicated by a white arrow in the nuclei 
panels. (B) Total Cx43 area per 1000 µm² was quantified. Gap27 significantly reduced Cx43 
expression in and around blood vessels.  Statistical comparisons were made using a one-
way analysis of variance (ANOVA). The data are shown as the means ± S.E.M. (n=5, 
*p<0.05 against NT tissue). Scale bar = 50 µm. NT = No treatment, G27 = Gap27. 
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Figure 4.3 Gap27 significantly reduced Cx43 expression at the wound edge, 
four hours after wounding 
(A) The panels show representative images of treated and non-treated tissue 4 hours after 
wounding. Tissue was immunolabeled for Cx43 (green) and nuclei (blue) and connexin 
profiles were measured at the wound edge or adjacent to the wound, approximately 200-400 
µm away from the wound edge. The epidermis and the dermis are separated by a white 
dashed line. (B) Total pixel area per nucleus within the epidermis was quantified at the 
wound edge and adjacent to the wound edge. (C) Total pixel area per 1000 µm² within the 
dermis was also quantified at the wound edge and adjacent to the wound. Application of 
Gap27 to the wound site significantly reduced Cx43 at the wound edge in both the epidermis 
and dermis. Note that the ‘no treatment-wound edge panel’ has auto fluorescence which was 
not quantified. Statistical comparisons were made using a one-way analysis of variance 
(ANOVA). The data are shown as the means ± S.E.M. (n=5, *p<0.05, **p<0.01 against NT 
wound edge tissue). White arrows indicate Cx43 expression. Scale bar = 50 µm. E = 
Epidermis, D = Dermis, NT = No treatment, G27 = Gap27. 
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Figure 4.4 Gap27 significantly reduced connexin hemichannel expression at 
the wound edge, four hours after wounding 
 (A) The panels show representative images of treated and non-treated tissue 4 hours after 
wounding. Tissue was immunolabeled for connexin hemichannels (green) and nuclei (blue) 
and connexin profiles were measured at the wound edge or adjacent to the wound, 
approximately 200-400 µm away from the wound edge. The epidermis and the dermis are 
separated by a white dashed line. (B) Total pixel area per nucleus within the epidermis was 
quantified at the wound edge and adjacent to the wound edge. (C) Total pixel area per 1000 
µm² within the dermis was also quantified at the wound edge and adjacent to the wound. 
Application of Gap27 to the wound site significantly reduced connexin hemichannel at the 
wound edge in both the epidermis and dermis. Note that the ‘no treatment-wound edge 
panel’ has auto fluorescence which was not quantified. Statistical comparisons were made 
using a one-way analysis of variance (ANOVA). The data are shown as the means ± S.E.M. 
(n=5, *p<0.05, **p<0.01 against NT wound edge tissue). White arrows indicate hemichannel 
expression. Scale bar = 50 µm. E = Epidermis, D = Dermis, NT = No treatment, G27 = 
Gap27. 
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Gap27 significantly reduced the number of neutrophils in the 
dermis, twenty-four hours after wounding 
Tissue was stained with Haematoxylin and Eosin to assess how treatment with 
Gap27 affected the number of neutrophils within the tissue, twenty four hours after 
wounding. Tissue was observed at the wound edge, distal to the wound and around 
wound edge blood vessels (figure 4.5A). Polymorphonuclear neutrophil leukocytes 
were identified through high powered imaging of the tissue (figure 4.5B) and 
leukocyte count per 1000 µm2 was quantified. Gap27 significantly reduced 
polymorphonuclear neutrophil leukocyte count at the wound edge, distal to the 
wound and around wound edge blood vessels (figure 4.6). 
 
Figure 4.5 Regions of interest in polymorphonuclear leukocyte count 
 (A)The cross section diagram of skin details the regions of interest measured in leukocyte 
count. The red boxes indicate the wound edge dermis (WE), distal tissue approximately 200-
400 µm away from the wound (DT) and tissue with wound edge dermal blood vessels (BV). 
E = Epidermis, D = Dermis, WE = Wound edge, DT = Distal tissue, BV = Blood vessels. (B) 
Example of polymorphonuclear neutrophils. Scale bar = 25 µm. 
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Figure 4.6 Gap27 significantly reduced the number of leukocytes in the 
dermis, twenty four hours after wounding 
The panels show representative histological images of treated and non-treated tissue 24 
hours after wounding. Tissue was observed at the wound edge (A), distal to the wound edge 
(C) and at blood vessels (E). Leukocyte count per 1000 µm² was quantified. Leukocyte 
neutrophils were identified by their multi-lobed nuclei (black arrows). At the wound edge (B), 
distal tissue (D) and surrounding blood vessels (F) Gap27 significantly reduced leukocyte 
count.  Statistical comparisons were made using a one-way analysis of variance (ANOVA). 
The data are shown as the means ± S.E.M. (n=6, *p<0.05, **p<0.01 against NT tissue). 
Scale bar = 200 µm. E = Epidermis, D = Dermis, GT = Granulation tissue. 
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A low concentration of Gap27 increased re-epithelialisation 
twenty four hours after wounding 
Tissue was stained with Haematoxylin and Eosin to assess the rate of re-
epithelialisation (figure 4.7). Re-epithelialisation was noted by measuring the 
distance from the top of the junctions between new and old epithelium (black arrow 
in figure 4.7) to the leading edge of new epithelial growth on both sides of the wound 
in the epidermis. This is shown as a red-dashed line in the representative images in 
figure 4.7. Low concentrations of Gap27 significantly increased the extent of re-
epithelialisation twenty four hours after wounding. In earlier preliminary studies, 
when tissue was collected three and seven days after wounding it was apparent that 
Gap27 did not have an any effect on the extent of re-epithelialisation in comparison 
to non-treated wounds in these later stages after wounding. 
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Figure 4.7 A low concentration of Gap27 significantly increased the extent of 
re-epithelialisation, twenty four hours after wounding 
(A) The panels show representative histological images of treated and non-treated tissue 24 
hours after wounding. The epidermis and the dermis are separated by a white dashed line. 
Wound edge is shown by a black arrow and new epidermal growth is shown as a red-dashed 
line. (B) Low concentrations of Gap27 significantly increased the extent of re-epithelialisation 
24 hours after wounding.  (C) Three and seven days after wounding Gap27 did not have any 
effect on the extent of re-epithelialisation in comparison to non-treated wounds in these later 
stages after wounding. Statistical comparisons were made using a one-way analysis of 
variance (ANOVA). The data are shown as the means ± S.E.M. (n=6, *p<0.05 against NT 
tissue). Scale bar = 100 µm. E = Epidermis, D = Dermis, GT = Granulation tissue, NT = No 
treatment, G27 = Gap27. 
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Connexin profiles in tissue 24 hours after wounding 
Tissue slices were immunolabeled for Cxs 26, 30 and 43 and imaged at the wound 
edge and adjacent to the wound site, twenty four hours after wounding. Within the 
epidermis, Cx43 expression decreased at the wound edge. Treatment with Gap27 
only slightly reduced this expression (figure 4.8B). A similar observation was noted 
in the dermis where Cx43 expression was also increased at the sites adjacent to the 
wound edge in comparison to the wound site. Again, treatment with Gap27 reduced 
this expression but was not deemed significant (figure 4.8C).  
Cx26 expression within the epidermis markedly increased at the wound edge of 
non-treated tissue in comparison to sites adjacent to the wound. Gap27 did not have 
any effect on this connexin expression. There was no difference in Cx26 expression 
between treated and non-treated tissue in any region measured (figure 4.9). A 
comparable observation was noted in Cx30 expression within the dermis where 
protein levels were markedly increased at the wound edge of non-treated tissue in 
comparison to sites adjacent to the wound. However, Cx30 protein expression was 
much lower than Cx26 expression and there was no measurable quantity of Cx30 
protein levels within the dermis (figure 4.10). 
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Figure 4.8 Gap27 did not significantly reduce Cx43 expression at the wound 
edge, twenty four hours after wounding 
 (A) The panels show representative images of treated and non-treated tissue 24 hours after 
wounding. Tissue was immunolabeled for Cx43 (green) and nuclei (blue) and connexin 
profiles were measured at the wound edge or adjacent to the wound, approximately 200-400 
µm away from the wound edge. The epidermis and the dermis are separated by a white 
dashed line. New epidermal growth is shown as a red-dashed line. (B) Total pixel area per 
nucleus within the epidermis was quantified at the wound edge and adjacent to the wound 
edge. (C) Total pixel area per 1000 µm² within the dermis was also quantified at the wound 
edge and adjacent to the wound. Application of Gap27 to the wound site slightly reduced 
Cx43 adjacent to the wound in both the epidermis and dermis. Statistical comparisons were 
made using a one-way analysis of variance (ANOVA). The data are shown as the means ± 
S.E.M. (n=6, *p<0.05 against NT wound edge tissue). White arrows indicate Cx43 
expression. Scale bar = 50 µm. E = Epidermis, D = Dermis, NT = No treatment, G27 = 
Gap27. 
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Figure 4.9 Gap27 did not significantly reduce Cx26 expression at the wound 
edge, twenty four hours after wounding 
 (A) The panels show representative images of treated and non-treated tissue 24 hours after 
wounding. Tissue was immunolabeled Cx26 (green) and nuclei (blue) and connexin profiles 
were measured at the wound edge or adjacent to the wound, approximately 200-400 µm 
away from the wound edge. The epidermis and the dermis are separated by a white dashed 
line. New epidermal growth is shown as a red dashed line. (B) Total pixel area per nucleus 
within the epidermis was quantified at the wound edge and adjacent to the wound edge. (C) 
Total pixel area per 1000 µm
2
 within the dermis was also quantified at the wound edge and 
adjacent to the wound. After application of Gap27 to the wound site, there was no difference 
in Cx26 expression between treated and non-treated tissue in any region measured. The 
data are shown as the means ± S.E.M. (n=6). White arrows indicate Cx26 expression. Scale 
bar = 50 µm. E = Epidermis, D = Dermis, NT = No treatment, G27 = Gap27. 
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Figure 4.10 Gap27 did not significantly reduce Cx30 expression at the wound 
edge, twenty four hours after wounding 
 (A) The panels show representative images of treated and non-treated tissue 24 hours after 
wounding. Tissue was immunolabeled Cx30 (green) and nuclei (blue) and connexin profiles 
were measured at the wound edge or adjacent to the wound, approximately 200-400 µm 
away from the wound edge. The epidermis and the dermis are separated by a white dashed 
line. New epidermal growth is shown as a red dashed line. (B) Total pixel area per nucleus 
within the epidermis was quantified at the wound edge and adjacent to the wound edge. (C) 
Total pixel area per 1000 µm
2
 within the dermis was also quantified at the wound edge and 
adjacent to the wound. After application of Gap27 to the wound site, there was no difference 
in Cx30 expression between treated and non-treated tissue the epidermis. There was no 
measurable quantity of Cx30 protein levels within the dermis. The data are shown as the 
means ± S.E.M. (n=6). White arrows indicate Cx30 expression. Scale bar = 50 µm. E = 
Epidermis, D = Dermis, NT = No treatment, G27 = Gap27. 
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4.3 Discussion 
Treatment with Gap27 significantly reduced blood vessel 
leakiness and dampened the inflammatory response 
A crucial novel finding reported in this chapter was that the application of connexin 
mimetic peptide Gap27 to full thickness wounds significantly reduced blood vessel 
leakiness around the wound site (figure 4.1). The effects of Gap27 were compared 
with a positive control of Cx43 asODN treatment and a negative control of non-
treated wounds. Blood vessel leakiness was more pronounced at the wound site 
and it was also noted that Cx43 expression was significantly increased in and 
around the blood vessels of the same site (figure 4.2).  
Similar results were reported by De Bock, Leybeart and colleagues on investigating 
blood-brain barrier endothelial permeability in rats. They described how bradykinin, 
as an inflammatory stimulus, significantly increased endothelial permeability both in 
vivo and in vitro (De Bock et al., 2011, De Bock et al., 2012).  Administration of 
Gap27 significantly reduced endothelial permeability in both environments. More 
recently, work carried out by Danesh-Meyer, Green and colleagues has also shown 
how Peptide 5  (a 12 amino acid long short connexin mimetic peptide that 
corresponds to the second extracellular loop of Cx43 and overlaps with Gap27 by 
seven amino acids) can also significantly reduce vascular leakage following retinal 
ischemia reperfusion (Danesh-Meyer et al., 2012). Another crucial observation 
reported in this chapter was that there was a correlation between blood vessel 
leakiness, Gap27 treatment and Cx43 expression. As blood vessel leakiness 
increased at the wound site four hours after wounding, it was observed that Cx43 
expression was also significantly increased in and around the blood vessel. 
Treatment with Gap27 significantly reduced blood vessel leakiness and Cx43 
expression (figure 4.2).  Cx43 protein reduction after connexin mimetic peptide 
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incubation was also reported by O’Carroll, Green and colleagues when incubating 
ex vivo spinal cord segments in Peptide 5. A markedly reduced expression of Cx43 
was observed in cultures through Western blot analysis when compared to cells 
incubated in a control peptide (O'Carroll et al., 2008). Cx43 reduction after Gap27 
incubation was also presented in the first research chapter of this thesis, where it 
was reported that Gap27 incubation in vitro reduced Cx43 expression in immortal 
fibroblast and keratinocyte cells.  
In a novel discovery reported in this chapter, it was observed that incubation with 
Gap27 significantly reduced the PMN leukocyte count at the wound edge, distal to 
the wound and around wound edge blood vessels, 24 hours after wounding (figure 
4.6).  In a comparable report given by Cronin, Becker and colleagues where rats 
were subjected to spinal cord injury, treatment with Cx43 asODN significantly 
rescued blood vessel leakiness by reducing the extravasation of FITC-BSA. They 
also noted how Cx43 asODN significantly reduced neutrophil recruitment to the site 
of injury. Transiently knocking down Cx43 in wounded tissue has previously shown 
to reduce neutrophil macrophage recruitment and decreased leukocyte infiltration in 
studies carried out by the same group (Qiu et al., 2003, Mori et al., 2006). Although 
it is apparent from these studies and the data reported here that connexins play a 
fundamental role during the early immune response, there is still some debate on 
how this happens. 
Gap junctions, hemichannels and connexins have been identified in leukocytes and 
vasculature endothelial cells and there is mounting evidence of functional 
communication in homotypic and heterotypic populations of these cell types during 
the inflammatory response (Oviedo-Orta and Howard Evans, 2004). Human 
monocytes and macrophages have been reported to express Cx43 when activated 
with lipopolysaccharides (LPS). Although these cells could form functional gap 
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junctions, their communication was inhibited by the known gap junction 
communication inhibitor 18α-Glycyrrhetinic acid (Eugenín et al., 2003). Time 
dependent and bi-directional cross talk has also been observed between 
populations of PMNs and human umbilical vein endothelial cells (HUVECs) and this 
gap junction based communication was inhibited by Gap26 incubation (Zahler et al., 
2003). Oviedo-Orta, Evans and colleagues were the first to note Cx43 expression in 
non-activated lymphocytes (Oviedo-Orta et al., 2000) however, incubation with 
either 18α-Glycyrrhetinic acid or Gap27 decreased dye transfer and therefore 
confirmed gap junction based communication between these cells.  
In a study conducted by Ovieda-Orta, Evans and colleagues, trans-endothelial 
migration was investigated using an in vitro model of heterotypic populations of 
endothelial cells and lymphocytes in a chamber system (Oviedo-Orta et al., 2002). 
Interestingly pre-incubation with connexin mimetic peptides inhibited dye transfer 
between gap junctions but did not slow down the transmigration process, suggesting 
that connexin mimetic peptides did not have any affect in the adhesion stage of 
extravasation. Controversially, a study exploring the interaction between mouse 
endothelial cells and neutrophils in vitro reported that when incubated with Gap26, 
adhesion between these two cell types was significantly reduced (Sarieddine et al., 
2009). These results, together with the data reported here, suggest that although not 
fully understood gap junctions and their connexins may have a heavy involvement in 
the complex sequence of events of the early inflammatory response. 
Although neutrophils within early inflammatory response can provide the body’s first 
active defensive mechanism against infectious disease and foreign material by 
having primary roles in killing invading microorganisms (Dovi et al., 2004), it is now 
thought that neutrophils may actually do more harm than good and retard wound 
closure (Martin and Leibovich, 2005).  It has been reported that wounded guinea 
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pigs depleted of inflammatory cells in a sterile environment does not impair wound 
debridement, granulation tissue deposition or tissue repair (Simpson and Ross, 
1972, Leibovich and Ross, 1975). Further studies using knockout models to reduce 
neutrophils in mice have demonstrated that dermal healing and collagen deposition 
is unaffected and that epidermal healing and wound closure was significantly faster 
than in control mice (Dovi et al., 2003, Dovi et al., 2004). Therefore, it seems that 
the chemokines released by neutrophils and actions of neutrophils within the tissue 
are either not essential or other cells are able to supply alternatives (Martin and 
Leibovich, 2005) and dampening down the inflammatory response  and neutrophil 
invasion by reducing Cx43 based communication may be beneficial to the wound 
healing process, particularly in a chronic wound environment.  
Treatment with low concentrations of Gap27 enhanced           
re-epithelialisation rates 
Research presented in this chapter has shown for the first time, using an in vivo 
murine wound healing model, that a low concentration of Gap27 can enhance the 
extent of re-epithelialisation twenty fours after wounding.  However, in a peculiar 
twist, higher concentrations of Gap27 did not enhance the re-epithelialisation rate 
beyond normal, non-treated control wounds (figure 4.7).  
Cx43 dynamics during acute wound healing are tightly regulated to ensure 
successful wound closure. Cx43 is moderately expressed in the strata basal and 
spinosum in non-wounded tissue but upon wounding, Cx43 expression significantly 
drops at the wound edge within the first hours after barrier disruption. Until 
approximately four days later, Cx43 expression remains absent in all proliferative 
and regenerative areas within the epidermis. Cx43 expression then significantly up-
regulates in the proliferating epidermis and remains elevated until six to seven days 
after wounding, when expression returns to pre-wounding levels (Coutinho et al., 
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2003). Coutinho and colleagues theorised that this observed reduction of Cx43 
expression in keratinocyte cells in the first few hours of wound healing, together with 
an observed increase in the proliferation marker Ki67+, is crucial in the 
transformation of leading edge keratinocyte cells into a migratory phenotype 
(Coutinho et al., 2003). Further work conducted by the same group has also shown 
that transient knockdown of Cx43 using Cx43 asODN can promote early 
keratinocyte migration, increase re-epithelialisation rates and close the wound gap 
earlier than wounds left untreated (Qiu et al., 2003, Mori et al., 2006, Wang et al., 
2007). In a similar knock-out study, this time investigating residual connexin 
expression in mouse tail epidermis using a Cx43Cre-ER(T)/flox mouse model, it was 
shown that a reduction in Cx43 expression was associated with the de-
differentiation and mobilization of keratinocytes at the wound edge during the first 
couple of days after wounding (Kretz et al., 2003, Kretz et al., 2004). Reducing Cx43 
in the mouse tail epidermis in this knock out mouse model promoted wound healing 
a day faster than wild-type control mice.  
In the previous research chapter, it was observed how high concentrations of Gap27 
significantly increased the rate of migration of immortal keratinocyte cells in an in 
vitro scratch wound assay. Early in vitro works conducted by the Martin group has 
also shown how connexin mimetic peptides Gap26 and Gap27 can increase the rate 
of migration in human keratinocyte cells (Wright et al., 2009, Pollok et al., 2011). 
Further studies using biologically relevant organotypic models of wound healing 
have shown a similar result (Kandyba et al., 2008, Pollok et al., 2011). In an ex vivo 
wound healing model using porcine skin, it has also been reported that Gap27 
treatment significantly increased re-epithelialisation and that treated sections 
expressed significantly more Ki67+ in leading edge epidermal cells (Pollok et al., 
2011). However, research presented in this chapter has shown that only a lower 
concentration of Gap27 can increase the rate of re-epithelialisation and keratinocyte 
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migration in an in vivo wound healing model (figure 4.7). This suggests that more 
than one element is at play in this stage of wound repair which has only been noted 
using an in vivo model of wound healing.  
Perhaps the extra element in play is an involvement of hemichannel communication 
during re-epithelialisation. Long term hemichannel protein disruption can be 
achieved through topical application of Cx43 asODN and in murine knock out 
models. However the differences between gap junction communication and 
hemichannel signalling can be teased out by application of small connexin mimetic 
peptides such as Gap27. Connexin mimetic peptides can rapidly block 
hemichannels and prevent gap junction formation, however, with more concentrated 
incubation periods, Gap27 can inhibit also gap junctional communication. For many 
years it was thought that hemichannels remained in a permanently closed form, until 
docked with its counter partner from a neighboring cell. However, recent research 
has emerged that shows hemichannels can open in cultured cells and provide a 
signaling pathway between the cell’s cytoplasm and the extracellular environment 
(Evans et al., 2006). 
Recent studies have shown that ATP can be released from open Cx43 
hemichannels (Stout et al., 2002, Eltzschig et al., 2006, Robertson et al., 2010, 
Orellana et al., 2012) and in a study using cultured neonatal keratinocytes that were 
briefly exposed to air, a robust long lasting ATP release was observed (Barr et al., 
2013). Using this novel in vitro wound healing model, it was also noted that Cx43 
mRNA significantly increased during this stress and that cell treatment with octanol 
and carbenoxolone significantly reduced ATP release. An additional study has also 
shown that during wound healing, platelets can release ATP that have the potential 
to expose the wounded epidermis to concentrations of ATP known to alter cellular 
functions (Pillai and Bikle, 1992).  ATP released from Cx43 hemichannels can also 
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cause cell death by acting on purinergic P2X receptors (Stout et al., 2002), leading 
to cellular permeation pathways to large molecules and ultimately causing cell death 
through osmotic imbalance.  It has been shown in both in vitro and in vivo models of 
wound healing that ATP release causes a reduction in keratinocyte number and 
epidermal thickness, a decrease in keratinocyte differentiation and a decline in 
barrier formation (Pillai and Bikle, 1992, Denda et al., 2002). Treatment with a P2X 
antagonist after wounding reversed these deleterious effects and accelerated barrier 
repair (Denda et al., 2002). Connexin mimetic peptides have also been shown to 
inhibit ATP release in a variety of cells in culture, including leukocytes (Eltzschig et 
al., 2006) , astroglial (Orellana et al., 2012) and endothelial cells (Robertson et al., 
2010) by plugging open hemichannels.  
As discussed in detail in the previous research chapter, it is thought that connexin 
mimetic peptides primarily interact with undocked hemichannels and at later 
incubation periods, prevent the docking of connexons to form functional gap 
junctions due to an increased rate of internalisation.  The initial interaction of 
connexin mimetic peptides has been shown to block open hemichannels and 
prevent ATP release. Therefore it is possible to believe that ATP is being released in 
the early stages of wound healing, (from surrounding damaged tissue, migrating 
leukocytes, platelets or stressed keratinocyte cells) and that treatment with a low 
concentration of Gap27, as shown in the data reported here, could reduce ATP 
release and enhance the re-epithelialisation rate. Expanding this theory would 
suggest that higher concentrations of Gap27 would completely disrupt Cx43 based 
gap junction communication in keratinocytes, which in the case presented in this 
research chapter, failed to have any enhancement in re-epithelialisation rate beyond 
normal, non-treated control wounds. This would suggest that communication 
between keratinocyte cells is a critical component of wound healing and Defranco 
and colleagues confirmed this by showing that migrating cells in a scratch wound 
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assay retain functional gap junction communication (Defranco et al., 2008). 
However, the data reported in this chapter is contradictory to a number of reports 
that have described that reducing Cx43 protein expression using in vivo models of 
wound healing, increases the rate of re-epithelialisation (Qiu et al., 2003, Mori et al., 
2006, Wang et al., 2007, Kretz et al., 2003). However, these studies reduced Cx43 
expression through protein disruption (using knock out models or asODN), whereas 
Gap27 most likely reduces Cx43 expression and gap junction communication 
through increasing the internalisation rate of connexins. Therefore, perhaps 
disrupting Cx43 protein expression will influence a compensatory increase in 
another connexin and this was shown and supported by Kretz and colleagues in 
their Cx43Cre-ER(T)/flox knock out mouse model. Animals with reduced Cx43 expression 
showed an increase in Cx30 expression in the epidermis (Kretz et al., 2003). This 
study would support the theory that cell to cell communication between migrating 
epidermis during wound repair is a critical component of wound healing and that a 
high concentration of Gap27 on a wound may disrupt this communication in such a 
way that is compensated by another connexin increase. Further immuno analysis 
investigation is required to support this theory. 
Connexin mimetic peptides during wound repair  
This chapter is the first to explore connexin profiles during wound repair after Gap27 
treatment in an in vivo model of wound healing. During the first four hours of healing, 
a single dose of a high concentration of Gap27 significantly reduced Cx43 
expression around the blood vasculature and within wound edge epidermis and 
dermis (figures 4.2 and 4.3). A single dose of lower concentrations only markedly 
reduced Cx43 expression within wound edge epidermis and dermis (figure 4.3). 
Similar results were observed on quantifying hemichannel expression where single 
doses of both high and low concentrations of Gap27 significantly reduced 
hemichannel expression in wound edge epidermis and dermis. A single dose of 
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Gap27 also significantly reduced hemichannel expression in the dermis adjacent to 
the wound (figure 4.4). Twenty four hours after wounding, a single dose of Gap27 
only slightly reduced Cx43 expression at the wound edge (figure 4.8) whereas there 
was no effect on Cxs 26 and 30 after a single dose of Gap27 treatment at the same 
time (figures 4.9 and 4.10). 
Comparable results were made in the previous research chapter where it was 
reported that a single dose of high concentrations of Gap27 significantly reduced 
Cx43 expression in immortal fibroblast and keratinocyte cells. Single doses of both 
high and low concentrations of Gap27 significantly reduced hemichannel expression 
in immortal fibroblast cells and only continuous incubation of Gap27 had any effect 
on the expression of Cxs 26 and 30 in immortal keratinocyte cells. It had been 
previously thought that Gap27 primarily interacts with undocked hemichannels and 
at later incubation periods or with higher concentrations, prevents the docking of 
connexons, thereby reducing connexin hemichannel and connexin gap junction 
based communication respectively. Work presented in the previous chapter built 
upon this theory by suggesting that after Gap27’s initial hemichannel interaction, an 
increase in the internalisation rate was triggered. This would reduce antibody 
interaction with connexins and would explain how Cx43 and connexin hemichannel 
expression is reduced in the first few hours after initial Gap27 treatment, as shown 
in both the previous research chapter and in the data reported in this chapter.  
By twenty four hours after wounding, it is clear that Gap27 no longer has a profound 
effect on reducing connexin expression. This may be due to the rapid turnover of 
connexins or as a result of peptide degradation in an in vivo system. Proteases 
within the animal will rapidly break down peptides, greatly reducing its half life and 
exonucleases within serum are also known to break down unmodified fragile 
components such as oligodeoxynucleotides (Shaw et al., 1991). Work carried out by 
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Wright and colleagues has also shown that the modified connexin mimetic peptide 
Gap26M has a peak level of effectiveness 90 minutes post application, remaining at 
a similar level of effectiveness 5 hours post application before dropping significantly 
to control levels 8 to 24 hours post application (Wright et al., 2009). To counteract 
the rapid breakdown, Gap27 was delivered within a Pluronic™ F-127 gel.  This gel 
has thermo-reversible properties (can be liquid at temperatures between 0 and 4 °C 
but sets rapidly at body temperature), that acts as a slow release reservoir that has 
successfully enabled a constant topical delivery for several hours when used to 
deliver Cx43 asODN to wounds  (Becker et al., 1999, Cronin et al., 2006). However, 
this delivery agent has not been adequate to successfully release the connexin 
mimetic peptide Gap27 over a long period of time in an in vivo model of wound 
healing and other delivery agents need to be considered. One such agent could be 
to use osmotic pumps that ensure a continuous delivery of the peptide over a 
defined study period. Subcutaneous implanted osmotic pumps delivering Gap27 
were used to reduce Cx43 expression in bile-duct ligated livers within mice. Gap27 
successfully reduced Cx43 expression in the liver, when compared to a scrambled 
peptide control, after two weeks of constant peptide delivery (Balasubramaniyan et 
al., 2013). No cardiotoxicity or any other adverse effects were noticed, making this 
delivery system a potential ideal route for connexin mimetic peptide treatment. 
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In recent years it has been realised that connexin mimetic peptides show a huge 
potential in enhancing the rate of wound repair and novel research reported in this 
chapter has supported this capability. The next two chapters explore the prospects 
of Gap27 in reducing the spread of cell damage and death caused in tissue 
ischemia reperfusion injury, with a detailed analysis on the pressure ulcer. 
Conclusions 
 During the first four hours of wounding, a single dose of Gap27 
significantly reduced blood vessel leakiness at the wound edge and 
delayed leukocyte infiltration to the wounded tissue observed 24 hours 
later. 
 Low concentrations of Gap27 significantly increased the rate of re-
epithelisation.  
 Gap27 significantly reduced Cx43 and connexin hemichannel expression 
in the early stages of wound healing. 
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5. Connexin based communication 
in ischemia reperfusion 
5.1 Introduction 
Research has consistently indicated the potential of connexin mimetic peptides in 
tackling connexin-based maladies. These prospects include enhancing the rate of 
wound repair in acute wounds (as demonstrated and expanded on in the previous 
research chapters) and reducing the spread of damage caused in tissue ischemia 
reperfusion injury. Tissue ischemia is caused by a restriction of blood supply to 
tissue, causing a severe shortage of oxygen, glucose and nutrients needed for cell 
survival. The majority of tissue injury often occurs during reperfusion; triggered by 
the return of blood supply during the restoration of circulation, causing inflammation 
and oxidative damage to the tissue that has been denied oxygen for a period of 
time. Often this damage spreads beyond the initial ischemic area as repeated or 
prolonged ischemia reperfusion injury can result in the spread of cell death by 
necrosis and apoptosis (Mustoe, 2004). As connexin, hemichannel and gap junction 
based communication play such essential roles within intact tissue and during the 
wound healing process, it is not surprising that connexins have been flagged to have 
possible roles in the spread of cell death and tissue damage during ischemia 
reperfusion injury (Cotrina et al., 1998a, García-Dorado et al., 2004, Thompson et 
al., 2006, Orellana et al., 2010). 
Gap junction mediated tissue ischemia reperfusion injury has been identified in a 
number of organs including cardiac tissue during heart attacks (García-Dorado et 
al., 2004) and cerebral tissue during strokes (Frantseva et al., 2002a, Frantseva et 
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al., 2002b).  Repeated ischemia reperfusion injury in the skin during pressure ulcer 
formation, can also cause severe tissue damage similar to the damage formed in 
cerebral and cardiac ischemia reperfusion.  Pressure ulcers develop on areas of the 
skin that have been deprived of oxygen flow for extended periods of time and are 
often seen in bed-ridden, wheelchair bound and elderly patients. Pressure ulcers are 
extremely debilitating and there are currently no effective treatments to reduce or 
reverse the spread of cell damage caused during ischemia reperfusion. It is 
estimated that up to 25% of elderly residents in long term geriatric wards will 
develop a pressure ulcer (Sen et al., 2009). This reflects a staggering cost of over 
£2 billion for the NHS every year (Bennett et al., 2004) and the medical need for an 
effective therapeutic will increase as the elderly population grows.  
Already there is mounting evidence that connexin mimetic peptides may provide 
cardiac and neuronal tissue protection during ischemia reperfusion models of heart 
attacks and strokes. Using a model of cerebral ischemia in foetal sheep, Davidson 
and colleagues demonstrated that connexin mimetic peptide treatment could not 
only increase the survival rate of cells during ischemia reperfusion but also reduce 
seizure activity (Davidson et al., 2012b). Cardiac protection has also been noted 
when rat models of myocardial infarction are treated with connexin mimetic peptides 
(Hawat et al., 2012) and treatment with connexin mimetic peptide significantly 
reduced the infarct size by over sixty percent. To date, there has been no published 
work indicating that connexin mimetic peptides could reduce the extensive 
progressive damage often seen in pressure ulcers. The work presented in this 
research chapter and the next explores how gap junctions are involved in the spread 
of damage in pressure ulcers, with the ultimate aim of developing a therapy to 
reduce the damage and promote healing.  
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Despite the growing evidence that marks connexin based communication as a key 
contributor to the spread of cell death in neighbouring cells after an ischemic insult, 
the mechanisms behind this spread of damage are still unclear. The “bystander 
effect” model suggests that death signals can spread laterally through gap junctions 
from dying cells into their healthy neighbouring cells (Mao et al., 2009, Danesh-
Meyer et al., 2012, Zhang et al., 2013). However, some reports attribute cell death in 
ischemia reperfusion models to the opening of undocked gap junctions, release of 
ATP and activation of purinergic receptors (Thompson et al., 2006, Orellana et al., 
2010, Poornima et al., 2012, Clarke et al., 2009). Understanding how cell death 
occurs and spreads will help in the development of a therapeutic to reduce spread of 
damage and the impact of ischemia reperfusion injury. A key step in this 
understanding will be to determine how dying cells communicate with non-ischemic 
neighbouring tissue.   
Current research has repeatedly demonstrated the unique dose response of 
connexin mimetic peptides. At low doses, Gap27 has been shown to block open 
hemichannels but can target gap junctional intercellular communication at high 
doses and for longer incubation periods. Research presented in this chapter uses an 
in vitro model of ischemia reperfusion and the unique properties of connexin mimetic 
peptides to determine the role of Cx43 following ischemia reperfusion insult. Further 
investigative steps were taken to establish whether the apoptosis observed was 
related to gap junction communication or through the opening of hemichannels.  
Hypothesis – Cx43 is involved in the spread of fibroblast cell death in an in vitro 
model of ischemia reperfusion and incubation with Gap27 will reduce the extent of 
cell loss. 
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5.2 Results 
The in vitro model of ischemia reperfusion significantly 
reduced oxygen in culture media 
To investigate the communication between cells during hypoxic stress, a well 
characterised model of in vitro ischemia reperfusion developed by Pringle and 
Sundstom was replicated using fibroblast cells (Pringle et al., 1997). Fibroblast cells 
were subjected to hypoxic conditions before reperfusion in an oxygen-glucose 
deprivation-reoxygenation (OGDR) insult. Partial pressure of oxygen within OGDR 
medium was measured using the fibre oxygen (FOXY) probe to confirm hypoxic 
conditions immediately after reperfusion (at OGD). In this model, the oxygen levels 
were reduced four times the normal environment (figure 5.1). 
 
Figure 5.1 OGDR model of ischemia reperfusion reduced O2 in culture media 
Graph shows oxygen percentage levels in medium that has undergone Oxygen Glucose 
Deprivation  stress in comparison to non-treated control medium. The data are shown as the 
means ± S.E.M. (n=5, ****p<0.0001). OGDR = Oxygen glucose deprivation.  
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OGDR significantly decreased cell viability 
Fibroblast cells were subjected to OGDR as described above. Control samples were 
left in control medium in atmospheric conditions. Cell viability was assessed using a 
standard MTT assay. OGDR significantly reduced cell viability over 24 hours in 3T3 
wild type fibroblast cells (figure 5.2A). Upon experimental replication, using Cx43 
shRNA transduced fibroblast cells (a transduced cell line where the majority of Cx43 
has been knocked down), no reduction in cell viability was observed (figure 5.2C). 
OGDR significantly reduced cell viability in fibroblast cells transduced with empty 
vectors, in a similar result to fibroblast cells (figure 5.2B)  
Cx43, p-Cx43 and hemichannel expression significantly 
increased in fibroblast cells during OGDR 
OGDR stress was induced in fibroblast cells as before. Control samples were again 
left in control medium in atmospheric conditions. Cells were fixed and 
immunolabeled for Cx43 and hemichannels before total pixel area per cell was 
quantified. Both Cx43 and hemichannel expressions significantly increased per cell 
during OGDR stress over 24 hours in comparison to control samples (figure 5.3). 
Further analysis of Cx43 protein expression by Western blotting confirmed that total 
Cx43 expression increased over 24 hours during OGDR stress in comparison to 
control cells (figure 5.4 C1, Cii). A similar pattern was observed in cells transduced 
with empty vectors (figure 5.4 Ai, Aii, Cii). However, as would be expected, there 
was no significant increase observed in total Cx43 expression in Cx43 shRNA 
transduced fibroblast cells during OGDR upon immuno (figure 5.4 Bi) and Western 
blot analysis (figure 5.4 Civ). No increase in connexin hemichannel expression was 
observed in the same cell type (figure 5.4 Bii).  
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Figure 5.2 Cell viability significantly reduced in wild-type and PSupp 3T3 
fibroblast cells during OGDR stress 
Wild-type 3T3 fibroblast cells were subjected to OGDR stress for 24 hours. Cell viability was 
assessed using a MTT assay in both OGDR stressed cells and control cells. Cell viability 
decreased in wild-type 3T3 fibroblast cells (A) and cells virally transduced with empty vector 
PSupp (B) during OGDR stress over 24 hours. Cell viability was unaffected in cells 
transduced with shRNA-Cx43 (C) during OGDR stress. Statistical comparisons were made 
using an independent-samples t-test. The null hypothesis was rejected using a multivariate 
analysis of variance (MANOVA). The data is shown as the means ± S.E.M. (n=3, *p<0.05). 
WT = Wild-type, EV = Empty vector, PSupp, shRNA = Cx43shRNA, OGDR = Oxygen 
glucose deprivation reoxygenation. 
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Figure 5.3 Cx43 and connexin hemichannel expression in wild-type fibroblast 
cells significantly increased during OGDR stress 
(A) The panels show representative images of control 3T3 fibroblast cells and those that 
have undergone OGDR stress for twenty-four hours. Cells were immunolabeled for Cx43 or 
connexin hemichannels (green) and nuclei (blue). Total Cx43 pixel area per cell (B) and total 
connexin hemichannel area per cell (C) were quantified. Both Cx43 and connexin 
hemichannel expression significantly increased throughout OGDR stress over 24 hours. 
Statistical comparisons were made using an independent-samples t-test. The null hypothesis 
was rejected using a multivariate analysis of variance (MANOVA). The data is shown as the 
means ± S.E.M. (n=4, *p<0.05). White arrows indicate Cx43 or connexin hemichannel 
expression. Scale bar = 20 µm. OGDR = Oxygen glucose deprivation reoxygentaion  
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Figure 5.4 Cx43, p-Cx43 and connexin hemichannel expression in PSupp 
transduced cells significantly increased during OGDR stress 
3T3 fibroblast cells virally transduced with empty vector PSupp were subjected to OGDR 
stress for 24 hours. Cells were immunolabeled for Cx43 and hemichannels and total pixel 
area per cell was measured. Total Cx43 pixel area per cell (Ai) and hemichannel pixel area 
per cell (Aii) significantly increased throughout OGDR stress. 3T3 fibroblast cells virally 
transduced with shRNA-Cx43 were also subjected to OGDR stress for twenty four hours. 
Total Cx43 pixel area per cell (Bi) and hemichannel pixel area per cell (Bii) did not change 
throughout OGDR stress. Total Cx43 protein expression during OGDR stress was confirmed 
through Western blot analysis. Pixel intensity of the bands was measured and the intensity of 
the protein of interest was measured relative to the intensity of the housekeeping protein. 
Alpha tubulin served as a loading control. (Ci) There was no significant change in Cx43 
protein quantification in control wild-type 3T3 fibroblast cells over 24 hours. During OGDR 
stress, Cx43 protein expression in wild-type 3T3 cells (Cii) and in cells transduced with 
empty vector PSupp (Ciii) significantly increased after 24 hours of OGDR stress. (Civ) There 
was little Cx43 protein expression in cells transduced with shRNA-Cx43, which did not 
significantly change over 24 hours of OGDR stress. Immunoanalysis statistical comparisons 
were made using an independent t-test. The data are shown as the means ± S.E.M. (n=4, 
*p<0.05). Western blot statistical comparisons were made using a one-way analysis of 
variance (ANOVA). The data are shown as the means ± S.E.M. (n=3, **p<0.01). EV = Empty 
vector, PSupp, shRNA = Cx43shRNA, HC = Hemichannel, WT = Wild-type, OGDR = 
Oxygen glucose deprivation reoxygenation. 
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Non confluent cells labelled for PI during OGDR stress 
To assess hemichannel activity during OGDR stress, PI uptake was observed and 
measured in low confluence fibroblast cells as described in detail in the methods 
section (figure 5.5). OGDR stress caused hemichannels to open and increase 
propidium iodide uptake. Incubation with connexin mimetic peptide Gap27 
significantly reduced PI uptake by plugging open hemichannels.  
OGDR induced a bystander effect observed by PI uptake 
To explore the possible “bystander effect” between cells during OGDR stress, 
propidium iodide uptake and transfer was observed over 24 hours as described in 
detail in the methods section (figure 5.6 and movie 1 – supplementary disc). PI will 
enter cells through open hemichannels and is therefore small enough to pass to 
neighbouring cells via gap junction communication Wild-type 3T3 fibroblast cells 
were grown to confluence to ensure gap junction formation between neighbouring 
cells (Behringer et al., 2012). OGDR caused PI uptake in random, non-contacting 
cells. From these initial cells, a wave of PI uptake was observed in neighbouring 
cells. Incubation with Gap27 significantly reduced PI labelling. High and low 
concentrations of Gap27 reduced PI labelling in OGDR stressed cells up to 18 hours 
after reperfusion. However, only higher concentrations of Gap27 reduced PI 
labelling 21-24 hours after reperfusion.  
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Figure 5.5 PI uptake after OGDR stress was reduced by Gap27 incubation 
 (A) The panels show representative images of wild-type fibroblast cells that have undergone 
OGDR stress. Cells were incubated with Calcein AM (green) and propidium iodide (PI).     
(B) Graph shows percentage of cells that have taken up PI. Non confluent cells labelled for 
PI during OGDR stress. Gap27 significantly reduced PI uptake. The Statistical comparisons 
were made using a one-way analysis of variance (ANOVA). The null hypothesis was rejected 
using a multivariate analysis of variance (MANOVA). The data is shown as the means ± 
S.E.M. (n=4, **p<0.01, ***p<0.001, ****p<0.0001 against No OGDR). Scale bar = 100 µm. PI 
= Propidium iodide, OGDR = Oxygen glucose deprivation reoxygenation.  
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Figure 5.6 Hemichannels open during OGDR stress before wave of PI uptake 
in neighbouring cells occurs 
 (A) The panels show representative images of wild type 3T3 fibroblast cells that have 
undergone OGDR stress for 24 hours. Cells were then incubated with Calcein AM (green) 
and propidium iodide (PI) (red). Cells undergoing OGDR took up PI randomly before 
contacting neighbouring cells were labelled with PI. The white arrows indicate the direction of 
PI uptake. Incubation with high concentrations of Gap27 significantly reduced PI labelling. 
(B) Graph shows percentage of cells that are labelled with PI after 4 (grey bars) 18 (red bars) 
21 (white bars) and 24 (black bars) hours after OGDR stress. Statistical comparisons were 
made using a one-way analysis of variance (ANOVA). The data are shown as the means ± 
S.E.M. (n=4, No OGDR versus OGDR No treatment and OGDR 100 µM *p<0.05, 
***p<0.001; OGDR No treatment versus OGDR treated cells at T18 ###p<0.001; OGDR No 
treatment versus OGDR treated cells at T21 +p<0.05; OGDR No treatment versus OGDR 
treated cells at T24 ~p<0.05). Scale bar = 100 µm. PI = Propidium iodide, SP = Scrambled 
peptide. OGDR = Oxygen glucose deprivation reoxygenation 
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Blocking downstream processes of ATP release did not prevent 
reduction in cell viability 
Under stress, Cx43 hemichannels will open and release ATP which will act upon 
purinergic receptors. To assess the downstream processes of ATP release during 
OGDR stress, purinergic receptor antagonists were used. Wild-type 3T3 fibroblast 
cells were subjected to OGDR insult and were treated with 100 µM Suramin upon 
reperfusion (a general, non-specific P2Y and P2X purinergic receptor antagonist) 
whereas control samples were left in control medium in atmospheric conditions. 
Suramin was first used as a specific antagonist for P2 purinergic receptor by Dunn 
and colleagues (Dunn and Blakeley, 1988) and was quickly identified as an 
antagonist for both P2Y and P2X purinergic receptors within a couple of years 
(Kennedy, 1990, Hoyle et al., 1990). Cell viability was assessed using a standard 
MTT assay. OGDR significantly reduced cell viability over 24 hour in wild type 3T3 
fibroblast cell. Treatment with Suramin salts did not prevent the decrease in cell 
viability (figure 5.7A). 
Cultures were again subjected to OGDR insult as described above and after 1.5 
hours of oxygen glucose deprivation, cells were subjected to reperfusion. Cells were 
then incubated with Calcein-AM and PI. Test samples were treated with a single 
incubation of 300 µM Gap27, 2 or 20 µM Brilliant Blue G (BBG) or left untreated 
(naive OptiMEM). BBG is a selective antagonist of P2Y purinergic receptors (Eschke 
et al., 2002, León et al., 2006, Díaz-Hernández et al., 2009). After 24 hours of 
reperfusion, 90% of untreated cells had taken up PI. Incubation in Gap27 
significantly reduced PI uptake to 53%. Treatment with high and low concentrations 
of BBG did not significantly reduce PI uptake (figure 5.7B). 
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Figure 5.7 Blocking purinergic signalling did not prevent the reduction in cell 
viability during OGDR stress 
 (A) Wild type fibroblast cells were subjected to OGDR stress for 24 hours. Cell viability was 
assessed using a MTT assay in OGDR stressed cells, (un-treated and treated with 100 µM 
Suramin salts) and control cells. The graph shows that by antagonistically blocking purigenic 
receptors with Suramin salts (a general, non-specific P2Y and P2X purinergic receptor 
antagonist) did not prevent a decrease in cell viability. (B) Cells were subjected to OGDR 
stress for twenty fours and incubated with Calcein-AM and propidium iodide (PI). The graph 
shows percentage of cells that have taken up PI after twenty-four hours of OGDR stress. 
Selectively antagonistically blocking P2Y purinergic receptors with Brilliant Blue G (BBG) did 
not prevent a decrease in PI uptake. MTT statistical comparisons were made using a one-
way analysis of variance (ANOVA). The null hypothesis was rejected using a multivariate 
analysis of variance (MANOVA). The data is shown as the means ± S.E.M. (n=4, **p<0.01, 
***p<0.001). PI uptake statistical comparisons were also made using a one-way analysis of 
variance (ANOVA). The data is shown as the means ± S.E.M. (n=4, ***p<0.001 against 
OGDR no treatment). OGDR = Oxygen glucose deprivation reoxygenation. 
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Communication between fibroblast cells increased during 
OGDR stress.  
To further explore the possible “bystander effect” between cells during OGDR, 
communication was assessed using Fluorescent Recovery after Photobleaching 
(FRAP). During OGDR stress, communication between cells significantly increased 
in comparison to control cells. Incubation with Gap27 significantly reduced this 
communication. Higher concentrations of Gap27 in OGDR stressed cells reduced 
communication beyond control cell levels (figure 5.8). 
Reducing Cx43 decreased cell death following OGDR stress  
Wild-type 3T3 fibroblast cells and Cx43 shRNA transduced fibroblast cells were 
subjected to OGDR insult. Cultures were then incubated with Calcein-Am and PI 
and were treated with a high concentration of Gap27 upon reperfusion. After 24 
hours of reperfusion, 90% of untreated wild-type 3T3 fibroblast cells had taken up 
PI. Cx43 shRNA transduced fibroblast cells had significantly reduced PI uptake at 
29% whereas wild-type 3T3 fibroblast cells incubated in a high concentration of 
Gap27 also had a significantly reduce PI uptake of 42% (figure 5.9A).  
In addition, wild-type 3T3 fibroblast cells were subjected to OGDR insult as 
described above and were treated with 30 or 300 µM Gap27 upon reperfusion 
whereas control samples were left in control medium in atmospheric conditions. Cell 
viability was assessed using a standard MTT assay. Cell viability significantly 
decreased in wild-type 3T3 fibroblast cells during OGDR stress over 24 hours but 
this cell death was not observed in cells treated with a high concentration of Gap27 
(figure 5.9B). 
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Figure 5.8 Communication between wild-type fibroblast cells significantly 
increased during OGDR stress 
(A) The panels show representative images of Fluorescence Recovery after Photobleaching 
(FRAP). (B) Graph shows the recovery profiles of fluorescence. OGDR stress significantly 
increased the recovery rate in comparison to control cells. During OGDR stress, 
communication was significantly reduced in cells in higher concentrations of Gap27. 
Statistical comparisons were made using a one-way analysis of variance (ANOVA). The null 
hypothesis was rejected using a multivariate analysis of variance (MANOVA). The data is 
shown as the means ± S.E.M. (n=4, between OGDR stress and control non-treated cells 
**p<0.01; between OGDR stress and OGDR plus 100 µM Gap27 ##p<0.01, ##p<0.001; 
between OGDR stress and OGDR plus 300 µM ++p<0.01, +++p<0.001, ++++p<0.0001). 
Scale bar = 25 µm. OGDR = Oxygen glucose deprivation reoxygenation, t = time. 
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Figure 5.9 Reducing Cx43 during OGDR reduced cell death 
 (A) Wild type 3T3 fibroblast cells were subjected to OGDR stress for 24 hours and 
incubated with Calcein-AM and propidium iodide (PI). The graph shows the percentage of 
cells that have taken up PI after 24 hours of OGDR stress. 3T3 fibroblast cells virally 
transduced with shRNA-Cx43 and 3T3 fibroblast wild type cells treated with 300 µM Gap27 
had significantly fewer cells take up PI in comparison to control cells subjected to OGDR 
stress. (B) Cells were subjected to OGDR stress for 24 hours. Cell viability was assessed 
using a MTT assay in OGDR stressed cells, (un-treated and treated with 30 or 300 µM 
Gap27 and control cells). Cell viability decreased in control cells during OGDR stress over 
24 hours. This cell death was not seen in cells treated with a high concentration of Gap27.  
Statistical comparisons were made using a one-way analysis of variance (ANOVA). In the 
MTT time lapse experiment the null hypothesis was rejected using a multivariate analysis of 
variance (MANOVA). The data is shown as the means ± S.E.M. (n=4, *p<0.05, ***p<0.001). 
PI = Propidium iodide, OGDR = Oxygen glucose deprivation reoxygenation, WT = Wild type, 
shRNA = Cx43shRNA. 
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5.3 Discussion 
OGDR decreased cell viability 
In order to assess and investigate the communication between 3T3 fibroblast cells 
during hypoxic stress, a well characterised in vitro model of ischemia reperfusion 
was used. Oxygen and glucose deprivation, followed by reoxygenation, was 
achieved by closely following the in vitro model of ischemia reperfusion developed 
by Pringle and Sundstom (Pringle et al., 1997). By replicating this protocol, medium 
oxygen levels were reduced four times the normal environment in the data reported 
in this chapter (figure 5.1). 
Similar examples of in vitro ischemia models have been used in rat embryonic 
fibroblast cell lines (Stoler et al., 1992, Gardner et al., 2003, Manotham et al., 2004), 
cardiac fibroblasts (Chen et al., 2004) and nasal polyp fibroblasts (Cohen et al., 
2011). In these examples, only oxygen and nutrient deprivation was achieved. Other 
approaches to accomplish oxygen and nutrient deprivation have included using 
coverslip hypoxia; whereby cells are grown as a monolayer before a glass coverslip 
is placed over the culture. This creates a localized diffusion barrier reducing 
nutrients and oxygen transfer (Pitts and Toombs, 2004). Chemical anoxia has also 
been used to reduce nutrient and oxygen levels in cultures (Rentsch et al., 2007, 
Contreras et al., 2002). Models of oxygen and nutrient deprivation, followed by 
reoxygenation, have been repeated using hippocampal slice cultures (Laake et al., 
1999, Frantseva et al., 2002b) and utilised in rat endothelial cells (Anderson et al., 
1995) astrocyte cell lines (Orellana et al., 2010, Wang et al., 2013b) and in NIH 3T3 
cells (Chen et al., 1999).  
In the in vitro model of ischemia reperfusion employed in this chapter, OGDR 
significantly reduced cell viability over 24 hours in 3T3 wild type fibroblast cells 
(figure 5.2A). A similar observation was made by Pringle and colleagues upon 
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analysis of cell death through PI uptake (Pringle et al., 1997). Hypoxia was induced 
for 60 minutes before reoxygentaion insult took place. They reported a significant 
increase in PI uptake between 12 and 24 hours after reoxygenation, however the 
majority of PI labelling did not occur until 24 hours post reperfusion. They also noted 
that there was a progressive spread of cell death and damage from the ischemic 
area to surrounding cells. A comparable report was made by Laake and colleagues, 
again using hippocampal slice cultures (Laake et al., 1999) where a significant 
increase of PI labelling was observed 24 hours after reoxygenation. In a similar 
report using NIH 3T3 cells, DNA fragmentation and chromatin condensation were 
observed upon reperfusion (Chen et al., 1999). Both are indicative of cell death.  
In an interesting twist in the same study, NIH 3T3 cells left in continuous anoxia for 
48 hours did not show a decrease in cell viability (Chen et al., 1999). This has also 
been observed in nasal fibroblasts that were left in continuous hypoxic conditions for 
12 or 24 hours using an in vitro model of ischemia (Cohen et al., 2011) and in rat 
endothelial fibroblast cells, where cell viability remained constant after 48 hours in a 
similar in vitro model of continuous anoxia (Stoler et al., 1992). This would suggest 
that it is the reoxygenation element of ischemia reperfusion stress that is 
responsible for the increase in the number of apoptotic cells and a reduction in cell 
viability. The oxidative injury during reoxygenation is thought to be a central 
mechanism in cellular damage and death, affecting most organisms and tissues 
after anoxic stress (Chen et al., 1999). Reactive Oxygen Species (ROS) are 
released in post anoxic reoxygenation (Caraceni et al., 1995) which can trigger 
Caspase 3 and 9 in hypoxia/reoxygenation induced apoptosis (Ho et al., 2006). 
Attenuating Caspase activation by introducing a catalase reduces apoptosis, 
indicating an important role for ROS in hypoxic/reoxygenation stress. Further studies 
using mouse retinal endothelial cells in an OGDR model of ischemia reperfusion 
reported progressive endothelial cell injury during the period of substrate 
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replenishment (Rieger et al., 2002). Addition of superoxide scavengers and oxidase 
inhibitors induced cell protection, and reduced apoptosis; further supporting the 
important and damaging roles of reactive oxidative species during ischemia 
reperfusion cell death.  
Cx43 and connexin hemichannel expression increased 
correlating with a decrease in cell viability during OGDR 
In a novel discovery, the data in the chapter reports a significant increase in Cx43, 
Cx43 phosphorylated isoforms and connexin hemichannels in 3T3 fibroblast cells 
during 24 hours of reoxygenation as supported by immuno and Western blot 
analysis (figure 5.3, 5.3Ci). This increase in protein expression correlated with a 
decrease in cell viability over the same 24 hour period (figure 5.2A). Upon repeating 
the experiment, using a transduced cell line where the majority of Cx43 has been 
knocked down, no reduction in cell viability was observed (figure 5.2B). Cells 
transduced with empty vectors served as a negative control and in a similar pattern 
to wild-type 3T3 fibroblast cells, Cx43 and connexin hemichannels expression 
increased in correlation with a reduction in cell viability (figure 5.2C, figure 5.4Ai, Aii 
and Ciii). These results strongly suggest that Cx43 plays a significant role in 
spreading cell death and damage during reoxygenation in an in vitro model of 
ischemia reperfusion.  
Comparable studies using cortical astrocytes in culture models of ischemia 
reperfusion have also reported that upon reoxygenation an increase in cell surface 
expression of Cx43 was observed and correlated with a decrease in cell viability 
(Orellana et al., 2010). A recent study performed by Wang and colleagues, using an 
astrocytic cell line in a model of OGDR, also reported that Cx43 expression 
significantly increased during reoxygenation, whereas cell viability significantly 
reduced in the same time period (Wang et al., 2013b). An increase in Cx43 plaque 
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size has also been described in similar circumstances (Cotrina et al., 1998a). 
Beardslee and colleagues have reported a marked increase in phosphorylated 
isoforms of Cx43 in reperfused adult rat hearts (Beardslee et al., 2000) whereas 
Turner and colleagues described how Cx43 became profoundly dephosphorylated 
during hypoxic conditions and was completely rephosphoryated within 30 minutes of 
reoxygenation (Turner et al., 2004). However, in prolonged ischemia it has been 
noted that phosphorylated isoforms markedly decrease (Clarke et al., 2009, 
Beardslee et al., 2000). Although the biological consequences of specific changes in 
Cx43 phosphorylation during chronic ischemia are not understood in detail, it has 
been suggested that there is a likely correlation with cellular uncoupling (Beardslee 
et al., 2000). 
Organotypic hippocampal slices that underwent OGDR were reported to have 
significant cell death over a 48 hour period. Treatment with carbenoxalone (a non-
specific inhibitor of gap junction communication) or Cx43 asODN significantly 
decreased cell death within the tissue during OGDR stress (Frantseva et al., 2002b). 
Apoptosis during metabolic inhibition was again noted in a human glial cell line 
transduced with Cx43 (Huang et al., 2001). Reducing Cx43 during the stress of 
ischemia reperfusion prevented the reduction of cell death. Despite the growing 
evidence in the literature discussed above, together with the data reported in this 
chapter, that marks Cx43 as a key contributor to the spread of cell death and 
damage after an ischemic insult, the mechanisms behind this damage are still 
unclear. 
Contributors of cell death during OGDR 
Some reports attribute cell death in ischemic reperfusion models to the opening of 
undocked gap junctions, releasing ATP and reducing cell viability through the 
activation of purinergic receptors. However, other reports suggest that the 
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“bystander effect” model is in play during hypoxia-reoxygenation apoptosis, as cell 
death signals spread laterally through gap junctions from dying cells into their 
healthy neighbours. In order to understand the contribution of hemichannels and 
gap junction based communication during hypoxic stress and reoxygenation insult, 
two methods of examination were used. The first was to distinguish between 
hemichannel and gap junction communication through different confluence levels of 
fibroblast cells whereas the second was to employ the connexin mimetic peptide 
Gap27 as a tool, as it has consistently shown to have a unique dose and time 
response during incubation. At low doses, Gap27 has been shown to block open 
hemichannels but can also target gap junctional intercellular communication at high 
doses and for longer incubation periods.  
Here it is shown that non-confluent cells subject to OGDR stress and treated with 
Gap27 do not label with PI (figure 5.5). However, in confluent cells subjected to the 
same insult, PI labelling initially occurs in random, non-contacting cells, before a 
wave of PI labelling was observed in neighbours (figure 5.6 and supplementary 
movies). High concentrations of Gap27 significantly reduced PI uptake. Although it 
is clear that Cx43 plays a role in communication and cell death during OGDR stress, 
it is still uncertain as to the mechanisms involved. This is discussed in more detail in 
the following sections. 
Cell death through hemichannel communication 
For many decades it was thought that hemichannels remained in a permanent 
closed state, until docked with their partners from a neighbouring cell, to avoid 
influencing cell death. However, recent research has shown how hemichannels can 
open under stress and provide a signalling pathway between the cytoplasm of the 
cell and the extracellular environment (Evans et al., 2006). To assess hemichannel 
activity during OGDR stress, PI labelling was observed in low confluence 3T3 
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fibroblast cells (figure 5.5). It was noted that OGDR insult caused cells to label with 
PI; indicating that cells were either dying, opening their hemichannels or both. 
Treatment with Gap27 reduced this dye uptake. If Cx43 based communication 
wasn’t involved, incubation in Gap27 would have made no difference in PI labelling 
during OGDR stress; heavily suggesting that hemichannel opening is involved 
during reperfusion insults. 
Similar observations were made in models of ischemia reperfusion using metabolic 
inhibition. Both cardiac ventricular myocyte and rat cortical astrocyte cultures 
opened their hemichannels during reperfusion stress as shown by 
electrophysiological analysis and dye uptake (John et al., 1999, Contreras et al., 
2002). Cells subjected to oxidative stress, via ROS application or through a lowered 
redox potential, also demonstrated hemichannel opening (Ramachandran et al., 
2007, Retamal et al., 2007). A comparable report was made by Shintani-Ishida and 
colleagues upon subjecting rat neonatal cardiomyocytes to OGDR stress. They 
observed that hemichannels opened during the reperfusion period and that 
incubation with Gap26 reduced dye uptake.  
It is still unclear as to whether surface hemichannels have similar permeability 
properties to gap junctions formed of the same connexins, however it is becoming 
increasingly apparent that hemichannels possess bi-directional properties as shown 
by dye uptake and ATP release (Evans et al., 2006). Research by Clarke and 
colleagues has demonstrated how cardiac myocytes undergoing ischemic stress 
release ATP, whereas treatment with Gap26 significantly abolishes this release 
(Clarke et al., 2009). Eltzschig and colleagues have demonstrated that 
polymorphonuclear leukocyte cells release ATP from Cx43 hemichannels (Eltzschig 
et al., 2006) whereas Stout and colleagues have described similar results in 
astrocytes (Stout et al., 2002). Orriss and colleagues demonstrated that during 
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hypoxic stress osteoblasts released ATP (Orriss et al., 2009) while Orellana and 
contemporaries have also described how astrocytes subjected to hypoxia in high 
glucose increased cell permeabilisation via Cx43 hemichannels (Orellana et al., 
2011). Not only was there a reported increase in dye uptake, an increase in ATP 
release and a reduction in cell viability were also observed. During stress, ATP 
release has been inhibited by connexin mimetic peptides in endothelial cells (Braet 
et al., 2003a, Braet et al., 2003b, Leybaert et al., 2003), polymorphonuclear 
leukocytes (Eltzschig et al., 2006) and HeLa cells transduced with Cx43 (Wang et 
al., 2012).  
ATP released from Cx43 hemichannels has been shown to mediate calcium wave 
signalling in astrocyte cultures (Stout et al., 2002), epithelial cells (Pearson et al., 
2005) and in HeLa cells transduced with Cx43 (Cotrina et al., 1998b, Verma et al., 
2009). Upon disrupting Cx43 based communication, by either using wild-type HeLa 
cells that have no connexin expression (Verma et al., 2009) or through incubation 
with gap junction communication inhibitors (Stout et al., 2002) calcium propagation 
is reduced, suggesting connexin participation in calcium signalling is likely. High 
concentrations of calcium release can lead to cell death in a generation of 
pathological calcium signals, which result in compromising calcium homeostatic 
machinery, mitochondrial dysfunction, a release of pro-apoptotic factors and the 
activation of calcium dependent degrading enzymes (Verkhratsky, 2008). Although 
ATP released from Cx43 hemichannels has been shown to influence cell death 
through the mediation of calcium signalling, reduced cell viability can also be caused 
through ATP activation of purinergic signals.  
Purinergic receptors are found in almost all mammalian tissues and are a family of 
plasma membrane molecules that respond to the release of adenosine (PI 
receptors) or ATP (P2 receptors). P2 receptors can be further divided into five 
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subclasses, P2X, P2Y, P2Z, P2U and P2T, which can be grouped into metabotropic 
receptors (P2Y, P2U and P2T) and ionotropic receptors (P2X and P2Z). P2Y 
purinergic receptors are metabotropic G-protein coupled receptors and their 
activation leads to phospholipase C activation, the generation of IP3 and an increase 
in cytosolic calcium (Baroja-Mazo et al., 2013). Brief ATP stimulation on P2X 
purinergic receptors, particularly P2X7 purinergic receptors, induces the opening of 
non-selective cation-carrying pores, leading to a Ca2+ and Na+ influx and K+ efflux 
and resulting in the depolarisation of the plasma membrane (Di Virgilio et al., 1998, 
Pelegrin, 2011). Prolonged and repetitive ATP stimulation on P2X7 purinergic 
receptors leads to the opening of a non-selective “large pore” that is permeable to 
higher molecular weight molecules up to 900 Daltons (Di Virgilio et al., 1998, 
Pelegrin, 2011, Baroja-Mazo et al., 2013). Virgiono and colleagues reported how 
prolonged activation of P2X7 receptors with ATP resulted in the pore size increasing 
from 0.8nm to 3.5nm (Virginio et al., 1999). This caused an osmotic balance, plasma 
membrane depolarisation, swelling and disaggregation of the cytoskeletal network 
and ultimately cell death as shown in lymphocytes (Di Virgilio et al., 1989, Di Virgilio 
et al., 1998, Tsukimoto et al., 2005) and both normal and diabetic human fibroblast 
cells (Solini et al., 2004). Fibroblasts cells have been shown to express P2Y and 
P2X purinergic receptors (Giovannardi et al., 1992, Solini et al., 1999, Burnstock 
and Verkhratsky, 2009, Knight, 2009) but predominately express P2X7 receptors 
(Knight, 2009). 
To assess the downstream processes of ATP release during OGDR stress, 
purinergic receptor antagonists were employed. OGDR significantly reduced cell 
viability over 24 hours whereas treatment with Suramin did not prevent the decrease 
in cell viability (figure 5.7A). Further work was carried out to investigate whether the 
P2X7 pore was involved in the reduction of cell viability during OGDR stress (figure 
5.7B). After 24 hours of reperfusion 90% of untreated cells had labelled with PI, 
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whereas treatment with both high and low concentrations of BBG did not 
significantly reduce PI uptake. The results presented here would suggest that 
although hemichannels are opening in 3T3 fibroblasts during OGDR stress and 
potentially releasing ATP, this release is not enough to induce cell death. Blocking 
ATP purinergic receptors by using Suramin and BBG was not enough to save the 
reduction in cell viability. Interestingly, incubation in a high concentration of Gap27 
significantly reduced PI uptake to 53%. As described in detail before, it is high 
concentrations of mimetic peptides that have been shown to reduce gap junction 
communication between confluent cells. It is possible that incubation in Gap27 was 
inhibiting the bystander effect in connected cells and this theory was explored 
further. 
Cell death through gap junction communication 
The “bystander effect” model suggests that death signals can spread laterally 
through gap junctions from dying cells into their healthy neighbours. The term was 
first used by Nagasawa and colleagues to explain the phenomenon in which un-
irradiated cells exhibited the effects of radiation as a direct result of signals received 
from damaged irradiated neighbours (Nagasawa et al., 2002, Little et al., 2002). In 
cells that were genetically or chemically gap-junction compromised, less damage 
spread to neighbours (Azzam et al., 2001). Further reports of the bystander effect 
have been observed in Herpes Simplex Virus – Thymidine Kinases gene therapy for 
colorectal cancer (McMasters et al., 1998, Burrows et al., 2002, Sanson et al., 2002) 
and it was reported that expression of Cx43 based gap junctions were necessary 
components of the bystander effect in human colon tumour cells. A close correlation 
between Cx43 gap junction based communication and an increase in the 
consequences of the bystander effects was noted. Gap junction mediated spread of 
cell death has also been documented in models of in vitro metabolic stress (Lin et 
al., 1998, Cotrina et al., 1998a, Nodin et al., 2005), rodent models of stroke injury 
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(Frantseva et al., 2002b, Rawanduzy et al., 1997, Zhang et al., 2013), rodent 
models of cardiac ischemia reperfusion injury (Mao et al., 2005, Mao et al., 2009) 
rodent models of spinal cord injury (Cronin et al., 2008) and rodent models of retinal 
ischemia injury (Danesh-Meyer et al., 2012).  
To explore the possible bystander effect between confluent cells during OGDR 
stress, PI uptake and transfer was observed over 24 hours (figure 5.6 and movie 1 – 
supplementary disc). Research presented in this chapter has already demonstrated 
how non-confluent cells in OGDR stress open their hemichannels and label with PI. 
Treatment with Gap27 plugs open hemichannels and significantly reduced PI 
labelling. However, it was observed that PI uptake in confluent cells subjected to the 
same insult followed a different pattern. OGDR insult initially caused PI uptake in 
random, non-contacting untreated cells 18 hours after reperfusion. From these initial 
cells, a wave of PI uptake was observed in neighbouring cells until 90% of cells 
observed were labelled with PI, 24 hours after reperfusion. Cx43 shRNA transduced 
fibroblast cells, that underwent the same hypoxic stress, had significantly reduced PI 
uptake to 29% at 24 hours after reperfusion whereas wild-type 3T3 fibroblast cells 
incubated in a high concentration of Gap27 also had a significantly reduced PI 
uptake (figure 5.6 and 5.9A).  This data further contributes to the mounting evidence 
that Cx43 based communication is involved during ischemic reperfusion stress in 
culture models and that by reducing communication by either removing Cx43 or 
inhibiting gap junction communication, PI labelling is reduced in cells undergoing 
OGDR stress. 
Further evidence of increased gap junction based communication between 
neighbouring cells during OGDR insults was observed using FRAP analysis (figure 
5.8). Communication between cells significantly increased during OGDR stress and 
incubation with Gap27 significantly reduced this communication.  Similar results 
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were observed by Lin and colleagues when investigating whether gap junctions 
propagated trans-cellular signals during metabolic stress (Lin et al., 1998). By also 
using FRAP analysis they observed how gap junctions remained open during 
metabolic stress, which correlated with an increase in cell death. Cell treatment 
using the non-specific gap junction blocker Octanol both reduced cell 
communication and cell death during metabolic insult.   
Research presented in a previous chapter in this thesis has shown how higher 
concentrations of Gap27 significantly reduced communication between neighbouring 
cells, with further studies showing that Gap27 significantly reduced communication 
in fibroblast like COS-7 cells (Chaytor et al., 1999, Dora et al., 1999), Schwann cells 
(Mambetisaeva et al., 1999), leukocyte cells (Oviedo-Orta et al., 2000), alveolar 
cells (Isakson et al., 2003) and HeLa cells transduced with Cx43 (Berman et al., 
2002). Incubation concentrations of Gap27 in these investigations typically ranged 
between 130 and 500 µM, supporting the theory that primarily higher concentrations 
of Gap27 will significantly reduce gap junction communication. In a novel report 
presented in this research chapter 3T3 fibroblast cells were once again subjected to 
OGDR stress before being treated with a low (30 µM) or high (300 µM) 
concentration of Gap27 upon reperfusion (figure 5.9B). As reported before, cell 
viability significantly decreased in untreated cells during OGDR insult whereas 
treatment with Gap27 prevented this reduction in cell death. However, it was only 
treatment in higher concentrations of Gap27 that significantly prevented a reduction 
in cell viability observed during OGDR stress. This would suggest that 
communication (and therefore the consequences of the bystander effect) is being 
significantly reduced during OGDR stress with a higher concentration of Gap27, 
which ultimately prevents a reduction in cell viability.  
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A controversial study carried out by Decrock and colleagues using glioma cells 
transduced with Cx43 reported that gap junctions contributed to the spread of 
apoptosis in an area close to where apoptosis was initially triggered (Decrock et al., 
2009). However, hemichannels also promoted cell death beyond this area. Long 
incubation periods with Gap27 (targeting gap junction based communication) 
reduced apoptosis in both area 1 (close to the apoptotic region) and area 2 (further 
beyond this region) whereas short incubation periods with Gap27 (targeting open 
hemichannels) only reduced apoptosis in area 2. However, this work was not carried 
out under ischemic reperfusion stress, which may explain the difference in connexin 
based spread of cell death and damage presented in this chapter (reperfusion stress 
triggers hemichannel opening before gap junction communication promotes a 
reduction in cell viability).  
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Further studies to build upon the research presented in this chapter would include 
an observation in calcium movement during OGDR stress. It is been theorised that 
during the bystander effect an apoptotic signal is transferred via gap junction 
communication between dying cells and healthy neighbouring cells (Cusato et al., 
2003). Krutovskikh and colleagues hypothesise that calcium ions are the most 
probable cell killing signal that pass between gap junctions (Krutovskikh et al., 2002) 
as also shown by Isakson and colleagues in investigating mechanically perturbed rat 
alveolar cells (Krutovskikh et al., 2002). They observed an increase in calcium wave 
propagation from stressed cells to healthy neighbouring cells that was inhibited by 
Gap27 incubation. Therefore it is likely that calcium signals are promoting apoptosis 
between dying cells to healthy neighbours via gap junctions in the bystander effect 
observed in OGDR stress in this research chapter. The next chapter further explores 
the role of Cx43 based spread of cell death and damage using an in vivo model of 
pressure ulcers in mice.  
Conclusions 
 During Oxygen-Glucose Deprivation Reoxygentaion (OGDR) stress, 3T3 
fibroblast cell viability decreased in correlation with an increase in Cx43, 
phosphorylated Cx43 isoforms and connexin hemichannel expressions. 
 Non confluent 3T3 fibroblast cells labelled with Propidium Iodide (PI) 
during OGDR stress. 
 Blocking downstream processes of ATP release did not prevent reduction 
3T3 fibroblast cell viability. 
 Communication between fibroblast cells increased during OGDR stress. 
 Reducing Cx43 expression using Cx43 shRNA transduced 3T3 fibroblast 
cells or reducing gap junction based communication prevented this 
reduction in cell viability. 
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6. The role of Cx43 in a model of 
pressure ulcers 
6.1 Introduction 
In the previous chapter it was reported that Cx43 based communication was heavily 
involved in the spread of fibroblast cell death and damage in an in vitro model of 
ischemia reperfusion. The research presented in this chapter further investigates the 
role of Cx43 and hemichannels in a murine model of pressure ulcers. 
Pressure ulcers can be caused by either prolonged or repeated incidents of 
ischemia reperfusion in the skin. They are often found on bony prominences and are 
classed as chronic wounds. Chronic wounds are those that do not heal in an orderly 
set of phases nor in a predictable amount of time in the way that most acute wounds 
do. As chronic wounds take an unusually long time to heal, do not heal properly or 
constantly re-occur, independence and quality of life of the sufferer is compromised. 
A large percentage of chronic wounds fall into three main categories; diabetic foot 
ulcers, venous leg ulcers and pressure ulcers (Mustoe, 2004).  
Pressure ulcers are an enormous economic burden to health services across the 
globe. It is estimated that there are currently 7.4 million people with pressure ulcers 
in the world and every year over 400,000 new patients will develop a pressure ulcer 
in the UK (Bennett et al., 2004). Approximations currently suggest that this is costing 
the NHS over £2bn a year in nursing, dressings, support and complication costs 
(Bennett et al., 2004). The incidence of pressure ulcers among hospital patients is 
between 4 and 20% whereas approximately 25% of patients resident in long-term 
geriatric wards will develop a pressure ulcer (Bennett et al., 2004, Sen et al., 2009). 
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Improvements in Western civilization health care, living standards and socio-
economic status means that more and more people are now living to an older age 
(Wicke et al., 2009).  Between the years 2000 and 2020 the UK population of over 
65’s is forecast to increase by 23% from 9.2 million to 11.3 million. This will mean 
that over a fifth of the UK’s population will be over 65 by 2020 (Bennett et al., 2004). 
As the global elderly population continues to grow, so will the number of pressure 
ulcers. The staggering financial burden will only get bigger and therefore the need 
for an effective pressure ulcer treatment is paramount. 
Pressure ulcers are attributed to ischemia reperfusion injury, caused by the return of 
blood to tissues that has encountered a period of oxygen deprivation. Local oxygen 
tensions are crucial during the wound healing process as oxygen has roles within 
the inflammatory response (producing toxic oxidants to tackle infection), fibroblast 
proliferation, collagen and biological energy equivalents production (Tandara and 
Mustoe, 2004). During wound healing there is an increase in energy demand and 
oxygen aids in the production of ATP that is needed for processes such as aerobic 
glycolysis, citric acid cycle and oxidation of fatty acids (Schreml et al., 2010). Tissue 
hypoxia profoundly impairs and delays wound healing and it has been shown that 
lower extremities with a partial oxygen pressure of less than 30 mmHg will fail to 
heal (Mustoe et al., 2006). However, it has been observed in cardiac and neuronal 
models of ischemia reperfusion that the majority of tissue damage often occurs 
during the reoxygenation phase (Miyazaki et al., 1987, García-Dorado et al., 1989, 
Rawanduzy et al., 1997). While reperfusion may be necessary to reduce the 
irreversible cellular injury caused by tissue hypoxia, reperfusion can also cause 
additional tissue impairment (Mustoe, 2004). Indeed, most pressure ulcer damage 
occurs due to the repetitive nature of ischemic reperfusion in patients. As described 
by Mustoe, most critically ill patients or patients with impaired mobility are often 
placed on a strict turning regime (Mustoe et al., 2006). In fact, advice from a leading 
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pressure ulcer prevention advisory panel recommends that a patient is repositioned 
every 2-6 hours depending on the severity of the injury (EPUAP, 2009). While good 
intentions are intended, the cyclic intervals of variable blood flow caused by this 
regime may have further detrimental clinical effects.  
Vulnerable patients who will develop pressure ulcers are those who suffer from 
impaired mobility or sensation, such as the elderly, wheelchair bound or bedridden. 
Pressure ulcers are also extremely common in long term hospitalised patients. 
Pressure induced ischemia occurs when the patient is recumbent which is then 
followed by hyperaemia when a change in patient position provides a return of blood 
flow (Mustoe, 2004). The return of blood supply during the restoration of circulation 
causes inflammation and oxidative damage to the tissue, which often spreads 
beyond the initial ischemic area. Healthcare professionals use a grading system to 
describe the severity of pressure ulcer damage and often the higher the grade 
diagnosed means a more severe injury to the skin and underlying tissue (EPUAP, 
2009). People with the highest grade of pressure ulcer, grade 4, have a high risk of 
developing a life threatening infection as they suffer full skin thickness loss that 
exposes the bone or muscle. 
At present, our understanding of how these chronic wounds occur and why they 
take longer than average to heal is incomplete. Recent research has identified gap 
junction mediate ischemia reperfusion injury in the cardiac (García-Dorado et al., 
2004) and cerebral tissue (Frantseva et al., 2002b), however there has been no 
published investigation (human or rodent based) into the role of gap junction based 
communication in the pressure ulcer. Using an in vivo model of pressure ulcers 
developed by Thomas Mustoe, this chapter examines the role of Cx43, 
hemichannels and gap junctions during ischemia reperfusion injury in the skin.  
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Hypothesis – Cx43 propagates cell injury and death during ischemia reperfusion 
injury in murine skin. 
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6.2 Results 
Development of an ischemia reperfusion model in murine skin 
In order to create an early stage pressure ulcer model, a surgical procedure adapted 
from a protocol developed by Thomas Mustoe was implemented (Reid et al., 2004) 
as described in detail in the methods section. Tissue was observed at the three key 
sites (figure 6.1C) the pressure site (PS), adjacent to the pressure site (AT) and in 
distal tissue (DT). Initial observations confirmed that magnet pressure caused 
greater damage at the pressure site and in areas adjacent to the pressure site after 
1.5 hours of ischemia followed by 24 hours of reperfusion (figure 6.1B).  The 
European Pressure Ulcer Advisory Panel categorizes early stage pressure ulcers in 
humans as intact skin with non-blanchable redness which can develop into partial 
thickness loss of dermis in later stages (EPUAP, 2009). Macroscopic and 
histological observations of murine skin that had undergone ischemic reperfusion 
injury confirmed similar findings. Tissue breakdown was noted along with an 
increase in inflammatory cells within the tissue. Application of Cx43 asODN at the 
wound site greatly reduced the extent of damage (figure 6.1B). 
  
Chapter 6 The role of Cx43 in a model of pressure ulcers 
209 
 
 
Figure 6.1 The skin ischemia reperfusion model caused tissue damage at the 
pressure site 
 (A) The panel shows a representative histological image of tissue that has not been 
subjected to pressure. (B) The panels show representative histological images of tissue that 
has been subjected to 1.5 hours of pressure followed by relief for 24 hours. Tissue was 
either treated with Cx43 asODN or left untreated. Pressure caused greater tissue damage at 
the pressure site and in areas adjacent to the pressure site. Application of Cx43 asODN at 
the wound site greatly reduced the extent of damage. (C) Diagram indicates areas of interest 
around the pressure site. n=5, Scale bar = 150 µm. PS = Pressure site, AT = Adjacent 
tissue, DT = Distal tissue, E= Epidermis, D=Dermis 
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Cx43 and connexin hemichannel expression significantly 
increased after ischemia reperfusion 
Cx43 and connexin hemichannel expression profiles were examined in three key 
sites; the pressure site, adjacent to the pressure site and in distal tissue. Within the 
epidermis, Cx43 and connexin hemichannel expression did not differ at the pressure 
site in comparison to the distal tissue (figure 6.2A, Ci and figure 6.3A, Ci) four hours 
after pressure relief. However, Cx43 expression significantly increased at the 
pressure site in the upper dermis four hours after pressure relief (figure 6.2A, Cii) 
and connexin hemichannel expression significantly increased at the pressure site in 
both the upper and lower dermis four hours after pressure relief (figure 6.3A, B, Cii, 
Ciii) Application with Cx43 asODN at the pressure site significantly reduced the 
increase in both Cx43 and connexin hemichannel expression.  
Twenty four hours after pressure relief, Cx43 and hemichannel expression within the 
epidermis still did not differ at the pressure site in comparison to the distal tissue 
(figure 6.4A, Ci and figure 6.5B). Cx43 expression significantly increased at the 
pressure site in both the upper and lower dermis twenty four hours after pressure 
relief (figure 6.4A, B, Cii, Ciii). However there was no significant change in connexin 
hemichannel expression within the dermis at the pressure site or surrounding tissue, 
twenty four hours after pressure relief (figure 6.5B and C). 
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Figure 6.2 Cx43 expression in the skin ischemia reperfusion model four hours 
after pressure relief 
The panels show representative images of epidermis tissue (A) and dermal tissue (B) that 
has not been subjected to pressure (distal and adjacent tissue) and tissue that has been 
subjected to 1.5 hours of pressure followed by relief for 4 hours (pressure site). Tissue was 
either treated with Cx43 asODN or left untreated. Tissue was immunolabeled for Cx43 
(green) and nuclei (blue). The epidermis and dermis are separated by a white dashed line. 
(C) Total pixel area per nucleus within the epidermis was quantified. Cx43 expression did not 
differ at the pressure site in comparison to distal tissue. Total pixel area per 1000 µm² within 
the upper (D) and lower (E) dermis was quantified. Cx43 expression significantly increased 
at the pressure site in the upper dermis. Application of Cx43 asODN at the wound site 
significantly reduced this increase Statistical comparisons were made using a one-way 
analysis of variance (ANOVA). The data are shown as the means ± S.E.M. (n=5, *p<0.05). 
White arrows indicate Cx43 expression. Scale bar = 50 µm. E = epidermis, D = Dermis, DT = 
Distal tissue, AT = Adjacent tissue, PS = Pressure site. 
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Figure 6.3 Connexin hemichannel expression in the skin ischemia reperfusion 
model four hours after pressure relief 
The panels show representative images of epidermis tissue (A) and dermal tissue (B) that 
has not been subjected to pressure (distal and adjacent tissue) and tissue that has been 
subjected to 1.5 hours of pressure followed by relief for 4 hours (pressure site). Tissue was 
either treated with Cx43 asODN or left untreated. Tissue was immunolabeled for connexin 
hemichannels (green) and nuclei (blue). The epidermis and dermis are separated by a white 
dashed line. (C) Total pixel area per nucleus within the epidermis was quantified. Connexin 
hemichannel expression did not differ at the pressure site in comparison to distal tissue Total 
pixel area per 1000 µm² within the upper (D) and lower (E) dermis was quantified. Connexin 
hemichannel expression markedly increased in the both upper and lower dermis. Application 
of Cx43 asODN at the wound site significantly reduced this increase. Statistical comparisons 
were made using a one-way analysis of variance (ANOVA). The data are shown as the 
means ± S.E.M. (n=5, **p<0.01, ***p<0.001). White arrows indicate hemichannel expression. 
Scale bar = 50 µm. E = epidermis, D = Dermis, DT = Distal tissue, AT = Adjacent tissue, PS 
= Pressure site, Cx HC = Connexin hemichannel. 
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Figure 6.4 Cx43 expression in the skin ischemia reperfusion model twenty 
four hours after pressure relief 
The panels show representative images of epidermis tissue (A) and dermal tissue (B) that 
has not been subjected to pressure (distal and adjacent tissue) and tissue that has been 
subjected to 1.5 hours of pressure followed by relief for 24 hours (pressure site). Tissue was 
either treated with Cx43 asODN or left untreated. Tissue was immunolabeled for Cx43 
(green) and nuclei (blue). The epidermis and dermis are separated by a white dashed line. 
(C) Total pixel area per nucleus within the epidermis was quantified. Cx43 expression did not 
differ at the pressure site in comparison to distal tissue Total pixel area per 1000 µm² within 
the upper (D) and lower (E) dermis was quantified. Cx43 expression significantly increased 
in both upper and lower dermis. Again, application of Cx43 asODN at the wound site 
significantly reduced this increase. Statistical comparisons were made using a one-way 
analysis of variance (ANOVA). White arrows indicate Cx43 expression. The data are shown 
as the means ± S.E.M. (n=5, *p<0.05, **p<0.01). Scale bar = 50 µm. E = epidermis, D = 
Dermis, DT = Distal tissue, AT = Adjacent tissue, PS = Pressure site. 
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Figure 6.5 Connexin hemichannel expression in the skin ischemia reperfusion 
model twenty four hours after pressure relief 
Tissue was either subjected to 1.5 hours of pressure followed by relief for 24 hours or left un-
pressurised. Tissue was then either treated with Cx43 asODN or left untreated. (A) Total 
connexin hemichannel pixel area per nucleus within the epidermis was quantified. There was 
no significant change in connexin hemichannel expression at the pressure site or 
surrounding tissue. (B) Total connexin hemichannel pixel area per 1000 µm² within the upper 
and the lower dermis was quantified. There was no significant change in connexin 
hemichannel expression at the pressure site or surrounding tissue. Statistical comparisons 
were made using a one-way analysis of variance (ANOVA). The data are shown as the 
means ± S.E.M. (n=5). PS = Pressure site, AT = Adjacent tissue, DT = Distal tissue. 
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Blood vessel leakiness significantly increased at the pressure 
site.  
Thirty minutes before the mice were euthanized, 200 µl of 1.5% FITC-BSA was 
injected into the tail vein of each mouse, to assess vascular permeability of the 
pressure site. Blood vessel leakiness was assessed in three key sites; the pressure 
site, adjacent to the pressure site and in distal tissue. Blood vessel leakiness 
significantly increased at the pressure site in comparison to the distal tissue 4 hours 
after reperfusion (figure 6.6). Leakiness also significantly increased at the pressure 
site and markedly increased in tissue adjacent to the pressure site 24 hours after 
reperfusion, in comparison to the distal tissue (figure 6.7). Application of Cx43 
asODN at the wound site significantly reduced the extent of blood vessel leakiness 
at both time points.  
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Figure 6.6 Blood vessel leakiness significantly increased at the pressure site 
four hours after pressure relief 
Mice were intravenously injected with FITC flurophore conjugated with Bovine Serum 
Albumin (FITC-BSA). (A) The panel shows a representative image of tissue that has not 
been subjected to pressure. FITC-BSA (green). (B) The panels show representative images 
of tissue that has been subjected to 1.5 hours of pressure followed by 4 hours of relief. 
Tissue was either treated with Cx43 asODN or left untreated. (C) Total leakiness of blood 
vessels was quantified. Blood vessel leakiness significantly increased at the pressure site in 
comparison to distal tissue. Application of Cx43 asODN at the wound site significantly 
reduced the extent of leakiness. Statistical comparisons were made using a one-way 
analysis of variance (ANOVA). The data are shown as the means ± S.E.M. (n=5, *p<0.05, 
**p<0.01). Scale bar = 20 µm. PS = Pressure site, AT = Adjacent tissue, DT = Distal tissue, 
NT = Non treated, T = Treated. 
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Figure 6.7 Blood vessel leakiness further increased at and beyond the 
pressure site twenty four hours after pressure relief 
Mice were intravenously injected with FITC flurophore conjugated with Bovine Serum 
Albumin (FITC-BSA). (A) The panel shows a representative image of tissue that has not 
been subjected to pressure. FITC-BSA (green). (B) The panels show representative images 
of tissue that have been subjected to 1.5 hours of pressure followed by relief for 24 hours. 
Tissue was either treated with Cx43 asODN or left untreated. (C) Total leakiness of the 
tissue was quantified. Blood vessel leakiness significantly increased at the pressure site and 
in surrounding tissue. Application of Cx43 asODN at the wound site significantly reduced the 
extent of leakiness. . Statistical comparisons were made using a one-way analysis of 
variance (ANOVA). Data was tested for normality (Sharpiro-Wilk test) and equal variances 
(Levene test) before statistical comparisons were carried out. The data are shown as the 
means ± S.E.M. (n=5, *p<0.05). Scale bar = 20 µm. PS = Pressure site, AT = Adjacent 
tissue, DT = Distal tissue, NT = Non treated, T = Treated. 
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Leukocyte count significantly increased at the pressure site.  
The inflammatory response was assessed four and twenty four hours after pressure 
relief. Tissue was observed in three key sites; the pressure site, adjacent to the 
pressure site and in distal tissue. Polymorphonuclear neutrophil leukocytes were 
identified through high powered imaging of the tissue and leukocyte count per 1000 
µm2 was quantified. Leukocyte numbers were significantly greater at the pressure 
site in comparison to distal tissue four and twenty four hours after pressure relief 
(figure 6.8 and 6.9) and markedly increased in tissue adjacent to the tissue site in 
comparison to distal tissue twenty four hours after pressure relief (figure 6.9).  
Application of Cx43 asODN at the wound site significantly reduced leukocyte 
numbers at both time points. 
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Figure 6.8 The number of leukocytes significantly increased at the pressure 
site, four hours after pressure relief 
(A) The panel shows a representative histological image of tissue that has not been 
subjected to pressure. (B) The panels show representative histological images of tissue that 
has been subjected to 1.5 hours of pressure followed by relief for 4 hours. Tissue was either 
treated with Cx43 asODN or placebo delivery gel only. (C) Leukocyte count per 1000 µm² 
was quantified. Leukocyte neutrophils were identified by their multi-lobed nuclei (black 
arrow). Leukocyte numbers were significantly greater at the pressure site. Application of 
Cx43 asODN at the wound site significantly reduced the leukocyte number. Statistical 
comparisons were made using a one-way analysis of variance (ANOVA). The data are 
shown as the means ± S.E.M. (n=5, *p<0.05). Scale bar = 100 µm. PS = Pressure site, AT = 
Adjacent tissue, DT = Distal tissue. 
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Figure 6.9 The number of leukocytes significantly increased at the pressure 
site, twenty-four hours after pressure relief 
(A) The panel shows a representative histological image of tissue that has not been 
subjected to pressure. (B) The panels show representative histological images of tissue that 
have been subjected to 1.5 hours of pressure followed by relief for 24 hours. Tissue was 
either treated with Cx43 asODN or placebo delivery gel only. (C) Leukocyte count per 1000 
µm² was quantified. Leukocyte neutrophils were identified by their multi-lobed nuclei (black 
arrows). Leukocyte numbers were significantly greater at the pressure site and in the 
surrounding tissue. Application of Cx43 asODN to the pressure site significantly reduced the 
leukocyte number. Statistical comparisons were made using a one-way analysis of variance 
(ANOVA). The data are shown as the means ± S.E.M. (n=5, **p<0.01). Scale bar = 100 µm. 
PS = Pressure site, AT = Adjacent tissue, DT = Distal tissue. 
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6.3 Discussion 
Replicating pressure ulcers 
In this research chapter an in vivo ischemic reperfusion model was used to recreate 
an early stage pressure ulcer. Ischemia was executed for 1.5 hours whereas 
reperfusion was implemented for 4 or 24 hours. Initial observations confirmed 
damage to the skin 24 hours after reperfusion in comparison to non-pressured skin 
(figure 6.1). This was noted as tissue breakdown and an increase in inflammatory 
cells within the tissue. Similar observations were made by Peirce and colleagues 
who used a comparable pressure ulcer model on rat skin (Peirce et al., 2000). Not 
only was tissue injury reported in skin subjected to one cycle of ischemia 
reperfusion, but rats subjected to multiple or prolonged ischemia reperfusion cycles 
had progressively more tissue damage. Parallel studies have also reported that 
repeated cycles of ischemia reperfusion injury can cause a significant increase in 
skin damage in mouse (Reid et al., 2004) and rat (Jiang et al., 2011) skin.  
Connexins in ischemia reperfusion 
The data presented in this chapter reported that after just four hours of ischemia 
relief, Cx43 expression significantly increased in the sub-epidermal dermis at the 
pressure site in comparison to control distal tissue (figure 6.2 A and Cii). Within 
twenty fours of ischemia relief, Cx43 expression had significantly increased 
throughout the entire dermal layer at the pressure site in comparison to distal tissue 
(figure 6.3 A, B, Cii and D).  An increase in Cx43 expression has also been noted in 
models of myocardial ischemia (Hatanaka et al., 2004) and focal ischemic stroke 
(Haupt et al., 2007). Nakase and colleagues also reported an increase in Cx43 
expression in tissue samples from humans who had suffered from fatal strokes 
(Nakase et al., 2006)  whereas Danesh-Mayer and colleagues additionally reported 
an increase in Cx43 in astrocytes and vascular endothelial cells in a rat model of 
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retinal ischemia (Danesh-Meyer et al., 2012). They also noted that this increase 
correlated with an increase in retinal ganglion cell death. 
For many years it is has been theorised that physical interaction between cells is an 
important factor in the progression of tissue necrosis during ischemia reperfusion 
models (Ganote and Humphrey, 1985, García-Dorado et al., 1989). Rawanduzy 
noted that the extent of ischemic injury often does not occur immediately after 
arterial occlusion but that infarction expands over time in a step wise manner 
(Rawanduzy et al., 1997). This could explain the spread of Cx43 expression 
progressing across the dermal tissue within the pressure site, 24 hours after 
pressure relief. This increase in Cx43 expression also correlated with an increase in 
observed tissue damage (figure 6.1). An interesting observation made in the data 
presented in this research chapter was that after an initial increase in connexin 
hemichannel expression throughout the dermal layer four hours after pressure relief 
(figure 6.4A, B, Cii and D); there was no significant observed increase in connexin 
hemichannel expression twenty four later (figure 6.5B and C). This follows a similar 
pattern observed and reported in the previous research chapter where gap junction 
communication was far more detrimental in the spread of cell death than 
hemichannel based communication and suggests a more involved role for Cx43 gap 
junction based communication during the spread of tissue damage after pressure 
relief in this murine model of pressure ulcers.  
Treatment with Cx43 asODN markedly reduced the extent of damage observed 
twenty four after ischemia relief.  Comparable results have been reported in cardiac 
models of ischemic reperfusion (Mao et al., 2005, Mao et al., 2009) and in rodent 
stroke models (Rawanduzy et al., 1997) where reducing gap junction based 
communication using aliphatic alcohols significantly reduced the extent of infarct 
size. Treating hippocampal brain slices that underwent oxygen glucose deprivation, 
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with carbenoxolone also significantly reduced gap coupling and neuronal cell death 
(de Pina-Benabou et al., 2005). In the model of rat retinal ischemia reperfusion 
injury, treatment with connexin mimetic peptide ‘Peptide 5’ also significantly reduced 
retinal ganglion cell death (Danesh-Meyer et al., 2012).  
Throughout this thesis, the importance of Cx43 based communication during the 
wound healing process has been heavily discussed and it has been shown that by 
transiently reducing Cx43 expression in acute (Qiu et al., 2003, Mori et al., 2006) 
and chronic wounds (Wang et al., 2007) enhances the rate of wound closure in 
rodent models of wound healing. Coutinho and colleagues have also investigated 
the spread of cell death in burn injuries and its link with Cx43 expression (Coutinho 
et al., 2005). Burns create a lot of internal damage and this injury can spread to 
neighbouring cells. They reported a significant increase in Cx43 two to four days 
after the initial thermal injury and treatment with Cx43 asODN significantly reduced 
this expression and limited the spread of thermal damage. Treatment with Cx43 
asODN significantly improved the wound appearance and the rate of wound closure. 
Reducing Cx43 also significantly reduced the number of leukocytes within the 
damaged tissue.  
The inflammatory response during skin ischemia reperfusion 
Data presented in this research chapter noted that ischemia reperfusion injury within 
the skin had a profound effect on the immune system. FITC-BSA was used to 
ascertain the extent of blood vessel leakiness at the pressure site and in 
surrounding tissue. It was reported that leakiness significantly increased at the 
ischemic reperfusion site four hours after ischemia relief (figure 6.6) and that 
leakiness continued to spread to adjacent tissue twenty four hours later (figure 6.7). 
Treatment with Cx43 asODN significantly reduced the extent of blood vessel 
leakiness at both time points (figures 6.6 and 6.7). Again, a comparable report was 
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made in the retinal ischemia reperfusion model where treatment with Peptide 5 
significantly reduced blood vessel leakiness in retinal tissue (Danesh-Meyer et al., 
2012).  
FITC-BSA blood vessel leakiness studies are often used to investigate vascular 
permeability events such as extravasation. This inflammatory response process 
involves the recruitment of circulating leukocytes to actively leak from blood vessels, 
through the vascular endothelium, into the wound site. Here it is reported that 
ischemic reperfusion injury in mouse skin significantly increased the number of 
leukocytes in the injured tissue four hours after pressure relief (figure 6.8) and that 
leukocyte count was further significantly increased in both pressure site tissue and 
adjacent tissue twenty four hours later (figure 6.9). Increased leukocyte infiltration 
has also been observed in other models of skin pressure ulcers using magnet 
compression (Reid et al., 2004, Jiang et al., 2011). Once again, treatment with Cx43 
significantly reduced the extent of leukocyte infiltration (figures 6.8 and 6.9).  Early 
application of Cx43 asODN to acute wounds also dampens down the inflammatory 
response, eventually leading to earlier wound closure (Qiu et al., 2003, Mori et al., 
2006). 
Connexin mimetic peptides as therapeutics in pressure ulcers  
Connexin mimetic peptides have already been employed in reducing the extent of 
tissue damage in cardiac (Hawat et al., 2010, Hawat et al., 2012) and neuronal 
(Davidson et al., 2012b, Davidson et al., 2012a, Davidson et al., 2013) models of 
ischemia reperfusion. However, in both research groups, low concentrations of 
connexin mimetic peptides were used to successfully reduce infarct size by blocking 
open hemichannels. Although infarct size did not reduce beyond 60%, clearly 
leaving some room for improvement. Recent work by Wang and colleagues has  
shown successful blocking of open hemichannels in both in vitro and in vivo models 
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of ischemia reperfusion through treatment with a nonapeptide Gap19 (Wang et al., 
2013a). By mimetically binding to the cytoplasmic loop of Cx43, Gap19 prevents 
intramolecular CT-CL interactions and thereby inhibits hemichannels. In their 
cardiac in vivo model of ischemia reperfusion, infarct size reduced to 51.2%, 
compared to 63.8% in vehicle-treated control animals; a reduction of only 
approximately one-fifth. Surely by increasing the concentration of connexin mimetic 
peptide in these models would further reduce the extent of cell and tissue damage 
during ischemia reperfusion. However, this is not the case in cardiac and neuronal 
tissue as disrupting gap junction communication can disrupt key electrical cell-cell 
interactions. Indeed, in studies carried out by Davidson and colleagues, higher 
concentrations of Peptide 5 caused a greater secondary increase in brain cell 
swelling and mortality in foetal sheep subjected to carotid artery ischemia 
reperfusion (Davidson et al., 2012a). Studies using Cx43 knockout mice in models 
of neuronal ischemia reperfusion have also shown greater brain injury during this 
tissue stress (Nakase et al., 2004). However, no such electrical coupling is required 
for tissue viability in the skin; therefore high concentrations of Gap27 during 
ischemic reperfusion damage could successfully reduce the extent of injury. 
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As in vivo peptide investigation is still in the preliminary stages, there was some 
uncertainty as to the concentration of Gap27 treatment to use in the model of 
pressure ulcers. Therefore, the decision was made to employ Cx43 asODN in the 
initial study to completely reduce Cx43 based communication in the pressure ulcer 
model. The results reported here suggest that Cx43 based gap junction 
communication is responsible for the spread of tissue damage during ischemia 
reperfusion in the skin, therefore a high concentrations of Gap27 if most likely 
needed to have the same therapeutic effects.  
Conclusions 
 Ischemia reperfusion injury in the backs of mice correlated with an 
increase in Cx43 expression and connexin hemichannel expression. 
 Blood vessel leakiness and leukocyte count significantly increased at the 
pressure site. 
 Treatment with Cx43 asODN significantly reduced Cx43 and connexin 
hemichannel expression with correlated with a decrease in the extent to 
tissue damage and a reduced inflammatory response. 
 
 
Chapter 7 General discussion 
230 
 
7. General discussion 
The skin is the largest organ in the body and can regenerate effectively, even after 
considerable damage has occurred. Having roles as a defensive barrier between the 
body and the external world its long term integrity is essential and therefore a 
thorough understanding of the processes involved in its repair is extremely 
important. Wound healing occurs through an overlying sequence of events that can 
roughly be divided into three key overlapping stages; the immediate inflammatory 
response, new tissue formation and remodelling (Martin 1997, Gurtner, Wener et al. 
2008). The highly complex sequence of events in skin wound healing relies heavily 
on the communication of signals released during these stages and cell-to-cell 
communication is crucial in order for the tissues to co-ordinate their processes. 
Mounting evidence now supports the theory that gap junctions play a pivotal role in 
the communication of these signals. 
Salomon and colleagues in 1988 described how cells in normal and differentiated 
skin communicate with each other through gap junctions (Salomon, Sauret et al. 
1988). Gap junctions are specialised connections that provide a regulated pathway 
linking the cytoplasms of adjacent cells and allow molecular signals to pass freely 
between the two. Each gap junction is made of two connexons, or hemichannels, 
from opposing cells, which in turn are composed of six protein subunits called 
connexins. To date, 20 connexin genes have been identified in rodents and 21 in 
humans, with at least ten detectable within the skin.  
Three key connexins undergo dynamic changes and play integral roles during the 
wound healing process. Within the first few hours of wound closure, during the 
immediate inflammatory response, Cx43 protein expression is significantly up-
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regulated in blood vessels, yet significantly down-regulated in the leading edge 
tissue. This protein switch-off is accompanied by a significant increase in the 
expression of Cxs 26 and 30 in the leading edge tissue, corresponding to the onset 
of re-epithelialisation of epidermal keratinocytes and the migration of dermal 
fibroblasts. Upon the resolution of the wound, the expression profiles of these 
connexins proteins return to their pre-wound levels (Goliger and Paul 1995, Saitoh, 
Oyamada et al. 1997, Coutinho, Qiu et al. 2003). 
In recent years it has been realised that Cx43 protein dynamics during acute wound 
healing are tightly regulated to ensure successful closure of the wound. Of late, a 
promising therapeutic that could enhance the rate of acute and chronic wound 
healing has emerged as a Cx43 specific antisense oligodeoxynucleotide (Cx43 
asODN) that targets Cx43 mRNA and induces a Cx43 protein knockdown. This 
ODN has proven successful in promoting accelerated wound healing and appears to 
‘jump start’ the subsequent phases of wound closure (Qiu, Couthinho et al. 2003, 
Mori, Power et al. 2006, Wang, Lincoln et al. 2007). When immediately applied to a 
rodent skin wound, Cx43 asODN rapidly reduces Cx43 protein expression in wound 
edge keratinocytes, fibroblasts and blood vessels within two hours of wounding; 
nearly a complete day faster than in un-treated wounds (Qiu, Coutinho et al. 2003, 
Mori, Power et al. 2006). Early application of Cx43 asODN to acute wounds 
dampens tissue swelling and the inflammatory response, promotes early 
keratinocyte and fibroblast cell migration and closes the wound gap earlier than 
wounds left un-treated. Wounds treated with Cx43 asODN appear less red and 
swollen and rapidly reduce in size, resulting in smaller and thinner scar tissue.  
Although it is becoming increasingly certain that Cx43 plays an integral role in 
wound healing, it is still unclear whether these responses are attributed to 
hemichannel or gap junction based communication. Long term hemichannel down-
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regulation can be achieved through the topical application of Cx43 asODN; however 
it was realised that the differences between gap junction communication and 
hemichannel signalling can be teased out by the application of small connexin 
mimetic peptides. Acting on the extracellular loops of connexins, these peptides can 
rapidly block hemichannel communication and prevent gap junction formation. 
However, with longer or more concentrated incubation periods, connexin mimetic 
peptides can inhibit gap junction communication. Additionally, in recent years it has 
been noted that connexin mimetic peptides show a huge potential in tackling 
connexin-based maladies and show promise in translational and therapeutic 
possibilities. These prospects include enhancing the rate of wound repair and 
reducing the spread of damage caused in tissue ischemia reperfusion.  
The general aim of this thesis was to further explore the role and potential 
therapeutic implications of the connexin mimetic peptide Gap27 in both in vitro and 
in vivo models of wound healing while contributing to the characterisation of this 
mimetic peptide. In the first instance, owing to the encouraging work conducted by 
the Martin group that has shown the therapeutic possibilities of Gap27 using in vitro 
and ex vivo wound healing models (Wright, van Steensal et al. 2009, Pollok, Pfeiffer 
et al. 2011), it was hypothesised that application of Gap27 to in vitro and in vivo 
models of wound healing would increase the rate of migration in fibroblast and 
keratinocyte cells and enhance the earlier stages of wound repair. Using functional 
assays of Gap27, data presented in Chapter 3 demonstrated how high 
concentrations of Gap27 reduced communication in fibroblast cells and increased 
the rate of migration in both fibroblast and keratinocyte cells. Further investigations 
in Chapter 4 explored for the first time, using a murine model of wound healing, the 
ability of Gap27 to enhance the rate of wound repair. During the first four hours of 
wounding, a single dose of Gap27 significantly reduced blood vessel leakiness at 
the wound edge and delayed leukocyte infiltration to the wounded tissue observed 
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24 hours later. It was also reported that low concentrations of Gap27 significantly 
increased the rate of re-epithelialisation 24 hours after wounding. It was theorised 
that during wounding, ATP is released through open hemichannels and that 
treatment with a low concentration of Gap27 could reduce this release through 
blocking these open hemichannels. This ultimately enhanced the rate of re-
epithelialisation. It was clear that 24 hours after wounding Gap27 no longer had any 
effect on the rate of wound healing. This was most likely due to peptide degradation.  
A need exists to prolong a release of rapidly metabolised connexin mimetic peptides 
and further investigations are required to find a suitable delivery agent. One such 
agent could be to use osmotic pumps that ensure a continuous delivery of the 
peptide over a defined study period. Subcutaneous implanted osmotic pumps 
delivering Gap27 were used to reduce Cx43 expression in bile-duct ligated livers 
within mice. Gap27 successfully reduced Cx43 expression in the liver, when 
compared to a scrambled peptide control, after two weeks of constant peptide 
delivery (Balasubramaniyan, Dhar et al. 2013). No cardiotoxicity or any other 
adverse effects were noticed, making this delivery system a potential ideal route for 
connexin mimetic peptide treatment. Another delivery agent that is currently being 
considered to supply a controlled delivery of biomaterials and drugs, including 
connexin mimetic peptides, is sodium alginate microcapsules (Moore et al., 2013). 
As discussed previously, recent work conducted by the Becker group has shown by 
inhibiting Cx43 expression during wound repair, the rate of wound healing 
significantly increases (Qiu, Couthinho et al. 2003, Mori, Power et al. 2006, Wang, 
Lincoln et al. 2007). Work presented in Chapter 4 has shown that different 
concentrations of Gap27 can reduce either hemichannel or gap junction based 
communication and this connexin mimetic peptide has proven beneficial in the 
earlier stages of wound healing. Not only were these initial hypothesises confirmed, 
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research presented in Chapters 3 and 4 also shows for the first time that Gap27 
significantly reduced Cx43 expression in fibroblast cells, keratinocyte cells and 
murine tissue. This was confirmed using immunostaining and Western blot analysis. 
In Chapter 3 it was also shown that Gap27 significantly reduced connexin 
hemichannel expression in fibroblast cells although some care must be excised with 
these conclusions. It is possible that the two difference antibodies are staining for 
connexins regardless of their conformation as a hemichannel or gap junction unit. A 
double immunostain of Cx43 and connexin hemichannel should be carried out to 
confirm if Gap27 reduced both connexin hemichannels and Cx43 gap junctions. 
Gap27 also significantly reduced Cx26 and 30 expressions in keratinocyte cells after 
continuous incubation in Gap27. It had previously been thought that connexin 
mimetic peptides primarily interact with undocked hemichannels and at later 
incubation periods, prevent the docking of connexons, thereby reducing 
hemichannels and gap junction based communication respectively (Evans and 
Boitano 2001). Work presented in Chapter 5 initially confirmed that Gap27 could 
block hemichannel communication. To assess hemichannel activity during cell 
stress, PI uptake was observed and measured in low confluence fibroblast cells.  
The stress caused hemichannels to open and increase PI uptake whereas 
incubation in Gap27 significantly reduced PI uptake by plugging open hemichannels. 
Based on the research demonstrated in Chapters 3 and 4 an additional theory was 
proposed to explain how Cx43 and hemichannel expression were reduced in 
fibroblasts, keratinocytes and murine tissue after Gap27 incubation. The theory 
suggests that after Gap27 has bound to the extracellular surface of a connexon (and 
blocked hemichannel activity); an increased rate of internalisation is triggered (figure 
7.1). However, as discussed in detail previously, this theory needs further testing to 
validate its assumptions. One way in which this could be achieved is to use 
fluorescently tagged connexins together with fluorescently tagged mimetic peptides 
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to view in real time the effects of connexin mimetic peptides on connexin turnover. 
The design of the experiments needs to take into consideration the short lifespan of 
a connexin and the degradation rate of connexin mimetic peptides. 
 
Figure 7.1 Increased rate of internalisation theory 
This simplified diagram illustrates the theory that Gap27 increased the rate of internalisation 
of connexins and connexons and thereby reduced gap junction based communication. 
Gap27 primarily binds with the extracellular surface of a connexon and blocks hemichannel 
activity. This early interaction triggers an increased rate of internalisation and thereby 
reduced the amount of connexin or connexon to form functional gap junctions. 
Work presented in Chapters 3 and 4 has nonetheless supported the realisation of 
connexin mimetic peptide’s capability in enhancing the rate of wound repair. The 
next two chapters explored how fibroblast cells and tissue communicated during 
ischemic reperfusion stress. Due to the growing evidence that marks Cx43 as a key 
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contributor to the spread of cell death in cardiac and cerebral ischemic stress, it was 
hypothesised that Cx43 would also be responsible in the propagation of cell injury 
and death in ischemic reperfusion injury in the skin. 
Tissue ischemia injury is a major medical problem that plagues a number of organs 
and is caused by a restriction of blood supply to the tissue, causing severe shortage 
of oxygen, glucose and other nutrients needed for survival. Tissue ischemia is 
common in cardiac, cerebral and skin tissue; however most of the damage occurs 
upon reperfusion. This is when the blood supply returns in a restoration of circulation 
and causes inflammation and oxidative damage to the tissue that has been denied 
oxygen flow for a period of time. Often this damage spread beyond the initial 
ischemia area.  
Gap junction mediated tissue ischemia reperfusion injury has been identified in a 
number of organs including cardiac tissue during heart attacks (García-Dorado, 
Rodríguez-Sinovas et al. 2004) and cerebral tissue during strokes (Frantseva, 
Kokarovtseva et al. 2002, Frantseva, Kokarovtseva et al. 2002). Repeated ischemia 
reperfusion injury in the skin during pressure ulcer formation, can also cause severe 
tissue damage similar to the damage formed in cerebral and cardiac ischemia 
reperfusion. Despite the growing evidence that marks connexin based 
communication as a key contributor to the spread of cell death in neighbouring cells 
after an ischemic reperfusion insult, the mechanisms behind this spread of damage 
are still unclear. The “bystander effect” model suggests that death signals can 
spread laterally through gap junctions from dying cells into their healthy 
neighbouring cells (Mao, Chen et al. 2009, Danesh-Meyer, Kerr et al. 2012, Zhang, 
Li et al. 2013). However, some reports attribute cell death in ischemia reperfusion 
models to the opening of undocked gap junctions, release of ATP and activation of 
purinergic receptors that result in cell death (Thompson, Zhou et al. 2006, Clarke, 
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Williams et al. 2009, Orellana, Hernández et al. 2010, Poornima, Madhupriya et al. 
2012). Understanding how cell death occurs and spreads will help in the 
development of a therapeutic to reduce spread of damage and the impact of 
ischemia reperfusion injury.  
Using an in vitro model of ischemia reperfusion injury (oxygen glucose deprivation 
reoxygenation; OGDR) research in Chapter 5 explored how dying fibroblast cells 
communicated during an ischemic reperfusion stress. In a novel observation it was 
observed that OGDR stress significantly decreased cell viability in correlation with 
an increase in Cx43, phosphorylated Cx43 isoforms and connexin hemichannel 
expression. Reducing Cx43 expression in Cx43 shRNA transduced fibroblast cells 
prevented the reduction in cell viability; thereby contributing to the theory that Cx43 
based communication is heavily involved in spreading cell death signals during this 
model of in vitro ischemic reperfusion stress.  Further investigations into the 
communication mechanisms behind OGDR influenced cell death revealed that 
although ATP may be released through open hemichannels during this insult, it is 
not enough to promote cell death. However, communication between neighbouring 
cells propagated a cell death signal that is blocked by reducing Cx43 or inhibiting 
gap junction based communication using Gap27. 
Building upon this work, Chapter 6 further investigated the role of Cx43 and 
hemichannels in a murine model of pressure ulcers. This type of chronic wound can 
be caused by either prolonged or repeated incidences of ischemia reperfusion in the 
skin.  They are often found on bony prominences on elderly or bed ridden patients. 
Recent research has identified gap junction mediated ischemia reperfusion injury in 
the cardiac (García-Dorado, Rodríguez-Sinovas et al. 2004) and cerebral tissue 
Frantseva, Kokarovtseva et al. 2002, Frantseva, Kokarovtseva et al. 2002) however, 
until now, there has been no investigations into the role of gap junction based 
Chapter 7 General discussion 
238 
 
communication in the pressure ulcer. In this chapter it was reported that ischemia 
reperfusion injury on the back of mice associated with an increase in Cx43 
expression and an elevated inflammatory response. Treatment with Cx43 asODN 
significantly reduced Cx43 expression (and thereby Cx43 based communication), 
decreased the extent of tissue damage and dampened down the inflammatory 
response.  
Conclusions 
The potential therapeutic implications of the wound healing properties of connexin 
mimetic peptides are exciting, novel and promising. Work presented in this thesis 
has further explored the roles and therapeutic properties of the connexin mimetic 
peptide Gap27 in both in vitro and in vivo models of wound healing. In a novel 
discovery, it was reported here that Gap27 reduced Cxs 43, 26 and 30 and connexin 
hemichannel expressions. Gap27 also increased the rate of wound healing in the 
early stages of wound closure. With further investigations to find a suitable delivery 
agent that could prolong the effects of Gap27, there is huge potential for this 
mimetic peptide to become a major therapeutic competitor in connexin based 
maladies and wound repair.  
Research presented in the final results chapters of this thesis illustrate how Cx43 is 
associated with spreading cell death and damage as shown using an in vitro model 
of ischemia reperfusion. In a novel discovery, it was also reported how Cx43 
propagates cell injury and death shown using an in vivo model of ischemia 
reperfusion on mouse skin. This compelling research builds upon the expanding 
mountain of evidence that gap junctions, hemichannels and connexins play an 
integral role in tissue injury and repair. 
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Appendix I 
Abbreviations 
3D 3 dimensional 
°C degrees Celsius 
µg microgram 
µl microlitre 
µm micrometer 
µM micromole 
α alpha 
α-SMA smooth muscle actin 
ADP adenosine diphosphate 
ANOVA one way analysis of variance 
asODN antisense oligodeoxynucleotide 
ATP adenosine triphosphate 
ADP adenosine diphosphate 
β beta 
BBG brilliant blue G 
bFGF basic fibroblast growth factor 
bn billion 
BSA Bovine serum albumin 
Ca2+ Calcium ion 
calcein-AM calcein acetomethoxy ester 
cAMP cyclic adenosine monophosphate 
CL cytoplasmic loop 
CO2 Carbon dioxide 
CT carboxyl terminus 
Cx connexin 
dH2O deionised water 
Da Daltons 
DAMP damage associated molecular pattern molecule 
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DBS donor bovine serum 
DENDRA Derived from Dendronephthya sp. 
DMEM Dulbecco's modified essential medium 
DNA deoxyribonucleic acid  
EL extracellular loop 
ECL enhanced chemiluminescence 
ER endoplasmic reticulum 
EtOH Ethanol 
EPUAP European Pressure Ulcer Advisory Panel 
EVK erythrokeratodermia variabilis 
FACS fluorescence-activated cell sorting 
FDA Food and Drug Administration 
FGF fibroblast growth factor 
FGF-2 fibroblast growth factor 2 
FITC-BSA fluorescein isothiocyanate conjugated to Bovine serum albumin 
FOXY fibre optic oxygen  
FlAsH Fluorescein Arsenical Hairpin 
FRAP fluorescence recovery after photobleaching 
g grams 
GFP green fluorescent protein 
GJB1 gene coding for Cx32 
GJB2 gene coding for Cx26 
GJB3 gene coding for Cx31 
gt goat 
h hour 
HaCaT Human adult low Calcium Temperature keratinocytes 
HSC haematopoietic stem cell 
hc hemichannel 
HeLa Henrietta Lacks cells 
HCl Hydrochloric acid 
HID Hystrix-like Ichthyosis deafness 
HRP horseradish peroxidase 
HSC haematopoietic stem cell 
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HUVECs human umbilical vein endothelial cells 
ICR Institute of Cancer Research 
IL interleukin  
IP3 inositol triphosphate 
JNK jun N-terminal kinase 
K+ Potassium ion 
KID keratitis ichthyosis deafness 
l litre 
LED light emitting diode 
m meter 
M Mole 
M  transmembrane loop 
MANOVA multivariate analysis of variance 
MAPK  mitogen activated protein kinases 
MSC mesenchymal stem cell 
mg milligram 
min minute 
ml millilitre 
mm millimetre 
mM millimole 
MMP matrix metalloproteinase 
mRNA messenger ribonucleic acid 
MSC mesenchymal stem cell 
MTT 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide 
MW molecular weight 
n sample number 
N2 Nitrogen 
NaCl Sodium Chloride 
NAD nicotinamide adenine dinucleotide 
NHS National Health Service 
NIH 3T3 fibroblasts 
NT amino terminus 
OCT optimal cutting temperature 
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OGDR oxygen glucose deprivation reoxygenation 
OptiMEM opti-minimal essential medium 
PBS phosphate buffered saline 
PFA paraformaldehyde 
pH power of Hydrogen 
PI propidium iodide 
rb rabbit 
ReAsH Resorufin-derived red fluorescent Arsenical Hairpin 
RIPA radio-immunoprecipitation assay 
RNA ribonucleic acid 
ROI region of interest  
RT-PCR reverse transcription polymerase chain reaction 
SAPK stress activated protein kinase 
SDS sodium dodecyl sulphate 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEM standard error from the mean 
shRNA short hairpin ribonucleic acid 
STZ streptozotocin 
TGF-β transforming growth factor beta 
U units 
UV ultraviolet 
V Volts 
VEGF vascular endothelial growth factor 
vWF von Willebrand factor 
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Appendix II 
Supplementary figures 
 
Supplementary 1 - Immunofluorescence staining of Cx43 
Panels are representative of staining and second antibody control staining of Cx43 in NIH 3T3 
fibroblast cells, HaCaT keratinocyte cells and murine epidermal and upper dermal tissue. Tissue was 
immunolabeled Cx43 (green) and nuclei (blue).7 
 265 
 
 
Supplementary 2 - Immunofluorescence staining of hemichannels  
Panels are representative of staining and second antibody control staining of HC in NIH 3T3 fibroblast 
cells, and murine epidermal and upper dermal tissue. Tissue was immunolabeled HC (green) and 
nuclei (blue). 
 
Supplementary 3 - Immunofluorescence staining of Cx26 
Panels are representative of staining and second antibody control staining of Cx26 in HaCaT 
keratinocyte cells, and murine epidermal and upper dermal tissue. Tissue was immunolabeled Cx26 
(green) and nuclei (blue). 
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Supplementary 4 - Immunofluorescence staining of Cx30 
Panels are representative of staining and second antibody control staining of Cx30 in HaCaT 
keratinocyte cells, and murine epidermal and upper dermal tissue. Tissue was immunolabeled Cx30 
(green) and nuclei (blue). 
 
Supplementary 5 - Effect of scrambled peptide on Cx43 expression in 
fibroblast cells; Western blot analysis 
(A) Cx43 protein expression in fibroblast cells during incubation with scrambled peptide with Gap27 
was confirmed through Western blot analysis. The panels show representative blots. Alpha tubulin 
serves as a loading control protein. (B) The intensity of the protein was measured relative to the 
intensity of the housekeeping protein. The graph shows no difference in Cx43 protein expression 
between control and treated samples. The data are shown as the means ± S.E.M. NT = No treatment, 
SP = Scrambled peptide. 
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